id	sid	tid	token	lemma	pos
ajlm-2756	1	1	abstract	abstract	ADJ
ajlm-2756	1	2	introduction	introduction	NOUN
ajlm-2756	1	3	methods	method	NOUN
ajlm-2756	1	4	results	result	VERB
ajlm-2756	1	5	discussion	discussion	NOUN
ajlm-2756	1	6	conclusion	conclusion	NOUN
ajlm-2756	1	7	acknowledgements	acknowledgement	NOUN
ajlm-2756	1	8	references	reference	NOUN
ajlm-2756	1	9	about	about	ADP
ajlm-2756	1	10	the	the	DET
ajlm-2756	1	11	author(s	author(s	NOUN
ajlm-2756	1	12	)	)	PUNCT
ajlm-2756	1	13	lungile	lungile	PROPN
ajlm-2756	1	14	ndlovu	ndlovu	PROPN
ajlm-2756	1	15	department	department	PROPN
ajlm-2756	1	16	of	of	ADP
ajlm-2756	1	17	biomedical	biomedical	ADJ
ajlm-2756	1	18	science	science	NOUN
ajlm-2756	1	19	,	,	PUNCT
ajlm-2756	1	20	faculty	faculty	NOUN
ajlm-2756	1	21	of	of	ADP
ajlm-2756	1	22	applied	apply	VERB
ajlm-2756	1	23	and	and	CCONJ
ajlm-2756	1	24	health	health	NOUN
ajlm-2756	1	25	sciences	science	NOUN
ajlm-2756	1	26	,	,	PUNCT
ajlm-2756	1	27	mangosuthu	mangosuthu	NOUN
ajlm-2756	1	28	university	university	NOUN
ajlm-2756	1	29	of	of	ADP
ajlm-2756	1	30	technology	technology	NOUN
ajlm-2756	1	31	,	,	PUNCT
ajlm-2756	1	32	durban	durban	PROPN
ajlm-2756	1	33	,	,	PUNCT
ajlm-2756	1	34	south	south	PROPN
ajlm-2756	1	35	africa	africa	PROPN
ajlm-2756	1	36	nokukhanya	nokukhanya	PROPN
ajlm-2756	1	37	thembane	thembane	PROPN
ajlm-2756	1	38	department	department	PROPN
ajlm-2756	1	39	of	of	ADP
ajlm-2756	1	40	biomedical	biomedical	ADJ
ajlm-2756	1	41	science	science	NOUN
ajlm-2756	1	42	,	,	PUNCT
ajlm-2756	1	43	faculty	faculty	NOUN
ajlm-2756	1	44	of	of	ADP
ajlm-2756	1	45	applied	apply	VERB
ajlm-2756	1	46	and	and	CCONJ
ajlm-2756	1	47	health	health	NOUN
ajlm-2756	1	48	sciences	science	NOUN
ajlm-2756	1	49	,	,	PUNCT
ajlm-2756	1	50	mangosuthu	mangosuthu	NOUN
ajlm-2756	1	51	university	university	NOUN
ajlm-2756	1	52	of	of	ADP
ajlm-2756	1	53	technology	technology	NOUN
ajlm-2756	1	54	,	,	PUNCT
ajlm-2756	1	55	durban	durban	PROPN
ajlm-2756	1	56	,	,	PUNCT
ajlm-2756	1	57	south	south	PROPN
ajlm-2756	1	58	africa	africa	PROPN
ajlm-2756	1	59	ziningi	ziningi	PROPN
ajlm-2756	1	60	n.	n.	PROPN
ajlm-2756	1	61	jaya	jaya	PROPN
ajlm-2756	1	62	department	department	PROPN
ajlm-2756	1	63	of	of	ADP
ajlm-2756	1	64	biomedical	biomedical	ADJ
ajlm-2756	1	65	science	science	NOUN
ajlm-2756	1	66	,	,	PUNCT
ajlm-2756	1	67	faculty	faculty	NOUN
ajlm-2756	1	68	of	of	ADP
ajlm-2756	1	69	applied	apply	VERB
ajlm-2756	1	70	and	and	CCONJ
ajlm-2756	1	71	health	health	NOUN
ajlm-2756	1	72	sciences	science	NOUN
ajlm-2756	1	73	,	,	PUNCT
ajlm-2756	1	74	mangosuthu	mangosuthu	NOUN
ajlm-2756	1	75	university	university	NOUN
ajlm-2756	1	76	of	of	ADP
ajlm-2756	1	77	technology	technology	NOUN
ajlm-2756	1	78	,	,	PUNCT
ajlm-2756	1	79	durban	durban	PROPN
ajlm-2756	1	80	,	,	PUNCT
ajlm-2756	1	81	south	south	PROPN
ajlm-2756	1	82	africa	africa	PROPN
ajlm-2756	1	83	citation	citation	PROPN
ajlm-2756	1	84	ndlovu	ndlovu	PROPN
ajlm-2756	1	85	l	l	PROPN
ajlm-2756	1	86	,	,	PUNCT
ajlm-2756	1	87	thembane	thembane	PROPN
ajlm-2756	1	88	n	n	CCONJ
ajlm-2756	1	89	,	,	PUNCT
ajlm-2756	1	90	jaya	jaya	PROPN
ajlm-2756	1	91	zn	zn	AUX
ajlm-2756	1	92	.	.	PUNCT
ajlm-2756	1	93	comparative	comparative	ADJ
ajlm-2756	1	94	analysis	analysis	NOUN
ajlm-2756	1	95	of	of	ADP
ajlm-2756	1	96	inflammatory	inflammatory	ADJ
ajlm-2756	1	97	markers	marker	NOUN
ajlm-2756	1	98	in	in	ADP
ajlm-2756	1	99	hiv	hiv	PROPN
ajlm-2756	1	100	-	-	PUNCT
ajlm-2756	1	101	positive	positive	ADJ
ajlm-2756	1	102	individuals	individual	NOUN
ajlm-2756	1	103	on	on	ADP
ajlm-2756	1	104	antiretroviral	antiretroviral	ADJ
ajlm-2756	1	105	therapy	therapy	NOUN
ajlm-2756	1	106	versus	versus	ADP
ajlm-2756	1	107	hiv	hiv	PROPN
ajlm-2756	1	108	-	-	PUNCT
ajlm-2756	1	109	negative	negative	ADJ
ajlm-2756	1	110	individuals	individual	NOUN
ajlm-2756	1	111	in	in	ADP
ajlm-2756	1	112	south	south	PROPN
ajlm-2756	1	113	africa	africa	PROPN
ajlm-2756	1	114	.	.	PUNCT
ajlm-2756	2	1	afr	afr	PROPN
ajlm-2756	2	2	j	j	PROPN
ajlm-2756	2	3	lab	lab	PROPN
ajlm-2756	2	4	med	med	PROPN
ajlm-2756	2	5	.	.	PUNCT
ajlm-2756	3	1	2025;14(1	2025;14(1	NUM
ajlm-2756	3	2	)	)	PUNCT
ajlm-2756	3	3	,	,	PUNCT
ajlm-2756	3	4	a2756	a2756	PROPN
ajlm-2756	3	5	.	.	PUNCT
ajlm-2756	3	6	https://doi.org/10.4102/ajlm.v14i1.2756	https://doi.org/10.4102/ajlm.v14i1.2756	ADP
ajlm-2756	3	7	original	original	ADJ
ajlm-2756	3	8	research	research	NOUN
ajlm-2756	3	9	comparative	comparative	ADJ
ajlm-2756	3	10	analysis	analysis	NOUN
ajlm-2756	3	11	of	of	ADP
ajlm-2756	3	12	inflammatory	inflammatory	ADJ
ajlm-2756	3	13	markers	marker	NOUN
ajlm-2756	3	14	in	in	ADP
ajlm-2756	3	15	hiv	hiv	PROPN
ajlm-2756	3	16	-	-	PUNCT
ajlm-2756	3	17	positive	positive	ADJ
ajlm-2756	3	18	individuals	individual	NOUN
ajlm-2756	3	19	on	on	ADP
ajlm-2756	3	20	antiretroviral	antiretroviral	ADJ
ajlm-2756	3	21	therapy	therapy	NOUN
ajlm-2756	3	22	versus	versus	ADP
ajlm-2756	3	23	hiv	hiv	PROPN
ajlm-2756	3	24	-	-	PUNCT
ajlm-2756	3	25	negative	negative	ADJ
ajlm-2756	3	26	individuals	individual	NOUN
ajlm-2756	3	27	in	in	ADP
ajlm-2756	3	28	south	south	PROPN
ajlm-2756	3	29	africa	africa	PROPN
ajlm-2756	3	30	lungile	lungile	PROPN
ajlm-2756	3	31	ndlovu	ndlovu	PROPN
ajlm-2756	3	32	,	,	PUNCT
ajlm-2756	3	33	nokukhanya	nokukhanya	PROPN
ajlm-2756	3	34	thembane	thembane	PROPN
ajlm-2756	3	35	,	,	PUNCT
ajlm-2756	3	36	ziningi	ziningi	PROPN
ajlm-2756	3	37	n.	n.	PROPN
ajlm-2756	3	38	jaya	jaya	PROPN
ajlm-2756	3	39	received	receive	VERB
ajlm-2756	3	40	:	:	PUNCT
ajlm-2756	3	41	10	10	NUM
ajlm-2756	3	42	jan	jan	PROPN
ajlm-2756	3	43	.	.	PROPN
ajlm-2756	3	44	2025	2025	NUM
ajlm-2756	3	45	;	;	PUNCT
ajlm-2756	3	46	accepted	accept	VERB
ajlm-2756	3	47	:	:	PUNCT
ajlm-2756	3	48	31	31	NUM
ajlm-2756	3	49	july	july	PROPN
ajlm-2756	3	50	2025	2025	NUM
ajlm-2756	3	51	;	;	PUNCT
ajlm-2756	3	52	published	publish	VERB
ajlm-2756	3	53	:	:	PUNCT
ajlm-2756	3	54	26	26	NUM
ajlm-2756	3	55	jan	jan	PROPN
ajlm-2756	3	56	.	.	PROPN
ajlm-2756	3	57	2025	2025	NUM
ajlm-2756	3	58	copyright	copyright	NOUN
ajlm-2756	3	59	:	:	PUNCT
ajlm-2756	3	60	©	©	PROPN
ajlm-2756	3	61	2025	2025	NUM
ajlm-2756	3	62	.	.	PUNCT
ajlm-2756	4	1	the	the	DET
ajlm-2756	4	2	author(s	author(s	PROPN
ajlm-2756	4	3	)	)	PUNCT
ajlm-2756	4	4	.	.	PUNCT
ajlm-2756	5	1	licensee	licensee	NOUN
ajlm-2756	5	2	:	:	PUNCT
ajlm-2756	5	3	aosis	aosis	NOUN
ajlm-2756	5	4	.	.	PUNCT
ajlm-2756	6	1	this	this	PRON
ajlm-2756	6	2	is	be	AUX
ajlm-2756	6	3	an	an	DET
ajlm-2756	6	4	open	open	ADJ
ajlm-2756	6	5	access	access	NOUN
ajlm-2756	6	6	article	article	NOUN
ajlm-2756	6	7	distributed	distribute	VERB
ajlm-2756	6	8	under	under	ADP
ajlm-2756	6	9	the	the	DET
ajlm-2756	6	10	terms	term	NOUN
ajlm-2756	6	11	of	of	ADP
ajlm-2756	6	12	the	the	DET
ajlm-2756	6	13	creative	creative	ADJ
ajlm-2756	6	14	commons	common	NOUN
ajlm-2756	6	15	attribution	attribution	NOUN
ajlm-2756	6	16	license	license	NOUN
ajlm-2756	6	17	,	,	PUNCT
ajlm-2756	6	18	which	which	PRON
ajlm-2756	6	19	permits	permit	VERB
ajlm-2756	6	20	unrestricted	unrestricted	ADJ
ajlm-2756	6	21	use	use	NOUN
ajlm-2756	6	22	,	,	PUNCT
ajlm-2756	6	23	distribution	distribution	NOUN
ajlm-2756	6	24	,	,	PUNCT
ajlm-2756	6	25	and	and	CCONJ
ajlm-2756	6	26	reproduction	reproduction	NOUN
ajlm-2756	6	27	in	in	ADP
ajlm-2756	6	28	any	any	DET
ajlm-2756	6	29	medium	medium	NOUN
ajlm-2756	6	30	,	,	PUNCT
ajlm-2756	6	31	provided	provide	VERB
ajlm-2756	6	32	the	the	DET
ajlm-2756	6	33	original	original	ADJ
ajlm-2756	6	34	work	work	NOUN
ajlm-2756	6	35	is	be	AUX
ajlm-2756	6	36	properly	properly	ADV
ajlm-2756	6	37	cited	cite	VERB
ajlm-2756	6	38	.	.	PUNCT
ajlm-2756	7	1	abstract	abstract	ADJ
ajlm-2756	7	2	background	background	NOUN
ajlm-2756	7	3	:	:	PUNCT
ajlm-2756	7	4	hiv	hiv	PROPN
ajlm-2756	7	5	is	be	AUX
ajlm-2756	7	6	associated	associate	VERB
ajlm-2756	7	7	with	with	ADP
ajlm-2756	7	8	chronic	chronic	ADJ
ajlm-2756	7	9	inflammation	inflammation	NOUN
ajlm-2756	7	10	and	and	CCONJ
ajlm-2756	7	11	immune	immune	ADJ
ajlm-2756	7	12	activation	activation	NOUN
ajlm-2756	7	13	,	,	PUNCT
ajlm-2756	7	14	which	which	PRON
ajlm-2756	7	15	can	can	AUX
ajlm-2756	7	16	persist	persist	VERB
ajlm-2756	7	17	even	even	ADV
ajlm-2756	7	18	in	in	ADP
ajlm-2756	7	19	individuals	individual	NOUN
ajlm-2756	7	20	on	on	ADP
ajlm-2756	7	21	antiretroviral	antiretroviral	ADJ
ajlm-2756	7	22	therapy	therapy	NOUN
ajlm-2756	7	23	(	(	PUNCT
ajlm-2756	7	24	art	art	NOUN
ajlm-2756	7	25	)	)	PUNCT
ajlm-2756	7	26	,	,	PUNCT
ajlm-2756	7	27	increasing	increase	VERB
ajlm-2756	7	28	the	the	DET
ajlm-2756	7	29	risk	risk	NOUN
ajlm-2756	7	30	of	of	ADP
ajlm-2756	7	31	cardiovascular	cardiovascular	ADJ
ajlm-2756	7	32	disease	disease	NOUN
ajlm-2756	7	33	,	,	PUNCT
ajlm-2756	7	34	neurocognitive	neurocognitive	ADJ
ajlm-2756	7	35	disorders	disorder	NOUN
ajlm-2756	7	36	,	,	PUNCT
ajlm-2756	7	37	and	and	CCONJ
ajlm-2756	7	38	other	other	ADJ
ajlm-2756	7	39	inflammatory	inflammatory	ADJ
ajlm-2756	7	40	conditions	condition	NOUN
ajlm-2756	7	41	.	.	PUNCT
ajlm-2756	8	1	objective	objective	NOUN
ajlm-2756	8	2	:	:	PUNCT
ajlm-2756	8	3	this	this	DET
ajlm-2756	8	4	study	study	NOUN
ajlm-2756	8	5	comparatively	comparatively	ADV
ajlm-2756	8	6	investigates	investigate	VERB
ajlm-2756	8	7	inflammatory	inflammatory	ADJ
ajlm-2756	8	8	markers	marker	NOUN
ajlm-2756	8	9	among	among	ADP
ajlm-2756	8	10	hiv	hiv	PROPN
ajlm-2756	8	11	-	-	PUNCT
ajlm-2756	8	12	positive	positive	ADJ
ajlm-2756	8	13	individuals	individual	NOUN
ajlm-2756	8	14	receiving	receive	VERB
ajlm-2756	8	15	art	art	NOUN
ajlm-2756	8	16	with	with	ADP
ajlm-2756	8	17	those	those	PRON
ajlm-2756	8	18	in	in	ADP
ajlm-2756	8	19	hiv	hiv	PROPN
ajlm-2756	8	20	-	-	PUNCT
ajlm-2756	8	21	negative	negative	ADJ
ajlm-2756	8	22	individuals	individual	NOUN
ajlm-2756	8	23	.	.	PUNCT
ajlm-2756	9	1	methods	method	NOUN
ajlm-2756	9	2	:	:	PUNCT
ajlm-2756	9	3	we	we	PRON
ajlm-2756	9	4	analysed	analyse	VERB
ajlm-2756	9	5	retrospective	retrospective	ADJ
ajlm-2756	9	6	laboratory	laboratory	NOUN
ajlm-2756	9	7	results	result	NOUN
ajlm-2756	9	8	,	,	PUNCT
ajlm-2756	9	9	including	include	VERB
ajlm-2756	9	10	viral	viral	ADJ
ajlm-2756	9	11	load	load	NOUN
ajlm-2756	9	12	,	,	PUNCT
ajlm-2756	9	13	c	c	NOUN
ajlm-2756	9	14	-	-	PUNCT
ajlm-2756	9	15	reactive	reactive	ADJ
ajlm-2756	9	16	protein	protein	NOUN
ajlm-2756	9	17	(	(	PUNCT
ajlm-2756	9	18	crp	crp	PROPN
ajlm-2756	9	19	)	)	PUNCT
ajlm-2756	9	20	,	,	PUNCT
ajlm-2756	9	21	and	and	CCONJ
ajlm-2756	10	1	d	d	X
ajlm-2756	10	2	-	-	PUNCT
ajlm-2756	10	3	dimer	dimer	ADJ
ajlm-2756	10	4	,	,	PUNCT
ajlm-2756	10	5	from	from	ADP
ajlm-2756	10	6	275	275	NUM
ajlm-2756	10	7	individuals	individual	NOUN
ajlm-2756	10	8	(	(	PUNCT
ajlm-2756	10	9	aged	aged	ADJ
ajlm-2756	10	10	0–39	0–39	NOUN
ajlm-2756	10	11	years	year	NOUN
ajlm-2756	10	12	)	)	PUNCT
ajlm-2756	10	13	treated	treat	VERB
ajlm-2756	10	14	at	at	ADP
ajlm-2756	10	15	a	a	DET
ajlm-2756	10	16	tertiary	tertiary	ADJ
ajlm-2756	10	17	hospital	hospital	NOUN
ajlm-2756	10	18	in	in	ADP
ajlm-2756	10	19	south	south	PROPN
ajlm-2756	10	20	africa	africa	PROPN
ajlm-2756	10	21	.	.	PUNCT
ajlm-2756	11	1	the	the	DET
ajlm-2756	11	2	study	study	NOUN
ajlm-2756	11	3	period	period	NOUN
ajlm-2756	11	4	commenced	commence	VERB
ajlm-2756	11	5	on	on	ADP
ajlm-2756	11	6	02	02	NUM
ajlm-2756	11	7	december	december	PROPN
ajlm-2756	11	8	2023	2023	NUM
ajlm-2756	11	9	and	and	CCONJ
ajlm-2756	11	10	ended	end	VERB
ajlm-2756	11	11	on	on	ADP
ajlm-2756	11	12	28	28	NUM
ajlm-2756	11	13	october	october	PROPN
ajlm-2756	11	14	2024	2024	NUM
ajlm-2756	11	15	.	.	PUNCT
ajlm-2756	12	1	spearman	spearman	NOUN
ajlm-2756	12	2	’s	’s	PART
ajlm-2756	12	3	rank	rank	NOUN
ajlm-2756	12	4	correlation	correlation	NOUN
ajlm-2756	12	5	was	be	AUX
ajlm-2756	12	6	used	use	VERB
ajlm-2756	12	7	to	to	PART
ajlm-2756	12	8	evaluate	evaluate	VERB
ajlm-2756	12	9	relationships	relationship	NOUN
ajlm-2756	12	10	among	among	ADP
ajlm-2756	12	11	demographic	demographic	ADJ
ajlm-2756	12	12	factors	factor	NOUN
ajlm-2756	12	13	,	,	PUNCT
ajlm-2756	12	14	viral	viral	ADJ
ajlm-2756	12	15	load	load	NOUN
ajlm-2756	12	16	,	,	PUNCT
ajlm-2756	12	17	and	and	CCONJ
ajlm-2756	12	18	inflammatory	inflammatory	ADJ
ajlm-2756	12	19	markers	marker	NOUN
ajlm-2756	12	20	.	.	PUNCT
ajlm-2756	13	1	results	result	NOUN
ajlm-2756	13	2	:	:	PUNCT
ajlm-2756	13	3	findings	finding	NOUN
ajlm-2756	13	4	revealed	reveal	VERB
ajlm-2756	13	5	that	that	SCONJ
ajlm-2756	13	6	hiv	hiv	PROPN
ajlm-2756	13	7	-	-	PUNCT
ajlm-2756	13	8	positive	positive	ADJ
ajlm-2756	13	9	individuals	individual	NOUN
ajlm-2756	13	10	had	have	VERB
ajlm-2756	13	11	significantly	significantly	ADV
ajlm-2756	13	12	higher	high	ADJ
ajlm-2756	13	13	crp	crp	NOUN
ajlm-2756	13	14	levels	level	NOUN
ajlm-2756	13	15	(	(	PUNCT
ajlm-2756	13	16	r	r	NOUN
ajlm-2756	13	17	=	=	SYM
ajlm-2756	13	18	0.140	0.140	NUM
ajlm-2756	13	19	,	,	PUNCT
ajlm-2756	13	20	p	p	X
ajlm-2756	13	21	=	=	NOUN
ajlm-2756	13	22	0.010	0.010	NUM
ajlm-2756	13	23	)	)	PUNCT
ajlm-2756	13	24	,	,	PUNCT
ajlm-2756	13	25	indicating	indicate	VERB
ajlm-2756	13	26	persistent	persistent	ADJ
ajlm-2756	13	27	inflammation	inflammation	NOUN
ajlm-2756	13	28	despite	despite	SCONJ
ajlm-2756	13	29	art	art	NOUN
ajlm-2756	13	30	.	.	PUNCT
ajlm-2756	14	1	d	d	X
ajlm-2756	14	2	-	-	PUNCT
ajlm-2756	14	3	dimer	dimer	ADJ
ajlm-2756	14	4	levels	level	NOUN
ajlm-2756	14	5	remained	remain	VERB
ajlm-2756	14	6	high	high	ADJ
ajlm-2756	14	7	within	within	ADP
ajlm-2756	14	8	normal	normal	ADJ
ajlm-2756	14	9	ranges	range	NOUN
ajlm-2756	14	10	across	across	ADP
ajlm-2756	14	11	the	the	DET
ajlm-2756	14	12	sample	sample	NOUN
ajlm-2756	14	13	,	,	PUNCT
ajlm-2756	14	14	suggesting	suggest	VERB
ajlm-2756	14	15	a	a	DET
ajlm-2756	14	16	generally	generally	ADV
ajlm-2756	14	17	low	low	ADJ
ajlm-2756	14	18	thrombotic	thrombotic	ADJ
ajlm-2756	14	19	risk	risk	NOUN
ajlm-2756	14	20	,	,	PUNCT
ajlm-2756	14	21	though	though	SCONJ
ajlm-2756	14	22	elevated	elevate	VERB
ajlm-2756	14	23	in	in	ADP
ajlm-2756	14	24	a	a	DET
ajlm-2756	14	25	small	small	ADJ
ajlm-2756	14	26	subset	subset	NOUN
ajlm-2756	14	27	of	of	ADP
ajlm-2756	14	28	hiv	hiv	PROPN
ajlm-2756	14	29	-	-	PUNCT
ajlm-2756	14	30	positive	positive	ADJ
ajlm-2756	14	31	individuals	individual	NOUN
ajlm-2756	14	32	.	.	PUNCT
ajlm-2756	15	1	it	it	PRON
ajlm-2756	15	2	also	also	ADV
ajlm-2756	15	3	revealed	reveal	VERB
ajlm-2756	15	4	that	that	SCONJ
ajlm-2756	15	5	crp	crp	PROPN
ajlm-2756	15	6	levels	level	NOUN
ajlm-2756	15	7	were	be	AUX
ajlm-2756	15	8	notably	notably	ADV
ajlm-2756	15	9	higher	high	ADJ
ajlm-2756	15	10	among	among	ADP
ajlm-2756	15	11	male	male	ADJ
ajlm-2756	15	12	patients	patient	NOUN
ajlm-2756	15	13	(	(	PUNCT
ajlm-2756	15	14	r	r	NOUN
ajlm-2756	15	15	=	=	SYM
ajlm-2756	15	16	0.133	0.133	NUM
ajlm-2756	15	17	,	,	PUNCT
ajlm-2756	15	18	p	p	X
ajlm-2756	15	19	=	=	NOUN
ajlm-2756	15	20	0.014	0.014	NUM
ajlm-2756	15	21	)	)	PUNCT
ajlm-2756	15	22	compared	compare	VERB
ajlm-2756	15	23	to	to	ADP
ajlm-2756	15	24	female	female	ADJ
ajlm-2756	15	25	patients	patient	NOUN
ajlm-2756	15	26	.	.	PUNCT
ajlm-2756	16	1	the	the	DET
ajlm-2756	16	2	age	age	NOUN
ajlm-2756	16	3	group	group	NOUN
ajlm-2756	16	4	with	with	ADP
ajlm-2756	16	5	the	the	DET
ajlm-2756	16	6	highest	high	ADJ
ajlm-2756	16	7	inflammatory	inflammatory	ADJ
ajlm-2756	16	8	markers	marker	NOUN
ajlm-2756	16	9	,	,	PUNCT
ajlm-2756	16	10	such	such	ADJ
ajlm-2756	16	11	as	as	ADP
ajlm-2756	16	12	crp	crp	PROPN
ajlm-2756	16	13	,	,	PUNCT
ajlm-2756	16	14	were	be	AUX
ajlm-2756	16	15	young	young	ADJ
ajlm-2756	16	16	adults	adult	NOUN
ajlm-2756	16	17	(	(	PUNCT
ajlm-2756	16	18	18–39	18–39	NUM
ajlm-2756	16	19	years	year	NOUN
ajlm-2756	16	20	old	old	ADJ
ajlm-2756	16	21	)	)	PUNCT
ajlm-2756	16	22	.	.	PUNCT
ajlm-2756	17	1	distribution	distribution	NOUN
ajlm-2756	17	2	results	result	NOUN
ajlm-2756	17	3	show	show	VERB
ajlm-2756	17	4	the	the	DET
ajlm-2756	17	5	predominant	predominant	ADJ
ajlm-2756	17	6	gender	gender	NOUN
ajlm-2756	17	7	being	be	AUX
ajlm-2756	17	8	female	female	ADJ
ajlm-2756	17	9	(	(	PUNCT
ajlm-2756	17	10	n	n	NOUN
ajlm-2756	17	11	=	=	SYM
ajlm-2756	17	12	211	211	NUM
ajlm-2756	17	13	;	;	PUNCT
ajlm-2756	17	14	76.7	76.7	NUM
ajlm-2756	17	15	%	%	NOUN
ajlm-2756	17	16	)	)	PUNCT
ajlm-2756	17	17	versus	versus	ADP
ajlm-2756	17	18	male	male	NOUN
ajlm-2756	17	19	(	(	PUNCT
ajlm-2756	17	20	n	n	NOUN
ajlm-2756	17	21	=	=	SYM
ajlm-2756	17	22	64	64	NUM
ajlm-2756	17	23	;	;	PUNCT
ajlm-2756	17	24	23.3	23.3	NUM
ajlm-2756	17	25	%	%	NOUN
ajlm-2756	17	26	)	)	PUNCT
ajlm-2756	17	27	.	.	PUNCT
ajlm-2756	18	1	conclusion	conclusion	NOUN
ajlm-2756	18	2	:	:	PUNCT
ajlm-2756	18	3	this	this	DET
ajlm-2756	18	4	study	study	NOUN
ajlm-2756	18	5	highlights	highlight	VERB
ajlm-2756	18	6	the	the	DET
ajlm-2756	18	7	need	need	NOUN
ajlm-2756	18	8	for	for	ADP
ajlm-2756	18	9	tailored	tailor	VERB
ajlm-2756	18	10	strategies	strategy	NOUN
ajlm-2756	18	11	to	to	PART
ajlm-2756	18	12	manage	manage	VERB
ajlm-2756	18	13	inflammation	inflammation	NOUN
ajlm-2756	18	14	and	and	CCONJ
ajlm-2756	18	15	reduce	reduce	VERB
ajlm-2756	18	16	cardiovascular	cardiovascular	ADJ
ajlm-2756	18	17	risks	risk	NOUN
ajlm-2756	18	18	in	in	ADP
ajlm-2756	18	19	hiv	hiv	PROPN
ajlm-2756	18	20	-	-	PUNCT
ajlm-2756	18	21	positive	positive	ADJ
ajlm-2756	18	22	individuals	individual	NOUN
ajlm-2756	18	23	,	,	PUNCT
ajlm-2756	18	24	especially	especially	ADV
ajlm-2756	18	25	young	young	ADJ
ajlm-2756	18	26	adults	adult	NOUN
ajlm-2756	18	27	and	and	CCONJ
ajlm-2756	18	28	male	male	ADJ
ajlm-2756	18	29	patients	patient	NOUN
ajlm-2756	18	30	.	.	PUNCT
ajlm-2756	19	1	what	what	PRON
ajlm-2756	19	2	this	this	DET
ajlm-2756	19	3	study	study	NOUN
ajlm-2756	19	4	adds	add	VERB
ajlm-2756	19	5	:	:	PUNCT
ajlm-2756	19	6	this	this	DET
ajlm-2756	19	7	study	study	NOUN
ajlm-2756	19	8	provides	provide	VERB
ajlm-2756	19	9	insight	insight	NOUN
ajlm-2756	19	10	into	into	ADP
ajlm-2756	19	11	specific	specific	ADJ
ajlm-2756	19	12	inflammatory	inflammatory	ADJ
ajlm-2756	19	13	markers	marker	NOUN
ajlm-2756	19	14	that	that	PRON
ajlm-2756	19	15	are	be	AUX
ajlm-2756	19	16	reduced	reduce	VERB
ajlm-2756	19	17	or	or	CCONJ
ajlm-2756	19	18	elevated	elevate	VERB
ajlm-2756	19	19	in	in	ADP
ajlm-2756	19	20	people	people	NOUN
ajlm-2756	19	21	living	live	VERB
ajlm-2756	19	22	with	with	ADP
ajlm-2756	19	23	hiv	hiv	PROPN
ajlm-2756	19	24	.	.	PUNCT
ajlm-2756	20	1	it	it	PRON
ajlm-2756	20	2	also	also	ADV
ajlm-2756	20	3	assessed	assess	VERB
ajlm-2756	20	4	how	how	SCONJ
ajlm-2756	20	5	art	art	NOUN
ajlm-2756	20	6	influences	influence	VERB
ajlm-2756	20	7	the	the	DET
ajlm-2756	20	8	immune	immune	ADJ
ajlm-2756	20	9	response	response	NOUN
ajlm-2756	20	10	in	in	ADP
ajlm-2756	20	11	hiv	hiv	PROPN
ajlm-2756	20	12	-	-	PUNCT
ajlm-2756	20	13	positive	positive	ADJ
ajlm-2756	20	14	individuals	individual	NOUN
ajlm-2756	20	15	,	,	PUNCT
ajlm-2756	20	16	particularly	particularly	ADV
ajlm-2756	20	17	in	in	ADP
ajlm-2756	20	18	terms	term	NOUN
ajlm-2756	20	19	of	of	ADP
ajlm-2756	20	20	inflammation	inflammation	NOUN
ajlm-2756	20	21	.	.	PUNCT
ajlm-2756	21	1	this	this	PRON
ajlm-2756	21	2	can	can	AUX
ajlm-2756	21	3	help	help	VERB
ajlm-2756	21	4	in	in	ADP
ajlm-2756	21	5	developing	develop	VERB
ajlm-2756	21	6	targeted	target	VERB
ajlm-2756	21	7	therapies	therapy	NOUN
ajlm-2756	21	8	and	and	CCONJ
ajlm-2756	21	9	monitoring	monitor	VERB
ajlm-2756	21	10	disease	disease	NOUN
ajlm-2756	21	11	progression	progression	NOUN
ajlm-2756	21	12	.	.	PUNCT
ajlm-2756	22	1	keywords	keyword	NOUN
ajlm-2756	22	2	:	:	PUNCT
ajlm-2756	22	3	inflammatory	inflammatory	ADJ
ajlm-2756	22	4	markers	marker	NOUN
ajlm-2756	22	5	;	;	PUNCT
ajlm-2756	22	6	antiretroviral	antiretroviral	ADJ
ajlm-2756	22	7	therapy	therapy	NOUN
ajlm-2756	22	8	;	;	PUNCT
ajlm-2756	22	9	art	art	NOUN
ajlm-2756	22	10	;	;	PUNCT
ajlm-2756	22	11	hiv	hiv	PROPN
ajlm-2756	22	12	-	-	PUNCT
ajlm-2756	22	13	positive	positive	ADJ
ajlm-2756	22	14	individuals	individual	NOUN
ajlm-2756	22	15	;	;	PUNCT
ajlm-2756	22	16	hiv	hiv	PROPN
ajlm-2756	22	17	-	-	PUNCT
ajlm-2756	22	18	negative	negative	ADJ
ajlm-2756	22	19	individuals	individual	NOUN
ajlm-2756	22	20	;	;	PUNCT
ajlm-2756	22	21	comparative	comparative	ADJ
ajlm-2756	22	22	analysis	analysis	NOUN
ajlm-2756	22	23	;	;	PUNCT
ajlm-2756	22	24	immune	immune	ADJ
ajlm-2756	22	25	response	response	NOUN
ajlm-2756	22	26	.	.	PUNCT
ajlm-2756	23	1	introduction	introduction	NOUN
ajlm-2756	23	2	kwazulu	kwazulu	NOUN
ajlm-2756	23	3	-	-	PUNCT
ajlm-2756	23	4	natal	natal	ADJ
ajlm-2756	23	5	,	,	PUNCT
ajlm-2756	23	6	particularly	particularly	ADV
ajlm-2756	23	7	durban	durban	NOUN
ajlm-2756	23	8	,	,	PUNCT
ajlm-2756	23	9	has	have	VERB
ajlm-2756	23	10	the	the	DET
ajlm-2756	23	11	highest	high	ADJ
ajlm-2756	23	12	hiv	hiv	PROPN
ajlm-2756	23	13	prevalence	prevalence	NOUN
ajlm-2756	23	14	in	in	ADP
ajlm-2756	23	15	south	south	PROPN
ajlm-2756	23	16	africa	africa	PROPN
ajlm-2756	23	17	,	,	PUNCT
ajlm-2756	23	18	with	with	ADP
ajlm-2756	23	19	approximately	approximately	ADV
ajlm-2756	23	20	27.3	27.3	NUM
ajlm-2756	23	21	%	%	NOUN
ajlm-2756	23	22	of	of	ADP
ajlm-2756	23	23	the	the	DET
ajlm-2756	23	24	population	population	NOUN
ajlm-2756	23	25	living	live	VERB
ajlm-2756	23	26	with	with	ADP
ajlm-2756	23	27	hiv.1,2	hiv.1,2	PROPN
ajlm-2756	23	28	of	of	ADP
ajlm-2756	23	29	these	these	PRON
ajlm-2756	23	30	,	,	PUNCT
ajlm-2756	23	31	61.8	61.8	NUM
ajlm-2756	23	32	%	%	NOUN
ajlm-2756	23	33	are	be	AUX
ajlm-2756	23	34	on	on	ADP
ajlm-2756	23	35	antiretroviral	antiretroviral	ADJ
ajlm-2756	23	36	therapy	therapy	NOUN
ajlm-2756	23	37	(	(	PUNCT
ajlm-2756	23	38	art	art	NOUN
ajlm-2756	23	39	)	)	PUNCT
ajlm-2756	23	40	,	,	PUNCT
ajlm-2756	23	41	and	and	CCONJ
ajlm-2756	23	42	58.6	58.6	NUM
ajlm-2756	23	43	%	%	NOUN
ajlm-2756	23	44	of	of	ADP
ajlm-2756	23	45	art	art	NOUN
ajlm-2756	23	46	users	user	NOUN
ajlm-2756	23	47	achieve	achieve	VERB
ajlm-2756	23	48	viral	viral	ADJ
ajlm-2756	23	49	suppression.3	suppression.3	NOUN
ajlm-2756	23	50	chronic	chronic	ADJ
ajlm-2756	23	51	immune	immune	ADJ
ajlm-2756	23	52	activation	activation	NOUN
ajlm-2756	23	53	and	and	CCONJ
ajlm-2756	23	54	inflammation	inflammation	NOUN
ajlm-2756	23	55	,	,	PUNCT
ajlm-2756	23	56	which	which	PRON
ajlm-2756	23	57	are	be	AUX
ajlm-2756	23	58	central	central	ADJ
ajlm-2756	23	59	to	to	ADP
ajlm-2756	23	60	hiv	hiv	PROPN
ajlm-2756	23	61	,	,	PUNCT
ajlm-2756	23	62	contribute	contribute	VERB
ajlm-2756	23	63	to	to	ADP
ajlm-2756	23	64	complications	complication	NOUN
ajlm-2756	23	65	such	such	ADJ
ajlm-2756	23	66	as	as	ADP
ajlm-2756	23	67	neurocognitive	neurocognitive	ADJ
ajlm-2756	23	68	disorders	disorder	NOUN
ajlm-2756	23	69	,	,	PUNCT
ajlm-2756	23	70	coronary	coronary	ADJ
ajlm-2756	23	71	artery	artery	NOUN
ajlm-2756	23	72	disease	disease	NOUN
ajlm-2756	23	73	,	,	PUNCT
ajlm-2756	23	74	liver	liver	NOUN
ajlm-2756	23	75	/	/	SYM
ajlm-2756	23	76	kidney	kidney	NOUN
ajlm-2756	23	77	issues	issue	NOUN
ajlm-2756	23	78	,	,	PUNCT
ajlm-2756	23	79	metabolic	metabolic	NOUN
ajlm-2756	23	80	syndrome	syndrome	NOUN
ajlm-2756	23	81	,	,	PUNCT
ajlm-2756	23	82	osteoporosis	osteoporosis	NOUN
ajlm-2756	23	83	,	,	PUNCT
ajlm-2756	23	84	and	and	CCONJ
ajlm-2756	23	85	certain	certain	ADJ
ajlm-2756	23	86	cancers.4	cancers.4	PROPN
ajlm-2756	23	87	this	this	PRON
ajlm-2756	23	88	poses	pose	VERB
ajlm-2756	23	89	significant	significant	ADJ
ajlm-2756	23	90	concerns	concern	NOUN
ajlm-2756	23	91	for	for	ADP
ajlm-2756	23	92	the	the	DET
ajlm-2756	23	93	south	south	ADJ
ajlm-2756	23	94	african	african	ADJ
ajlm-2756	23	95	department	department	PROPN
ajlm-2756	23	96	of	of	ADP
ajlm-2756	23	97	health	health	NOUN
ajlm-2756	23	98	,	,	PUNCT
ajlm-2756	23	99	as	as	SCONJ
ajlm-2756	23	100	hiv	hiv	PROPN
ajlm-2756	23	101	is	be	AUX
ajlm-2756	23	102	an	an	DET
ajlm-2756	23	103	inflammatory	inflammatory	ADJ
ajlm-2756	23	104	disease.5	disease.5	NOUN
ajlm-2756	23	105	inflammation	inflammation	NOUN
ajlm-2756	23	106	in	in	ADP
ajlm-2756	23	107	hiv	hiv	PROPN
ajlm-2756	23	108	-	-	PUNCT
ajlm-2756	23	109	positive	positive	ADJ
ajlm-2756	23	110	individuals	individual	NOUN
ajlm-2756	23	111	is	be	AUX
ajlm-2756	23	112	indicated	indicate	VERB
ajlm-2756	23	113	by	by	ADP
ajlm-2756	23	114	elevated	elevated	ADJ
ajlm-2756	23	115	levels	level	NOUN
ajlm-2756	23	116	of	of	ADP
ajlm-2756	23	117	biomarkers	biomarker	NOUN
ajlm-2756	23	118	such	such	ADJ
ajlm-2756	23	119	as	as	ADP
ajlm-2756	23	120	interleukin-6	interleukin-6	PROPN
ajlm-2756	23	121	(	(	PUNCT
ajlm-2756	23	122	il-6	il-6	NUM
ajlm-2756	23	123	)	)	PUNCT
ajlm-2756	23	124	,	,	PUNCT
ajlm-2756	23	125	c	c	NOUN
ajlm-2756	23	126	-	-	PUNCT
ajlm-2756	23	127	reactive	reactive	ADJ
ajlm-2756	23	128	protein	protein	NOUN
ajlm-2756	23	129	(	(	PUNCT
ajlm-2756	23	130	crp	crp	PROPN
ajlm-2756	23	131	)	)	PUNCT
ajlm-2756	23	132	,	,	PUNCT
ajlm-2756	23	133	and	and	CCONJ
ajlm-2756	23	134	d	d	X
ajlm-2756	23	135	-	-	PUNCT
ajlm-2756	23	136	dimer.6	dimer.6	NOUN
ajlm-2756	23	137	raised	raise	VERB
ajlm-2756	23	138	crp	crp	PROPN
ajlm-2756	23	139	levels	level	NOUN
ajlm-2756	23	140	are	be	AUX
ajlm-2756	23	141	linked	link	VERB
ajlm-2756	23	142	to	to	ADP
ajlm-2756	23	143	inflammation	inflammation	NOUN
ajlm-2756	23	144	and	and	CCONJ
ajlm-2756	23	145	a	a	DET
ajlm-2756	23	146	higher	high	ADJ
ajlm-2756	23	147	risk	risk	NOUN
ajlm-2756	23	148	of	of	ADP
ajlm-2756	23	149	cardiovascular	cardiovascular	ADJ
ajlm-2756	23	150	disease,7	disease,7	NOUN
ajlm-2756	23	151	while	while	SCONJ
ajlm-2756	23	152	increased	increase	VERB
ajlm-2756	23	153	il-6	il-6	NOUN
ajlm-2756	23	154	levels	level	NOUN
ajlm-2756	23	155	are	be	AUX
ajlm-2756	23	156	associated	associate	VERB
ajlm-2756	23	157	with	with	ADP
ajlm-2756	23	158	heart	heart	NOUN
ajlm-2756	23	159	disease	disease	NOUN
ajlm-2756	23	160	and	and	CCONJ
ajlm-2756	23	161	cognitive	cognitive	ADJ
ajlm-2756	23	162	decline.8	decline.8	PROPN
ajlm-2756	23	163	elevated	elevated	ADJ
ajlm-2756	23	164	d	d	X
ajlm-2756	23	165	-	-	PUNCT
ajlm-2756	23	166	dimer	dimer	ADJ
ajlm-2756	23	167	levels	level	NOUN
ajlm-2756	23	168	signal	signal	VERB
ajlm-2756	23	169	enhanced	enhanced	ADJ
ajlm-2756	23	170	coagulation	coagulation	NOUN
ajlm-2756	23	171	and	and	CCONJ
ajlm-2756	23	172	inflammation	inflammation	NOUN
ajlm-2756	23	173	,	,	PUNCT
ajlm-2756	23	174	increasing	increase	VERB
ajlm-2756	23	175	the	the	DET
ajlm-2756	23	176	risk	risk	NOUN
ajlm-2756	23	177	of	of	ADP
ajlm-2756	23	178	cardiovascular	cardiovascular	ADJ
ajlm-2756	23	179	events	event	NOUN
ajlm-2756	23	180	and	and	CCONJ
ajlm-2756	23	181	venous	venous	ADJ
ajlm-2756	23	182	thromboembolism.9	thromboembolism.9	ADJ
ajlm-2756	23	183	antiretroviral	antiretroviral	ADJ
ajlm-2756	23	184	therapy	therapy	NOUN
ajlm-2756	23	185	has	have	AUX
ajlm-2756	23	186	reduced	reduce	VERB
ajlm-2756	23	187	hiv	hiv	PROPN
ajlm-2756	23	188	-	-	PUNCT
ajlm-2756	23	189	related	relate	VERB
ajlm-2756	23	190	mortality	mortality	NOUN
ajlm-2756	23	191	and	and	CCONJ
ajlm-2756	23	192	may	may	AUX
ajlm-2756	23	193	lower	lower	VERB
ajlm-2756	23	194	inflammation	inflammation	NOUN
ajlm-2756	23	195	,	,	PUNCT
ajlm-2756	23	196	but	but	CCONJ
ajlm-2756	23	197	also	also	ADV
ajlm-2756	23	198	introduces	introduce	VERB
ajlm-2756	23	199	other	other	ADJ
ajlm-2756	23	200	complications.10	complications.10	PROPN
ajlm-2756	23	201	a	a	DET
ajlm-2756	23	202	key	key	ADJ
ajlm-2756	23	203	consideration	consideration	NOUN
ajlm-2756	23	204	in	in	ADP
ajlm-2756	23	205	managing	manage	VERB
ajlm-2756	23	206	hiv	hiv	PROPN
ajlm-2756	23	207	treatment	treatment	NOUN
ajlm-2756	23	208	is	be	AUX
ajlm-2756	23	209	therapeutic	therapeutic	ADJ
ajlm-2756	23	210	drug	drug	NOUN
ajlm-2756	23	211	monitoring	monitoring	NOUN
ajlm-2756	23	212	,	,	PUNCT
ajlm-2756	23	213	which	which	PRON
ajlm-2756	23	214	can	can	AUX
ajlm-2756	23	215	assess	assess	VERB
ajlm-2756	23	216	art	art	NOUN
ajlm-2756	23	217	adherence	adherence	NOUN
ajlm-2756	23	218	and	and	CCONJ
ajlm-2756	23	219	drug	drug	NOUN
ajlm-2756	23	220	efficacy.11	efficacy.11	PROPN
ajlm-2756	23	221	therapeutic	therapeutic	ADJ
ajlm-2756	23	222	drug	drug	NOUN
ajlm-2756	23	223	monitoring	monitoring	NOUN
ajlm-2756	23	224	is	be	AUX
ajlm-2756	23	225	usually	usually	ADV
ajlm-2756	23	226	integrated	integrate	VERB
ajlm-2756	23	227	to	to	PART
ajlm-2756	23	228	track	track	VERB
ajlm-2756	23	229	art	art	NOUN
ajlm-2756	23	230	drug	drug	NOUN
ajlm-2756	23	231	concentrations	concentration	NOUN
ajlm-2756	23	232	in	in	ADP
ajlm-2756	23	233	patients	patient	NOUN
ajlm-2756	23	234	,	,	PUNCT
ajlm-2756	23	235	and	and	CCONJ
ajlm-2756	23	236	to	to	PART
ajlm-2756	23	237	determine	determine	VERB
ajlm-2756	23	238	how	how	SCONJ
ajlm-2756	23	239	these	these	DET
ajlm-2756	23	240	levels	level	NOUN
ajlm-2756	23	241	correlate	correlate	VERB
ajlm-2756	23	242	with	with	ADP
ajlm-2756	23	243	inflammatory	inflammatory	ADJ
ajlm-2756	23	244	marker	marker	NOUN
ajlm-2756	23	245	profiles	profile	NOUN
ajlm-2756	23	246	(	(	PUNCT
ajlm-2756	23	247	il-6	il-6	NUM
ajlm-2756	23	248	,	,	PUNCT
ajlm-2756	23	249	crp	crp	PROPN
ajlm-2756	23	250	,	,	PUNCT
ajlm-2756	23	251	d	d	X
ajlm-2756	23	252	-	-	PUNCT
ajlm-2756	23	253	dimer	dimer	NUM
ajlm-2756	23	254	)	)	PUNCT
ajlm-2756	23	255	.	.	PUNCT
ajlm-2756	24	1	this	this	PRON
ajlm-2756	24	2	provides	provide	VERB
ajlm-2756	24	3	insight	insight	NOUN
ajlm-2756	24	4	into	into	ADP
ajlm-2756	24	5	whether	whether	SCONJ
ajlm-2756	24	6	suboptimal	suboptimal	ADJ
ajlm-2756	24	7	art	art	NOUN
ajlm-2756	24	8	concentrations	concentration	NOUN
ajlm-2756	24	9	contribute	contribute	VERB
ajlm-2756	24	10	to	to	ADP
ajlm-2756	24	11	ongoing	ongoing	ADJ
ajlm-2756	24	12	inflammation	inflammation	NOUN
ajlm-2756	24	13	or	or	CCONJ
ajlm-2756	24	14	inadequate	inadequate	ADJ
ajlm-2756	24	15	viral	viral	ADJ
ajlm-2756	24	16	suppression	suppression	NOUN
ajlm-2756	24	17	.	.	PUNCT
ajlm-2756	25	1	while	while	SCONJ
ajlm-2756	25	2	inflammatory	inflammatory	ADJ
ajlm-2756	25	3	markers	marker	NOUN
ajlm-2756	25	4	in	in	ADP
ajlm-2756	25	5	hiv	hiv	PROPN
ajlm-2756	25	6	-	-	PUNCT
ajlm-2756	25	7	positive	positive	ADJ
ajlm-2756	25	8	individuals	individual	NOUN
ajlm-2756	25	9	have	have	AUX
ajlm-2756	25	10	been	be	AUX
ajlm-2756	25	11	studied	study	VERB
ajlm-2756	25	12	,	,	PUNCT
ajlm-2756	25	13	direct	direct	ADJ
ajlm-2756	25	14	comparisons	comparison	NOUN
ajlm-2756	25	15	with	with	ADP
ajlm-2756	25	16	hiv	hiv	PROPN
ajlm-2756	25	17	-	-	PUNCT
ajlm-2756	25	18	negative	negative	ADJ
ajlm-2756	25	19	individuals	individual	NOUN
ajlm-2756	25	20	are	be	AUX
ajlm-2756	25	21	limited.12	limited.12	NOUN
ajlm-2756	25	22	thus	thus	ADV
ajlm-2756	25	23	,	,	PUNCT
ajlm-2756	25	24	this	this	DET
ajlm-2756	25	25	study	study	NOUN
ajlm-2756	25	26	aims	aim	VERB
ajlm-2756	25	27	to	to	PART
ajlm-2756	25	28	address	address	VERB
ajlm-2756	25	29	this	this	DET
ajlm-2756	25	30	gap	gap	NOUN
ajlm-2756	25	31	by	by	ADP
ajlm-2756	25	32	comparing	compare	VERB
ajlm-2756	25	33	il-6	il-6	NUM
ajlm-2756	25	34	,	,	PUNCT
ajlm-2756	25	35	crp	crp	PROPN
ajlm-2756	25	36	,	,	PUNCT
ajlm-2756	25	37	and	and	CCONJ
ajlm-2756	25	38	d	d	X
ajlm-2756	25	39	-	-	PUNCT
ajlm-2756	25	40	dimer	dimer	ADJ
ajlm-2756	25	41	levels	level	NOUN
ajlm-2756	25	42	in	in	ADP
ajlm-2756	25	43	both	both	DET
ajlm-2756	25	44	groups	group	NOUN
ajlm-2756	25	45	,	,	PUNCT
ajlm-2756	25	46	helping	help	VERB
ajlm-2756	25	47	to	to	PART
ajlm-2756	25	48	evaluate	evaluate	VERB
ajlm-2756	25	49	the	the	DET
ajlm-2756	25	50	effectiveness	effectiveness	NOUN
ajlm-2756	25	51	of	of	ADP
ajlm-2756	25	52	art	art	NOUN
ajlm-2756	25	53	in	in	ADP
ajlm-2756	25	54	normalising	normalise	VERB
ajlm-2756	25	55	inflammation	inflammation	NOUN
ajlm-2756	25	56	.	.	PUNCT
ajlm-2756	26	1	monitoring	monitor	VERB
ajlm-2756	26	2	these	these	DET
ajlm-2756	26	3	markers	marker	NOUN
ajlm-2756	26	4	is	be	AUX
ajlm-2756	26	5	essential	essential	ADJ
ajlm-2756	26	6	for	for	ADP
ajlm-2756	26	7	assessing	assess	VERB
ajlm-2756	26	8	treatment	treatment	NOUN
ajlm-2756	26	9	effectiveness	effectiveness	NOUN
ajlm-2756	26	10	and	and	CCONJ
ajlm-2756	26	11	preventing	prevent	VERB
ajlm-2756	26	12	complications	complication	NOUN
ajlm-2756	26	13	,	,	PUNCT
ajlm-2756	26	14	ultimately	ultimately	ADV
ajlm-2756	26	15	improving	improve	VERB
ajlm-2756	26	16	the	the	DET
ajlm-2756	26	17	health	health	NOUN
ajlm-2756	26	18	outcomes	outcome	NOUN
ajlm-2756	26	19	and	and	CCONJ
ajlm-2756	26	20	quality	quality	NOUN
ajlm-2756	26	21	of	of	ADP
ajlm-2756	26	22	life	life	NOUN
ajlm-2756	26	23	for	for	ADP
ajlm-2756	26	24	people	people	NOUN
ajlm-2756	26	25	living	live	VERB
ajlm-2756	26	26	with	with	ADP
ajlm-2756	26	27	hiv	hiv	PROPN
ajlm-2756	26	28	.	.	PUNCT
ajlm-2756	27	1	this	this	DET
ajlm-2756	27	2	study	study	NOUN
ajlm-2756	27	3	aimed	aim	VERB
ajlm-2756	27	4	to	to	PART
ajlm-2756	27	5	investigate	investigate	VERB
ajlm-2756	27	6	the	the	DET
ajlm-2756	27	7	distribution	distribution	NOUN
ajlm-2756	27	8	of	of	ADP
ajlm-2756	27	9	inflammatory	inflammatory	ADJ
ajlm-2756	27	10	markers	marker	NOUN
ajlm-2756	27	11	–	–	PUNCT
ajlm-2756	27	12	crp	crp	NOUN
ajlm-2756	27	13	and	and	CCONJ
ajlm-2756	27	14	d	d	NOUN
ajlm-2756	27	15	-	-	PUNCT
ajlm-2756	27	16	dimer	dimer	ADJ
ajlm-2756	27	17	–	–	PUNCT
ajlm-2756	27	18	and	and	CCONJ
ajlm-2756	27	19	viral	viral	ADJ
ajlm-2756	27	20	load	load	NOUN
ajlm-2756	27	21	among	among	ADP
ajlm-2756	27	22	hiv	hiv	PROPN
ajlm-2756	27	23	-	-	PUNCT
ajlm-2756	27	24	positive	positive	ADJ
ajlm-2756	27	25	individuals	individual	NOUN
ajlm-2756	27	26	in	in	ADP
ajlm-2756	27	27	durban	durban	PROPN
ajlm-2756	27	28	,	,	PUNCT
ajlm-2756	27	29	kwazulu	kwazulu	NOUN
ajlm-2756	27	30	-	-	PUNCT
ajlm-2756	27	31	natal	natal	NOUN
ajlm-2756	27	32	,	,	PUNCT
ajlm-2756	27	33	and	and	CCONJ
ajlm-2756	27	34	to	to	PART
ajlm-2756	27	35	explore	explore	VERB
ajlm-2756	27	36	potential	potential	ADJ
ajlm-2756	27	37	correlations	correlation	NOUN
ajlm-2756	27	38	between	between	ADP
ajlm-2756	27	39	these	these	DET
ajlm-2756	27	40	biomarkers	biomarker	NOUN
ajlm-2756	27	41	.	.	PUNCT
ajlm-2756	28	1	kwazulu	kwazulu	VERB
ajlm-2756	28	2	-	-	PUNCT
ajlm-2756	28	3	natal	natal	PROPN
ajlm-2756	28	4	’s	’s	PART
ajlm-2756	28	5	high	high	ADJ
ajlm-2756	28	6	hiv	hiv	PROPN
ajlm-2756	28	7	prevalence	prevalence	NOUN
ajlm-2756	28	8	highlights	highlight	VERB
ajlm-2756	28	9	ongoing	ongoing	ADJ
ajlm-2756	28	10	challenges	challenge	NOUN
ajlm-2756	28	11	in	in	ADP
ajlm-2756	28	12	managing	manage	VERB
ajlm-2756	28	13	hiv	hiv	PROPN
ajlm-2756	28	14	,	,	PUNCT
ajlm-2756	28	15	particularly	particularly	ADV
ajlm-2756	28	16	persistent	persistent	ADJ
ajlm-2756	28	17	inflammation	inflammation	NOUN
ajlm-2756	28	18	,	,	PUNCT
ajlm-2756	28	19	which	which	PRON
ajlm-2756	28	20	contributes	contribute	VERB
ajlm-2756	28	21	to	to	ADP
ajlm-2756	28	22	complications	complication	NOUN
ajlm-2756	28	23	such	such	ADJ
ajlm-2756	28	24	as	as	ADP
ajlm-2756	28	25	cardiovascular	cardiovascular	ADJ
ajlm-2756	28	26	diseases	disease	NOUN
ajlm-2756	28	27	and	and	CCONJ
ajlm-2756	28	28	neurocognitive	neurocognitive	ADJ
ajlm-2756	28	29	decline	decline	NOUN
ajlm-2756	28	30	.	.	PUNCT
ajlm-2756	29	1	methods	method	NOUN
ajlm-2756	29	2	ethical	ethical	ADJ
ajlm-2756	29	3	considerations	consideration	NOUN
ajlm-2756	29	4	ethical	ethical	ADJ
ajlm-2756	29	5	approval	approval	NOUN
ajlm-2756	29	6	for	for	ADP
ajlm-2756	29	7	this	this	DET
ajlm-2756	29	8	study	study	NOUN
ajlm-2756	29	9	was	be	AUX
ajlm-2756	29	10	granted	grant	VERB
ajlm-2756	29	11	by	by	ADP
ajlm-2756	29	12	the	the	DET
ajlm-2756	29	13	mangosuthu	mangosuthu	NOUN
ajlm-2756	29	14	university	university	PROPN
ajlm-2756	29	15	of	of	ADP
ajlm-2756	29	16	technology	technology	NOUN
ajlm-2756	29	17	research	research	NOUN
ajlm-2756	29	18	ethics	ethic	NOUN
ajlm-2756	29	19	committee	committee	PROPN
ajlm-2756	29	20	(	(	PUNCT
ajlm-2756	29	21	reference	reference	NOUN
ajlm-2756	29	22	number	number	NOUN
ajlm-2756	29	23	:	:	PUNCT
ajlm-2756	29	24	rd5/28/2024	rd5/28/2024	NOUN
ajlm-2756	29	25	)	)	PUNCT
ajlm-2756	29	26	.	.	PUNCT
ajlm-2756	30	1	retrospective	retrospective	ADJ
ajlm-2756	30	2	laboratory	laboratory	NOUN
ajlm-2756	30	3	data	datum	NOUN
ajlm-2756	30	4	were	be	AUX
ajlm-2756	30	5	obtained	obtain	VERB
ajlm-2756	30	6	from	from	ADP
ajlm-2756	30	7	the	the	DET
ajlm-2756	30	8	national	national	PROPN
ajlm-2756	30	9	health	health	PROPN
ajlm-2756	30	10	laboratory	laboratory	PROPN
ajlm-2756	30	11	service	service	PROPN
ajlm-2756	30	12	academic	academic	ADJ
ajlm-2756	30	13	affairs	affairs	PROPN
ajlm-2756	30	14	and	and	CCONJ
ajlm-2756	30	15	research	research	NOUN
ajlm-2756	30	16	management	management	NOUN
ajlm-2756	30	17	system	system	NOUN
ajlm-2756	30	18	.	.	PUNCT
ajlm-2756	31	1	patient	patient	ADJ
ajlm-2756	31	2	details	detail	NOUN
ajlm-2756	31	3	were	be	AUX
ajlm-2756	31	4	anonymised	anonymise	VERB
ajlm-2756	31	5	to	to	PART
ajlm-2756	31	6	ensure	ensure	VERB
ajlm-2756	31	7	confidentiality	confidentiality	NOUN
ajlm-2756	31	8	;	;	PUNCT
ajlm-2756	31	9	no	no	DET
ajlm-2756	31	10	names	name	NOUN
ajlm-2756	31	11	,	,	PUNCT
ajlm-2756	31	12	identity	identity	NOUN
ajlm-2756	31	13	numbers	number	NOUN
ajlm-2756	31	14	,	,	PUNCT
ajlm-2756	31	15	or	or	CCONJ
ajlm-2756	31	16	any	any	DET
ajlm-2756	31	17	personal	personal	ADJ
ajlm-2756	31	18	information	information	NOUN
ajlm-2756	31	19	was	be	AUX
ajlm-2756	31	20	disclosed	disclose	VERB
ajlm-2756	31	21	.	.	PUNCT
ajlm-2756	32	1	data	datum	NOUN
ajlm-2756	32	2	were	be	AUX
ajlm-2756	32	3	securely	securely	ADV
ajlm-2756	32	4	stored	store	VERB
ajlm-2756	32	5	in	in	ADP
ajlm-2756	32	6	a	a	DET
ajlm-2756	32	7	password	password	NOUN
ajlm-2756	32	8	-	-	PUNCT
ajlm-2756	32	9	protected	protect	VERB
ajlm-2756	32	10	microsoft	microsoft	PROPN
ajlm-2756	32	11	excel	excel	PROPN
ajlm-2756	32	12	file	file	NOUN
ajlm-2756	32	13	,	,	PUNCT
ajlm-2756	32	14	accessible	accessible	ADJ
ajlm-2756	32	15	only	only	ADV
ajlm-2756	32	16	to	to	ADP
ajlm-2756	32	17	the	the	DET
ajlm-2756	32	18	research	research	NOUN
ajlm-2756	32	19	team	team	NOUN
ajlm-2756	32	20	.	.	PUNCT
ajlm-2756	33	1	study	study	NOUN
ajlm-2756	33	2	design	design	NOUN
ajlm-2756	33	3	and	and	CCONJ
ajlm-2756	33	4	setting	set	VERB
ajlm-2756	33	5	this	this	DET
ajlm-2756	33	6	study	study	NOUN
ajlm-2756	33	7	,	,	PUNCT
ajlm-2756	33	8	conducted	conduct	VERB
ajlm-2756	33	9	between	between	ADP
ajlm-2756	33	10	02	02	NUM
ajlm-2756	33	11	december	december	PROPN
ajlm-2756	33	12	2023	2023	NUM
ajlm-2756	33	13	and	and	CCONJ
ajlm-2756	33	14	28	28	NUM
ajlm-2756	33	15	october	october	PROPN
ajlm-2756	33	16	2024	2024	NUM
ajlm-2756	33	17	,	,	PUNCT
ajlm-2756	33	18	used	use	VERB
ajlm-2756	33	19	a	a	DET
ajlm-2756	33	20	retrospective	retrospective	ADJ
ajlm-2756	33	21	cohort	cohort	NOUN
ajlm-2756	33	22	design	design	NOUN
ajlm-2756	33	23	,	,	PUNCT
ajlm-2756	33	24	in	in	ADP
ajlm-2756	33	25	which	which	PRON
ajlm-2756	33	26	retrospective	retrospective	ADJ
ajlm-2756	33	27	laboratory	laboratory	NOUN
ajlm-2756	33	28	results	result	NOUN
ajlm-2756	33	29	were	be	AUX
ajlm-2756	33	30	utilised	utilise	VERB
ajlm-2756	33	31	from	from	ADP
ajlm-2756	33	32	an	an	DET
ajlm-2756	33	33	accredited	accredit	VERB
ajlm-2756	33	34	laboratory	laboratory	NOUN
ajlm-2756	33	35	based	base	VERB
ajlm-2756	33	36	at	at	ADP
ajlm-2756	33	37	a	a	DET
ajlm-2756	33	38	tertiary	tertiary	ADJ
ajlm-2756	33	39	hospital	hospital	NOUN
ajlm-2756	33	40	in	in	ADP
ajlm-2756	33	41	durban	durban	PROPN
ajlm-2756	33	42	,	,	PUNCT
ajlm-2756	33	43	kwazulu	kwazulu	NOUN
ajlm-2756	33	44	-	-	PUNCT
ajlm-2756	33	45	natal	natal	NOUN
ajlm-2756	33	46	.	.	PUNCT
ajlm-2756	34	1	kwazulu	kwazulu	VERB
ajlm-2756	34	2	-	-	PUNCT
ajlm-2756	34	3	natal	natal	NOUN
ajlm-2756	34	4	is	be	AUX
ajlm-2756	34	5	a	a	DET
ajlm-2756	34	6	region	region	NOUN
ajlm-2756	34	7	with	with	ADP
ajlm-2756	34	8	one	one	NUM
ajlm-2756	34	9	of	of	ADP
ajlm-2756	34	10	the	the	DET
ajlm-2756	34	11	highest	high	ADJ
ajlm-2756	34	12	hiv	hiv	PROPN
ajlm-2756	34	13	prevalence	prevalence	NOUN
ajlm-2756	34	14	rates	rate	NOUN
ajlm-2756	34	15	in	in	ADP
ajlm-2756	34	16	south	south	PROPN
ajlm-2756	34	17	africa	africa	PROPN
ajlm-2756	34	18	.	.	PUNCT
ajlm-2756	35	1	the	the	DET
ajlm-2756	35	2	study	study	NOUN
ajlm-2756	35	3	analysed	analyse	VERB
ajlm-2756	35	4	retrospective	retrospective	ADJ
ajlm-2756	35	5	inflammatory	inflammatory	ADJ
ajlm-2756	35	6	marker	marker	NOUN
ajlm-2756	35	7	laboratory	laboratory	NOUN
ajlm-2756	35	8	results	result	NOUN
ajlm-2756	35	9	of	of	ADP
ajlm-2756	35	10	people	people	NOUN
ajlm-2756	35	11	living	live	VERB
ajlm-2756	35	12	with	with	ADP
ajlm-2756	35	13	hiv	hiv	PROPN
ajlm-2756	35	14	and	and	CCONJ
ajlm-2756	35	15	hiv	hiv	PROPN
ajlm-2756	35	16	-	-	PUNCT
ajlm-2756	35	17	negative	negative	ADJ
ajlm-2756	35	18	patients	patient	NOUN
ajlm-2756	35	19	tested	test	VERB
ajlm-2756	35	20	between	between	ADP
ajlm-2756	35	21	january	january	PROPN
ajlm-2756	35	22	2020	2020	NUM
ajlm-2756	35	23	and	and	CCONJ
ajlm-2756	35	24	december	december	PROPN
ajlm-2756	35	25	2023	2023	NUM
ajlm-2756	35	26	.	.	PUNCT
ajlm-2756	36	1	the	the	DET
ajlm-2756	36	2	data	datum	NOUN
ajlm-2756	36	3	included	include	VERB
ajlm-2756	36	4	inflammatory	inflammatory	ADJ
ajlm-2756	36	5	markers	marker	NOUN
ajlm-2756	36	6	such	such	ADJ
ajlm-2756	36	7	as	as	ADP
ajlm-2756	36	8	crp	crp	PROPN
ajlm-2756	36	9	,	,	PUNCT
ajlm-2756	36	10	interleukins	interleukin	VERB
ajlm-2756	36	11	,	,	PUNCT
ajlm-2756	36	12	and	and	CCONJ
ajlm-2756	36	13	d	d	X
ajlm-2756	36	14	-	-	PUNCT
ajlm-2756	36	15	dimer	dimer	NOUN
ajlm-2756	36	16	.	.	PUNCT
ajlm-2756	37	1	data	datum	NOUN
ajlm-2756	37	2	collection	collection	NOUN
ajlm-2756	37	3	and	and	CCONJ
ajlm-2756	37	4	processing	process	VERB
ajlm-2756	37	5	an	an	DET
ajlm-2756	37	6	excel	excel	NOUN
ajlm-2756	37	7	spreadsheet	spreadsheet	NOUN
ajlm-2756	37	8	containing	contain	VERB
ajlm-2756	37	9	anonymised	anonymise	VERB
ajlm-2756	37	10	laboratory	laboratory	NOUN
ajlm-2756	37	11	records	record	NOUN
ajlm-2756	37	12	was	be	AUX
ajlm-2756	37	13	received	receive	VERB
ajlm-2756	37	14	.	.	PUNCT
ajlm-2756	38	1	after	after	ADP
ajlm-2756	38	2	obtaining	obtain	VERB
ajlm-2756	38	3	the	the	DET
ajlm-2756	38	4	downloaded	download	VERB
ajlm-2756	38	5	laboratory	laboratory	NOUN
ajlm-2756	38	6	data	datum	NOUN
ajlm-2756	38	7	from	from	ADP
ajlm-2756	38	8	electronic	electronic	ADJ
ajlm-2756	38	9	records	record	NOUN
ajlm-2756	38	10	,	,	PUNCT
ajlm-2756	38	11	a	a	DET
ajlm-2756	38	12	process	process	NOUN
ajlm-2756	38	13	of	of	ADP
ajlm-2756	38	14	data	datum	NOUN
ajlm-2756	38	15	cleaning	cleaning	NOUN
ajlm-2756	38	16	and	and	CCONJ
ajlm-2756	38	17	organisation	organisation	NOUN
ajlm-2756	38	18	was	be	AUX
ajlm-2756	38	19	performed	perform	VERB
ajlm-2756	38	20	.	.	PUNCT
ajlm-2756	39	1	initially	initially	ADV
ajlm-2756	39	2	a	a	DET
ajlm-2756	39	3	total	total	NOUN
ajlm-2756	39	4	of	of	ADP
ajlm-2756	39	5	204	204	NUM
ajlm-2756	39	6	131	131	NUM
ajlm-2756	39	7	results	result	NOUN
ajlm-2756	39	8	were	be	AUX
ajlm-2756	39	9	obtained	obtain	VERB
ajlm-2756	39	10	for	for	ADP
ajlm-2756	39	11	the	the	DET
ajlm-2756	39	12	requested	request	VERB
ajlm-2756	39	13	period	period	NOUN
ajlm-2756	39	14	.	.	PUNCT
ajlm-2756	40	1	the	the	DET
ajlm-2756	40	2	data	datum	NOUN
ajlm-2756	40	3	set	set	VERB
ajlm-2756	40	4	also	also	ADV
ajlm-2756	40	5	included	include	VERB
ajlm-2756	40	6	data	datum	NOUN
ajlm-2756	40	7	not	not	PART
ajlm-2756	40	8	related	relate	VERB
ajlm-2756	40	9	to	to	ADP
ajlm-2756	40	10	the	the	DET
ajlm-2756	40	11	study	study	NOUN
ajlm-2756	40	12	,	,	PUNCT
ajlm-2756	40	13	leading	lead	VERB
ajlm-2756	40	14	to	to	ADP
ajlm-2756	40	15	its	its	PRON
ajlm-2756	40	16	removal	removal	NOUN
ajlm-2756	40	17	and	and	CCONJ
ajlm-2756	40	18	exclusion	exclusion	NOUN
ajlm-2756	40	19	for	for	ADP
ajlm-2756	40	20	the	the	DET
ajlm-2756	40	21	current	current	ADJ
ajlm-2756	40	22	study	study	NOUN
ajlm-2756	40	23	.	.	PUNCT
ajlm-2756	41	1	after	after	ADP
ajlm-2756	41	2	data	datum	NOUN
ajlm-2756	41	3	cleaning	cleaning	NOUN
ajlm-2756	41	4	,	,	PUNCT
ajlm-2756	41	5	which	which	PRON
ajlm-2756	41	6	saw	see	VERB
ajlm-2756	41	7	the	the	DET
ajlm-2756	41	8	removal	removal	NOUN
ajlm-2756	41	9	of	of	ADP
ajlm-2756	41	10	duplicate	duplicate	ADJ
ajlm-2756	41	11	patient	patient	ADJ
ajlm-2756	41	12	results	result	NOUN
ajlm-2756	41	13	,	,	PUNCT
ajlm-2756	41	14	and	and	CCONJ
ajlm-2756	41	15	parameters	parameter	NOUN
ajlm-2756	41	16	ineligible	ineligible	ADJ
ajlm-2756	41	17	for	for	ADP
ajlm-2756	41	18	inclusion	inclusion	NOUN
ajlm-2756	41	19	because	because	SCONJ
ajlm-2756	41	20	of	of	ADP
ajlm-2756	41	21	missing	miss	VERB
ajlm-2756	41	22	values	value	NOUN
ajlm-2756	41	23	,	,	PUNCT
ajlm-2756	41	24	including	include	VERB
ajlm-2756	41	25	interleukins	interleukin	NOUN
ajlm-2756	41	26	,	,	PUNCT
ajlm-2756	41	27	only	only	ADV
ajlm-2756	41	28	275	275	NUM
ajlm-2756	41	29	records	record	NOUN
ajlm-2756	41	30	were	be	AUX
ajlm-2756	41	31	eligible	eligible	ADJ
ajlm-2756	41	32	for	for	ADP
ajlm-2756	41	33	the	the	DET
ajlm-2756	41	34	study	study	NOUN
ajlm-2756	41	35	.	.	PUNCT
ajlm-2756	42	1	of	of	ADP
ajlm-2756	42	2	these	these	PRON
ajlm-2756	42	3	,	,	PUNCT
ajlm-2756	42	4	162	162	NUM
ajlm-2756	42	5	were	be	AUX
ajlm-2756	42	6	hiv	hiv	PROPN
ajlm-2756	42	7	positive	positive	ADJ
ajlm-2756	42	8	and	and	CCONJ
ajlm-2756	42	9	113	113	NUM
ajlm-2756	42	10	were	be	AUX
ajlm-2756	42	11	hiv	hiv	PROPN
ajlm-2756	42	12	negative	negative	ADJ
ajlm-2756	42	13	.	.	PUNCT
ajlm-2756	43	1	additionally	additionally	ADV
ajlm-2756	43	2	,	,	PUNCT
ajlm-2756	43	3	a	a	DET
ajlm-2756	43	4	new	new	ADJ
ajlm-2756	43	5	column	column	NOUN
ajlm-2756	43	6	was	be	AUX
ajlm-2756	43	7	created	create	VERB
ajlm-2756	43	8	from	from	ADP
ajlm-2756	43	9	an	an	DET
ajlm-2756	43	10	existing	exist	VERB
ajlm-2756	43	11	variable	variable	NOUN
ajlm-2756	43	12	,	,	PUNCT
ajlm-2756	43	13	namely	namely	ADV
ajlm-2756	43	14	viral	viral	ADJ
ajlm-2756	43	15	load	load	NOUN
ajlm-2756	43	16	,	,	PUNCT
ajlm-2756	43	17	using	use	VERB
ajlm-2756	43	18	the	the	DET
ajlm-2756	43	19	amputation	amputation	NOUN
ajlm-2756	43	20	technique	technique	NOUN
ajlm-2756	43	21	to	to	PART
ajlm-2756	43	22	handle	handle	VERB
ajlm-2756	43	23	the	the	DET
ajlm-2756	43	24	missing	miss	VERB
ajlm-2756	43	25	data	datum	NOUN
ajlm-2756	43	26	.	.	PUNCT
ajlm-2756	44	1	the	the	DET
ajlm-2756	44	2	final	final	ADJ
ajlm-2756	44	3	analysis	analysis	NOUN
ajlm-2756	44	4	focused	focus	VERB
ajlm-2756	44	5	on	on	ADP
ajlm-2756	44	6	comparing	compare	VERB
ajlm-2756	44	7	changes	change	NOUN
ajlm-2756	44	8	in	in	ADP
ajlm-2756	44	9	inflammatory	inflammatory	ADJ
ajlm-2756	44	10	markers	marker	NOUN
ajlm-2756	44	11	,	,	PUNCT
ajlm-2756	44	12	such	such	ADJ
ajlm-2756	44	13	as	as	ADP
ajlm-2756	44	14	crp	crp	PROPN
ajlm-2756	44	15	and	and	CCONJ
ajlm-2756	44	16	d	d	NOUN
ajlm-2756	44	17	-	-	PUNCT
ajlm-2756	44	18	dimer	dimer	ADJ
ajlm-2756	44	19	,	,	PUNCT
ajlm-2756	44	20	with	with	ADP
ajlm-2756	44	21	percentages	percentage	NOUN
ajlm-2756	44	22	,	,	PUNCT
ajlm-2756	44	23	between	between	ADP
ajlm-2756	44	24	hiv	hiv	PROPN
ajlm-2756	44	25	-	-	PUNCT
ajlm-2756	44	26	positive	positive	ADJ
ajlm-2756	44	27	individuals	individual	NOUN
ajlm-2756	44	28	on	on	ADP
ajlm-2756	44	29	art	art	NOUN
ajlm-2756	44	30	and	and	CCONJ
ajlm-2756	44	31	hiv	hiv	NOUN
ajlm-2756	44	32	-	-	PUNCT
ajlm-2756	44	33	negative	negative	ADJ
ajlm-2756	44	34	individuals	individual	NOUN
ajlm-2756	44	35	.	.	PUNCT
ajlm-2756	45	1	although	although	SCONJ
ajlm-2756	45	2	this	this	DET
ajlm-2756	45	3	study	study	NOUN
ajlm-2756	45	4	utilised	utilise	VERB
ajlm-2756	45	5	retrospective	retrospective	ADJ
ajlm-2756	45	6	laboratory	laboratory	NOUN
ajlm-2756	45	7	results	result	NOUN
ajlm-2756	45	8	,	,	PUNCT
ajlm-2756	45	9	to	to	ADP
ajlm-2756	45	10	the	the	DET
ajlm-2756	45	11	researcher	researcher	NOUN
ajlm-2756	45	12	’s	’s	PART
ajlm-2756	45	13	knowledge	knowledge	NOUN
ajlm-2756	45	14	the	the	DET
ajlm-2756	45	15	analysis	analysis	NOUN
ajlm-2756	45	16	of	of	ADP
ajlm-2756	45	17	d	d	NOUN
ajlm-2756	45	18	-	-	PUNCT
ajlm-2756	45	19	dimer	dimer	NOUN
ajlm-2756	45	20	as	as	SCONJ
ajlm-2756	45	21	an	an	DET
ajlm-2756	45	22	inflammatory	inflammatory	ADJ
ajlm-2756	45	23	marker	marker	NOUN
ajlm-2756	45	24	was	be	AUX
ajlm-2756	45	25	conducted	conduct	VERB
ajlm-2756	45	26	using	use	VERB
ajlm-2756	45	27	sysmex	sysmex	NOUN
ajlm-2756	45	28	cs-2100	cs-2100	NOUN
ajlm-2756	45	29	automated	automate	VERB
ajlm-2756	45	30	blood	blood	NOUN
ajlm-2756	45	31	coagulation	coagulation	NOUN
ajlm-2756	45	32	analyser	analyser	NOUN
ajlm-2756	45	33	.	.	PUNCT
ajlm-2756	46	1	the	the	DET
ajlm-2756	46	2	cobas	cobas	ADJ
ajlm-2756	46	3	procedure	procedure	NOUN
ajlm-2756	46	4	for	for	ADP
ajlm-2756	46	5	assessing	assess	VERB
ajlm-2756	46	6	crp	crp	NOUN
ajlm-2756	46	7	involves	involve	VERB
ajlm-2756	46	8	an	an	DET
ajlm-2756	46	9	immunoturbidimetric	immunoturbidimetric	ADJ
ajlm-2756	46	10	assay	assay	NOUN
ajlm-2756	46	11	,	,	PUNCT
ajlm-2756	46	12	a	a	DET
ajlm-2756	46	13	highly	highly	ADV
ajlm-2756	46	14	sensitive	sensitive	ADJ
ajlm-2756	46	15	method	method	NOUN
ajlm-2756	46	16	used	use	VERB
ajlm-2756	46	17	to	to	PART
ajlm-2756	46	18	quantify	quantify	VERB
ajlm-2756	46	19	crp	crp	PROPN
ajlm-2756	46	20	levels	level	NOUN
ajlm-2756	46	21	in	in	ADP
ajlm-2756	46	22	blood	blood	NOUN
ajlm-2756	46	23	samples	sample	NOUN
ajlm-2756	46	24	.	.	PUNCT
ajlm-2756	47	1	statistical	statistical	ADJ
ajlm-2756	47	2	analysis	analysis	NOUN
ajlm-2756	47	3	the	the	DET
ajlm-2756	47	4	data	datum	NOUN
ajlm-2756	47	5	were	be	AUX
ajlm-2756	47	6	organised	organise	VERB
ajlm-2756	47	7	by	by	ADP
ajlm-2756	47	8	gender	gender	NOUN
ajlm-2756	47	9	,	,	PUNCT
ajlm-2756	47	10	age	age	NOUN
ajlm-2756	47	11	,	,	PUNCT
ajlm-2756	47	12	and	and	CCONJ
ajlm-2756	47	13	inflammatory	inflammatory	ADJ
ajlm-2756	47	14	markers	marker	NOUN
ajlm-2756	47	15	.	.	PUNCT
ajlm-2756	48	1	various	various	ADJ
ajlm-2756	48	2	charts	chart	NOUN
ajlm-2756	48	3	were	be	AUX
ajlm-2756	48	4	generated	generate	VERB
ajlm-2756	48	5	to	to	PART
ajlm-2756	48	6	visually	visually	ADV
ajlm-2756	48	7	represent	represent	VERB
ajlm-2756	48	8	the	the	DET
ajlm-2756	48	9	distribution	distribution	NOUN
ajlm-2756	48	10	of	of	ADP
ajlm-2756	48	11	age	age	NOUN
ajlm-2756	48	12	,	,	PUNCT
ajlm-2756	48	13	gender	gender	NOUN
ajlm-2756	48	14	,	,	PUNCT
ajlm-2756	48	15	and	and	CCONJ
ajlm-2756	48	16	inflammatory	inflammatory	ADJ
ajlm-2756	48	17	markers	marker	NOUN
ajlm-2756	48	18	such	such	ADJ
ajlm-2756	48	19	as	as	ADP
ajlm-2756	48	20	crp	crp	PROPN
ajlm-2756	48	21	and	and	CCONJ
ajlm-2756	48	22	d	d	NOUN
ajlm-2756	48	23	-	-	PUNCT
ajlm-2756	48	24	dimer	dimer	ADJ
ajlm-2756	48	25	,	,	PUNCT
ajlm-2756	48	26	with	with	ADP
ajlm-2756	48	27	percentages	percentage	NOUN
ajlm-2756	48	28	in	in	ADP
ajlm-2756	48	29	both	both	CCONJ
ajlm-2756	48	30	hiv	hiv	PROPN
ajlm-2756	48	31	-	-	PUNCT
ajlm-2756	48	32	positive	positive	ADJ
ajlm-2756	48	33	and	and	CCONJ
ajlm-2756	48	34	hiv	hiv	NOUN
ajlm-2756	48	35	-	-	PUNCT
ajlm-2756	48	36	negative	negative	ADJ
ajlm-2756	48	37	patients	patient	NOUN
ajlm-2756	48	38	.	.	PUNCT
ajlm-2756	49	1	descriptive	descriptive	ADJ
ajlm-2756	49	2	statistics	statistic	NOUN
ajlm-2756	49	3	such	such	ADJ
ajlm-2756	49	4	as	as	ADP
ajlm-2756	49	5	mean	mean	ADJ
ajlm-2756	49	6	,	,	PUNCT
ajlm-2756	49	7	standard	standard	ADJ
ajlm-2756	49	8	deviation	deviation	NOUN
ajlm-2756	49	9	,	,	PUNCT
ajlm-2756	49	10	and	and	CCONJ
ajlm-2756	49	11	mode	mode	NOUN
ajlm-2756	49	12	,	,	PUNCT
ajlm-2756	49	13	were	be	AUX
ajlm-2756	49	14	calculated	calculate	VERB
ajlm-2756	49	15	using	use	VERB
ajlm-2756	49	16	microsoft	microsoft	PROPN
ajlm-2756	49	17	excel	excel	PROPN
ajlm-2756	49	18	.	.	PUNCT
ajlm-2756	50	1	spearman	spearman	NOUN
ajlm-2756	50	2	’s	’s	PART
ajlm-2756	50	3	rank	rank	NOUN
ajlm-2756	50	4	correlation	correlation	NOUN
ajlm-2756	50	5	coefficient	coefficient	NOUN
ajlm-2756	50	6	was	be	AUX
ajlm-2756	50	7	applied	apply	VERB
ajlm-2756	50	8	to	to	PART
ajlm-2756	50	9	assess	assess	VERB
ajlm-2756	50	10	the	the	DET
ajlm-2756	50	11	relationship	relationship	NOUN
ajlm-2756	50	12	between	between	ADP
ajlm-2756	50	13	inflammatory	inflammatory	ADJ
ajlm-2756	50	14	markers	marker	NOUN
ajlm-2756	50	15	and	and	CCONJ
ajlm-2756	50	16	hiv	hiv	PROPN
ajlm-2756	50	17	status	status	NOUN
ajlm-2756	50	18	.	.	PUNCT
ajlm-2756	51	1	statistical	statistical	ADJ
ajlm-2756	51	2	analysis	analysis	NOUN
ajlm-2756	51	3	was	be	AUX
ajlm-2756	51	4	conducted	conduct	VERB
ajlm-2756	51	5	using	use	VERB
ajlm-2756	51	6	descriptive	descriptive	ADJ
ajlm-2756	51	7	tables	table	NOUN
ajlm-2756	51	8	and	and	CCONJ
ajlm-2756	51	9	spearman	spearman	NOUN
ajlm-2756	51	10	’s	’s	PART
ajlm-2756	51	11	rank	rank	NOUN
ajlm-2756	51	12	correlation	correlation	NOUN
ajlm-2756	51	13	for	for	ADP
ajlm-2756	51	14	assessing	assess	VERB
ajlm-2756	51	15	the	the	DET
ajlm-2756	51	16	relationships	relationship	NOUN
ajlm-2756	51	17	between	between	ADP
ajlm-2756	51	18	variables	variable	NOUN
ajlm-2756	51	19	.	.	PUNCT
ajlm-2756	52	1	the	the	DET
ajlm-2756	52	2	results	result	NOUN
ajlm-2756	52	3	of	of	ADP
ajlm-2756	52	4	this	this	DET
ajlm-2756	52	5	analysis	analysis	NOUN
ajlm-2756	52	6	were	be	AUX
ajlm-2756	52	7	then	then	ADV
ajlm-2756	52	8	used	use	VERB
ajlm-2756	52	9	to	to	PART
ajlm-2756	52	10	evaluate	evaluate	VERB
ajlm-2756	52	11	the	the	DET
ajlm-2756	52	12	hypothesis	hypothesis	NOUN
ajlm-2756	52	13	,	,	PUNCT
ajlm-2756	52	14	‘	'	PUNCT
ajlm-2756	52	15	there	there	PRON
ajlm-2756	52	16	is	be	VERB
ajlm-2756	52	17	a	a	DET
ajlm-2756	52	18	significant	significant	ADJ
ajlm-2756	52	19	positive	positive	ADJ
ajlm-2756	52	20	correlation	correlation	NOUN
ajlm-2756	52	21	between	between	ADP
ajlm-2756	52	22	viral	viral	ADJ
ajlm-2756	52	23	load	load	NOUN
ajlm-2756	52	24	,	,	PUNCT
ajlm-2756	52	25	crp	crp	PROPN
ajlm-2756	52	26	,	,	PUNCT
ajlm-2756	52	27	and	and	CCONJ
ajlm-2756	52	28	d	d	X
ajlm-2756	52	29	-	-	PUNCT
ajlm-2756	52	30	dimer	dimer	ADJ
ajlm-2756	52	31	levels	level	NOUN
ajlm-2756	52	32	in	in	ADP
ajlm-2756	52	33	hiv	hiv	PROPN
ajlm-2756	52	34	-	-	PUNCT
ajlm-2756	52	35	positive	positive	ADJ
ajlm-2756	52	36	individuals	individual	NOUN
ajlm-2756	52	37	art	art	NOUN
ajlm-2756	52	38	compared	compare	VERB
ajlm-2756	52	39	to	to	ADP
ajlm-2756	52	40	hiv	hiv	PROPN
ajlm-2756	52	41	-	-	PUNCT
ajlm-2756	52	42	negative	negative	ADJ
ajlm-2756	52	43	individuals	individual	NOUN
ajlm-2756	52	44	’	'	PUNCT
ajlm-2756	52	45	,	,	PUNCT
ajlm-2756	52	46	and	and	CCONJ
ajlm-2756	52	47	determine	determine	VERB
ajlm-2756	52	48	whether	whether	SCONJ
ajlm-2756	52	49	it	it	PRON
ajlm-2756	52	50	could	could	AUX
ajlm-2756	52	51	be	be	AUX
ajlm-2756	52	52	rejected	reject	VERB
ajlm-2756	52	53	or	or	CCONJ
ajlm-2756	52	54	supported	support	VERB
ajlm-2756	52	55	.	.	PUNCT
ajlm-2756	53	1	results	result	VERB
ajlm-2756	53	2	demographic	demographic	ADJ
ajlm-2756	53	3	distribution	distribution	NOUN
ajlm-2756	53	4	a	a	DET
ajlm-2756	53	5	total	total	NOUN
ajlm-2756	53	6	of	of	ADP
ajlm-2756	53	7	275	275	NUM
ajlm-2756	53	8	patient	patient	ADJ
ajlm-2756	53	9	records	record	NOUN
ajlm-2756	53	10	were	be	AUX
ajlm-2756	53	11	included	include	VERB
ajlm-2756	53	12	in	in	ADP
ajlm-2756	53	13	the	the	DET
ajlm-2756	53	14	study	study	NOUN
ajlm-2756	53	15	with	with	ADP
ajlm-2756	53	16	98.2	98.2	NUM
ajlm-2756	53	17	%	%	NOUN
ajlm-2756	53	18	(	(	PUNCT
ajlm-2756	53	19	n	n	NOUN
ajlm-2756	53	20	=	=	SYM
ajlm-2756	53	21	270	270	NUM
ajlm-2756	53	22	)	)	PUNCT
ajlm-2756	53	23	aged	age	VERB
ajlm-2756	53	24	18–39	18–39	NUM
ajlm-2756	53	25	years	year	NOUN
ajlm-2756	53	26	and	and	CCONJ
ajlm-2756	53	27	1.8	1.8	NUM
ajlm-2756	53	28	%	%	NOUN
ajlm-2756	53	29	aged	aged	ADJ
ajlm-2756	53	30	<	<	X
ajlm-2756	53	31	17	17	NUM
ajlm-2756	53	32	years	year	NOUN
ajlm-2756	53	33	.	.	PUNCT
ajlm-2756	54	1	the	the	DET
ajlm-2756	54	2	majority	majority	NOUN
ajlm-2756	54	3	of	of	ADP
ajlm-2756	54	4	results	result	NOUN
ajlm-2756	54	5	included	include	VERB
ajlm-2756	54	6	were	be	AUX
ajlm-2756	54	7	from	from	ADP
ajlm-2756	54	8	female	female	ADJ
ajlm-2756	54	9	patients	patient	NOUN
ajlm-2756	54	10	(	(	PUNCT
ajlm-2756	54	11	n	n	NOUN
ajlm-2756	54	12	=	=	SYM
ajlm-2756	54	13	211	211	NUM
ajlm-2756	54	14	;	;	PUNCT
ajlm-2756	54	15	76.7	76.7	NUM
ajlm-2756	54	16	%	%	NOUN
ajlm-2756	54	17	)	)	PUNCT
ajlm-2756	54	18	,	,	PUNCT
ajlm-2756	54	19	and	and	CCONJ
ajlm-2756	54	20	23.3	23.3	NUM
ajlm-2756	54	21	%	%	NOUN
ajlm-2756	54	22	(	(	PUNCT
ajlm-2756	54	23	n	n	NOUN
ajlm-2756	54	24	=	=	SYM
ajlm-2756	54	25	64	64	NUM
ajlm-2756	54	26	)	)	PUNCT
ajlm-2756	54	27	from	from	ADP
ajlm-2756	54	28	male	male	ADJ
ajlm-2756	54	29	patients	patient	NOUN
ajlm-2756	54	30	(	(	PUNCT
ajlm-2756	54	31	table	table	NOUN
ajlm-2756	54	32	1	1	NUM
ajlm-2756	54	33	)	)	PUNCT
ajlm-2756	54	34	.	.	PUNCT
ajlm-2756	55	1	table	table	NOUN
ajlm-2756	55	2	1	1	NUM
ajlm-2756	55	3	:	:	PUNCT
ajlm-2756	55	4	 	 	SPACE
ajlm-2756	55	5	demographic	demographic	ADJ
ajlm-2756	55	6	distribution	distribution	NOUN
ajlm-2756	55	7	of	of	ADP
ajlm-2756	55	8	study	study	NOUN
ajlm-2756	55	9	participants	participant	NOUN
ajlm-2756	55	10	by	by	ADP
ajlm-2756	55	11	age	age	NOUN
ajlm-2756	55	12	and	and	CCONJ
ajlm-2756	55	13	gender	gender	NOUN
ajlm-2756	55	14	in	in	ADP
ajlm-2756	55	15	south	south	PROPN
ajlm-2756	55	16	africa	africa	PROPN
ajlm-2756	55	17	between	between	ADP
ajlm-2756	55	18	january	january	PROPN
ajlm-2756	55	19	2020	2020	NUM
ajlm-2756	55	20	and	and	CCONJ
ajlm-2756	55	21	december	december	PROPN
ajlm-2756	55	22	2023	2023	NUM
ajlm-2756	55	23	.	.	PUNCT
ajlm-2756	56	1	distribution	distribution	NOUN
ajlm-2756	56	2	of	of	ADP
ajlm-2756	56	3	hiv	hiv	PROPN
ajlm-2756	56	4	infection	infection	NOUN
ajlm-2756	56	5	by	by	ADP
ajlm-2756	56	6	age	age	NOUN
ajlm-2756	56	7	group	group	NOUN
ajlm-2756	56	8	and	and	CCONJ
ajlm-2756	56	9	gender	gender	NOUN
ajlm-2756	56	10	among	among	ADP
ajlm-2756	56	11	tested	test	VERB
ajlm-2756	56	12	patients	patient	NOUN
ajlm-2756	56	13	a	a	DET
ajlm-2756	56	14	total	total	NOUN
ajlm-2756	56	15	of	of	ADP
ajlm-2756	56	16	113	113	NUM
ajlm-2756	56	17	(	(	PUNCT
ajlm-2756	56	18	41	41	NUM
ajlm-2756	56	19	%	%	NOUN
ajlm-2756	56	20	)	)	PUNCT
ajlm-2756	56	21	results	result	NOUN
ajlm-2756	56	22	were	be	AUX
ajlm-2756	56	23	hiv	hiv	NOUN
ajlm-2756	56	24	negative	negative	ADJ
ajlm-2756	56	25	,	,	PUNCT
ajlm-2756	56	26	while	while	SCONJ
ajlm-2756	56	27	162	162	NUM
ajlm-2756	56	28	(	(	PUNCT
ajlm-2756	56	29	59	59	NUM
ajlm-2756	56	30	%	%	NOUN
ajlm-2756	56	31	)	)	PUNCT
ajlm-2756	56	32	were	be	AUX
ajlm-2756	56	33	hiv	hiv	PROPN
ajlm-2756	56	34	positive	positive	ADJ
ajlm-2756	56	35	.	.	PUNCT
ajlm-2756	57	1	among	among	ADP
ajlm-2756	57	2	the	the	DET
ajlm-2756	57	3	275	275	NUM
ajlm-2756	57	4	tested	test	VERB
ajlm-2756	57	5	individuals	individual	NOUN
ajlm-2756	57	6	,	,	PUNCT
ajlm-2756	57	7	a	a	DET
ajlm-2756	57	8	higher	high	ADJ
ajlm-2756	57	9	prevalence	prevalence	NOUN
ajlm-2756	57	10	of	of	ADP
ajlm-2756	57	11	hiv	hiv	PROPN
ajlm-2756	57	12	was	be	AUX
ajlm-2756	57	13	observed	observe	VERB
ajlm-2756	57	14	in	in	ADP
ajlm-2756	57	15	the	the	DET
ajlm-2756	57	16	18–39	18–39	NUM
ajlm-2756	57	17	years	year	NOUN
ajlm-2756	57	18	age	age	NOUN
ajlm-2756	57	19	group	group	NOUN
ajlm-2756	57	20	(	(	PUNCT
ajlm-2756	57	21	158	158	NUM
ajlm-2756	57	22	positive	positive	ADJ
ajlm-2756	57	23	cases	case	NOUN
ajlm-2756	57	24	;	;	PUNCT
ajlm-2756	57	25	57	57	NUM
ajlm-2756	57	26	%	%	NOUN
ajlm-2756	57	27	)	)	PUNCT
ajlm-2756	57	28	,	,	PUNCT
ajlm-2756	57	29	and	and	CCONJ
ajlm-2756	57	30	among	among	ADP
ajlm-2756	57	31	female	female	ADJ
ajlm-2756	57	32	patients	patient	NOUN
ajlm-2756	57	33	(	(	PUNCT
ajlm-2756	57	34	112	112	NUM
ajlm-2756	57	35	positive	positive	ADJ
ajlm-2756	57	36	cases	case	NOUN
ajlm-2756	57	37	;	;	PUNCT
ajlm-2756	57	38	40	40	NUM
ajlm-2756	57	39	%	%	NOUN
ajlm-2756	57	40	)	)	PUNCT
ajlm-2756	57	41	.	.	PUNCT
ajlm-2756	58	1	the	the	DET
ajlm-2756	58	2	majority	majority	NOUN
ajlm-2756	58	3	of	of	ADP
ajlm-2756	58	4	participants	participant	NOUN
ajlm-2756	58	5	aged	age	VERB
ajlm-2756	58	6	<	<	X
ajlm-2756	58	7	17	17	NUM
ajlm-2756	58	8	years	year	NOUN
ajlm-2756	58	9	of	of	ADP
ajlm-2756	58	10	age	age	NOUN
ajlm-2756	58	11	tested	test	VERB
ajlm-2756	58	12	negative	negative	ADJ
ajlm-2756	58	13	for	for	ADP
ajlm-2756	58	14	hiv	hiv	PROPN
ajlm-2756	58	15	,	,	PUNCT
ajlm-2756	58	16	with	with	ADP
ajlm-2756	58	17	only	only	ADV
ajlm-2756	58	18	four	four	NUM
ajlm-2756	58	19	cases	case	NOUN
ajlm-2756	58	20	(	(	PUNCT
ajlm-2756	58	21	1.5	1.5	NUM
ajlm-2756	58	22	%	%	NOUN
ajlm-2756	58	23	)	)	PUNCT
ajlm-2756	58	24	testing	test	VERB
ajlm-2756	58	25	positive	positive	ADJ
ajlm-2756	58	26	(	(	PUNCT
ajlm-2756	58	27	table	table	NOUN
ajlm-2756	58	28	2	2	NUM
ajlm-2756	58	29	)	)	PUNCT
ajlm-2756	58	30	.	.	PUNCT
ajlm-2756	59	1	table	table	NOUN
ajlm-2756	59	2	2	2	NUM
ajlm-2756	59	3	:	:	PUNCT
ajlm-2756	59	4	 	 	SPACE
ajlm-2756	59	5	distribution	distribution	NOUN
ajlm-2756	59	6	of	of	ADP
ajlm-2756	59	7	hiv	hiv	PROPN
ajlm-2756	59	8	infection	infection	NOUN
ajlm-2756	59	9	by	by	ADP
ajlm-2756	59	10	age	age	NOUN
ajlm-2756	59	11	group	group	NOUN
ajlm-2756	59	12	and	and	CCONJ
ajlm-2756	59	13	gender	gender	NOUN
ajlm-2756	59	14	among	among	ADP
ajlm-2756	59	15	tested	test	VERB
ajlm-2756	59	16	patients	patient	NOUN
ajlm-2756	59	17	in	in	ADP
ajlm-2756	59	18	south	south	PROPN
ajlm-2756	59	19	africa	africa	PROPN
ajlm-2756	59	20	tested	test	VERB
ajlm-2756	59	21	between	between	ADP
ajlm-2756	59	22	january	january	PROPN
ajlm-2756	59	23	2020	2020	NUM
ajlm-2756	59	24	and	and	CCONJ
ajlm-2756	59	25	december	december	PROPN
ajlm-2756	59	26	2023	2023	NUM
ajlm-2756	59	27	.	.	PUNCT
ajlm-2756	60	1	distribution	distribution	NOUN
ajlm-2756	60	2	of	of	ADP
ajlm-2756	60	3	viral	viral	ADJ
ajlm-2756	60	4	load	load	NOUN
ajlm-2756	60	5	among	among	ADP
ajlm-2756	60	6	tested	test	VERB
ajlm-2756	60	7	patients	patient	NOUN
ajlm-2756	60	8	by	by	ADP
ajlm-2756	60	9	age	age	NOUN
ajlm-2756	60	10	group	group	NOUN
ajlm-2756	60	11	and	and	CCONJ
ajlm-2756	60	12	gender	gender	NOUN
ajlm-2756	60	13	table	table	NOUN
ajlm-2756	60	14	3	3	NUM
ajlm-2756	60	15	shows	show	VERB
ajlm-2756	60	16	the	the	DET
ajlm-2756	60	17	distribution	distribution	NOUN
ajlm-2756	60	18	of	of	ADP
ajlm-2756	60	19	viral	viral	ADJ
ajlm-2756	60	20	load	load	NOUN
ajlm-2756	60	21	among	among	ADP
ajlm-2756	60	22	tested	test	VERB
ajlm-2756	60	23	patients	patient	NOUN
ajlm-2756	60	24	,	,	PUNCT
ajlm-2756	60	25	categorised	categorise	VERB
ajlm-2756	60	26	by	by	ADP
ajlm-2756	60	27	age	age	NOUN
ajlm-2756	60	28	group	group	NOUN
ajlm-2756	60	29	and	and	CCONJ
ajlm-2756	60	30	gender	gender	NOUN
ajlm-2756	60	31	.	.	PUNCT
ajlm-2756	61	1	it	it	PRON
ajlm-2756	61	2	highlights	highlight	VERB
ajlm-2756	61	3	the	the	DET
ajlm-2756	61	4	prevalence	prevalence	NOUN
ajlm-2756	61	5	of	of	ADP
ajlm-2756	61	6	undetectable	undetectable	ADJ
ajlm-2756	61	7	viral	viral	ADJ
ajlm-2756	61	8	loads	load	NOUN
ajlm-2756	61	9	,	,	PUNCT
ajlm-2756	61	10	acceptable	acceptable	ADJ
ajlm-2756	61	11	levels	level	NOUN
ajlm-2756	61	12	,	,	PUNCT
ajlm-2756	61	13	and	and	CCONJ
ajlm-2756	61	14	the	the	DET
ajlm-2756	61	15	need	need	NOUN
ajlm-2756	61	16	for	for	ADP
ajlm-2756	61	17	monitoring	monitoring	NOUN
ajlm-2756	61	18	or	or	CCONJ
ajlm-2756	61	19	urgent	urgent	ADJ
ajlm-2756	61	20	medical	medical	ADJ
ajlm-2756	61	21	attention	attention	NOUN
ajlm-2756	61	22	across	across	ADP
ajlm-2756	61	23	different	different	ADJ
ajlm-2756	61	24	subgroups	subgroup	NOUN
ajlm-2756	61	25	.	.	PUNCT
ajlm-2756	62	1	table	table	NOUN
ajlm-2756	62	2	3	3	NUM
ajlm-2756	62	3	:	:	PUNCT
ajlm-2756	62	4	 	 	SPACE
ajlm-2756	62	5	distribution	distribution	NOUN
ajlm-2756	62	6	of	of	ADP
ajlm-2756	62	7	viral	viral	ADJ
ajlm-2756	62	8	load	load	NOUN
ajlm-2756	62	9	among	among	ADP
ajlm-2756	62	10	tested	test	VERB
ajlm-2756	62	11	patients	patient	NOUN
ajlm-2756	62	12	by	by	ADP
ajlm-2756	62	13	age	age	NOUN
ajlm-2756	62	14	group	group	NOUN
ajlm-2756	62	15	and	and	CCONJ
ajlm-2756	62	16	gender	gender	NOUN
ajlm-2756	62	17	in	in	ADP
ajlm-2756	62	18	south	south	PROPN
ajlm-2756	62	19	africa	africa	PROPN
ajlm-2756	62	20	tested	test	VERB
ajlm-2756	62	21	between	between	ADP
ajlm-2756	62	22	january	january	PROPN
ajlm-2756	62	23	2020	2020	NUM
ajlm-2756	62	24	and	and	CCONJ
ajlm-2756	62	25	december	december	PROPN
ajlm-2756	62	26	2023	2023	NUM
ajlm-2756	62	27	.	.	PUNCT
ajlm-2756	63	1	distribution	distribution	NOUN
ajlm-2756	63	2	of	of	ADP
ajlm-2756	63	3	normal	normal	ADJ
ajlm-2756	63	4	and	and	CCONJ
ajlm-2756	63	5	high	high	ADJ
ajlm-2756	63	6	c	c	NOUN
ajlm-2756	63	7	-	-	ADJ
ajlm-2756	63	8	reactive	reactive	ADJ
ajlm-2756	63	9	protein	protein	NOUN
ajlm-2756	63	10	levels	level	NOUN
ajlm-2756	63	11	by	by	ADP
ajlm-2756	63	12	age	age	NOUN
ajlm-2756	63	13	group	group	NOUN
ajlm-2756	63	14	and	and	CCONJ
ajlm-2756	63	15	gender	gender	NOUN
ajlm-2756	63	16	table	table	NOUN
ajlm-2756	63	17	4	4	NUM
ajlm-2756	63	18	shows	show	VERB
ajlm-2756	63	19	the	the	DET
ajlm-2756	63	20	distribution	distribution	NOUN
ajlm-2756	63	21	of	of	ADP
ajlm-2756	63	22	normal	normal	ADJ
ajlm-2756	63	23	and	and	CCONJ
ajlm-2756	63	24	elevated	elevated	ADJ
ajlm-2756	63	25	crp	crp	PROPN
ajlm-2756	63	26	levels	level	NOUN
ajlm-2756	63	27	across	across	ADP
ajlm-2756	63	28	different	different	ADJ
ajlm-2756	63	29	age	age	NOUN
ajlm-2756	63	30	groups	group	NOUN
ajlm-2756	63	31	and	and	CCONJ
ajlm-2756	63	32	genders	gender	NOUN
ajlm-2756	63	33	.	.	PUNCT
ajlm-2756	64	1	normal	normal	ADJ
ajlm-2756	64	2	range	range	NOUN
ajlm-2756	64	3	used	use	VERB
ajlm-2756	64	4	for	for	ADP
ajlm-2756	64	5	children	child	NOUN
ajlm-2756	64	6	,	,	PUNCT
ajlm-2756	64	7	adult	adult	NOUN
ajlm-2756	64	8	male	male	ADJ
ajlm-2756	64	9	and	and	CCONJ
ajlm-2756	64	10	female	female	ADJ
ajlm-2756	64	11	patients	patient	NOUN
ajlm-2756	64	12	is	be	AUX
ajlm-2756	64	13	less	less	ADJ
ajlm-2756	64	14	than	than	ADP
ajlm-2756	64	15	10.0	10.0	NUM
ajlm-2756	64	16	mg	mg	NUM
ajlm-2756	64	17	/	/	SYM
ajlm-2756	64	18	l.	l.	PROPN
ajlm-2756	65	1	the	the	DET
ajlm-2756	65	2	data	datum	NOUN
ajlm-2756	65	3	reveal	reveal	VERB
ajlm-2756	65	4	that	that	SCONJ
ajlm-2756	65	5	individuals	individual	NOUN
ajlm-2756	65	6	aged	age	VERB
ajlm-2756	65	7	<	<	X
ajlm-2756	65	8	17	17	NUM
ajlm-2756	65	9	years	year	NOUN
ajlm-2756	65	10	predominantly	predominantly	ADV
ajlm-2756	65	11	had	have	VERB
ajlm-2756	65	12	normal	normal	ADJ
ajlm-2756	65	13	crp	crp	NOUN
ajlm-2756	65	14	levels	level	NOUN
ajlm-2756	65	15	,	,	PUNCT
ajlm-2756	65	16	while	while	SCONJ
ajlm-2756	65	17	the	the	DET
ajlm-2756	65	18	18–39	18–39	NUM
ajlm-2756	65	19	years	year	NOUN
ajlm-2756	65	20	group	group	NOUN
ajlm-2756	65	21	had	have	VERB
ajlm-2756	65	22	a	a	DET
ajlm-2756	65	23	nearly	nearly	ADV
ajlm-2756	65	24	equal	equal	ADJ
ajlm-2756	65	25	distribution	distribution	NOUN
ajlm-2756	65	26	of	of	ADP
ajlm-2756	65	27	normal	normal	ADJ
ajlm-2756	65	28	and	and	CCONJ
ajlm-2756	65	29	high	high	ADJ
ajlm-2756	65	30	crp	crp	PROPN
ajlm-2756	65	31	levels	level	NOUN
ajlm-2756	65	32	.	.	PUNCT
ajlm-2756	66	1	additionally	additionally	ADV
ajlm-2756	66	2	,	,	PUNCT
ajlm-2756	66	3	female	female	ADJ
ajlm-2756	66	4	patients	patient	NOUN
ajlm-2756	66	5	had	have	VERB
ajlm-2756	66	6	a	a	DET
ajlm-2756	66	7	higher	high	ADJ
ajlm-2756	66	8	proportion	proportion	NOUN
ajlm-2756	66	9	of	of	ADP
ajlm-2756	66	10	normal	normal	ADJ
ajlm-2756	66	11	crp	crp	NOUN
ajlm-2756	66	12	levels	level	NOUN
ajlm-2756	66	13	,	,	PUNCT
ajlm-2756	66	14	whereas	whereas	SCONJ
ajlm-2756	66	15	male	male	ADJ
ajlm-2756	66	16	patients	patient	NOUN
ajlm-2756	66	17	exhibited	exhibit	VERB
ajlm-2756	66	18	a	a	DET
ajlm-2756	66	19	greater	great	ADJ
ajlm-2756	66	20	incidence	incidence	NOUN
ajlm-2756	66	21	of	of	ADP
ajlm-2756	66	22	elevated	elevated	ADJ
ajlm-2756	66	23	crp	crp	NOUN
ajlm-2756	66	24	levels	level	NOUN
ajlm-2756	66	25	.	.	PUNCT
ajlm-2756	67	1	table	table	NOUN
ajlm-2756	67	2	4	4	NUM
ajlm-2756	67	3	:	:	PUNCT
ajlm-2756	67	4	 	 	SPACE
ajlm-2756	67	5	distribution	distribution	NOUN
ajlm-2756	67	6	of	of	ADP
ajlm-2756	67	7	normal	normal	ADJ
ajlm-2756	67	8	and	and	CCONJ
ajlm-2756	67	9	high	high	ADJ
ajlm-2756	67	10	c	c	NOUN
ajlm-2756	67	11	-	-	ADJ
ajlm-2756	67	12	reactive	reactive	ADJ
ajlm-2756	67	13	protein	protein	NOUN
ajlm-2756	67	14	levels	level	NOUN
ajlm-2756	67	15	by	by	ADP
ajlm-2756	67	16	age	age	NOUN
ajlm-2756	67	17	group	group	NOUN
ajlm-2756	67	18	and	and	CCONJ
ajlm-2756	67	19	gender	gender	NOUN
ajlm-2756	67	20	in	in	ADP
ajlm-2756	67	21	south	south	PROPN
ajlm-2756	67	22	africa	africa	PROPN
ajlm-2756	67	23	tested	test	VERB
ajlm-2756	67	24	between	between	ADP
ajlm-2756	67	25	january	january	PROPN
ajlm-2756	67	26	2020	2020	NUM
ajlm-2756	67	27	and	and	CCONJ
ajlm-2756	67	28	december	december	PROPN
ajlm-2756	67	29	2023	2023	NUM
ajlm-2756	67	30	.	.	PUNCT
ajlm-2756	68	1	distribution	distribution	NOUN
ajlm-2756	68	2	of	of	ADP
ajlm-2756	68	3	d	d	ADJ
ajlm-2756	68	4	-	-	PUNCT
ajlm-2756	68	5	dimer	dimer	ADJ
ajlm-2756	68	6	levels	level	NOUN
ajlm-2756	68	7	by	by	ADP
ajlm-2756	68	8	age	age	NOUN
ajlm-2756	68	9	group	group	NOUN
ajlm-2756	68	10	and	and	CCONJ
ajlm-2756	68	11	gender	gender	NOUN
ajlm-2756	68	12	table	table	NOUN
ajlm-2756	68	13	5	5	NUM
ajlm-2756	68	14	shows	show	VERB
ajlm-2756	68	15	the	the	DET
ajlm-2756	68	16	distribution	distribution	NOUN
ajlm-2756	68	17	of	of	ADP
ajlm-2756	68	18	normal	normal	ADJ
ajlm-2756	68	19	and	and	CCONJ
ajlm-2756	68	20	elevated	elevated	ADJ
ajlm-2756	68	21	d	d	ADJ
ajlm-2756	68	22	-	-	PUNCT
ajlm-2756	68	23	dimer	dimer	ADJ
ajlm-2756	68	24	levels	level	NOUN
ajlm-2756	68	25	across	across	ADP
ajlm-2756	68	26	age	age	NOUN
ajlm-2756	68	27	groups	group	NOUN
ajlm-2756	68	28	and	and	CCONJ
ajlm-2756	68	29	genders	gender	NOUN
ajlm-2756	68	30	.	.	PUNCT
ajlm-2756	69	1	reference	reference	NOUN
ajlm-2756	69	2	normal	normal	ADJ
ajlm-2756	69	3	range	range	NOUN
ajlm-2756	69	4	used	use	VERB
ajlm-2756	69	5	was	be	AUX
ajlm-2756	69	6	less	less	ADJ
ajlm-2756	69	7	than	than	ADP
ajlm-2756	69	8	0.50	0.50	NUM
ajlm-2756	69	9	mg	mg	PROPN
ajlm-2756	69	10	/	/	SYM
ajlm-2756	69	11	l.	l.	PROPN
ajlm-2756	69	12	most	most	ADJ
ajlm-2756	69	13	participants	participant	NOUN
ajlm-2756	69	14	,	,	PUNCT
ajlm-2756	69	15	regardless	regardless	ADV
ajlm-2756	69	16	of	of	ADP
ajlm-2756	69	17	age	age	NOUN
ajlm-2756	69	18	or	or	CCONJ
ajlm-2756	69	19	gender	gender	NOUN
ajlm-2756	69	20	,	,	PUNCT
ajlm-2756	69	21	exhibited	exhibit	VERB
ajlm-2756	69	22	normal	normal	ADJ
ajlm-2756	69	23	d	d	ADJ
ajlm-2756	69	24	-	-	PUNCT
ajlm-2756	69	25	dimer	dimer	ADJ
ajlm-2756	69	26	levels	level	NOUN
ajlm-2756	69	27	,	,	PUNCT
ajlm-2756	69	28	with	with	ADP
ajlm-2756	69	29	only	only	ADV
ajlm-2756	69	30	a	a	DET
ajlm-2756	69	31	small	small	ADJ
ajlm-2756	69	32	proportion	proportion	NOUN
ajlm-2756	69	33	showing	show	VERB
ajlm-2756	69	34	elevated	elevated	ADJ
ajlm-2756	69	35	levels	level	NOUN
ajlm-2756	69	36	.	.	PUNCT
ajlm-2756	70	1	notably	notably	ADV
ajlm-2756	70	2	,	,	PUNCT
ajlm-2756	70	3	all	all	DET
ajlm-2756	70	4	individuals	individual	NOUN
ajlm-2756	70	5	in	in	ADP
ajlm-2756	70	6	the	the	DET
ajlm-2756	70	7	<	<	X
ajlm-2756	70	8	17	17	NUM
ajlm-2756	70	9	years	year	NOUN
ajlm-2756	70	10	age	age	NOUN
ajlm-2756	70	11	group	group	NOUN
ajlm-2756	70	12	had	have	VERB
ajlm-2756	70	13	normal	normal	ADJ
ajlm-2756	70	14	levels	level	NOUN
ajlm-2756	70	15	,	,	PUNCT
ajlm-2756	70	16	and	and	CCONJ
ajlm-2756	70	17	elevated	elevated	ADJ
ajlm-2756	70	18	levels	level	NOUN
ajlm-2756	70	19	were	be	AUX
ajlm-2756	70	20	rare	rare	ADJ
ajlm-2756	70	21	among	among	ADP
ajlm-2756	70	22	both	both	CCONJ
ajlm-2756	70	23	female	female	ADJ
ajlm-2756	70	24	and	and	CCONJ
ajlm-2756	70	25	male	male	ADJ
ajlm-2756	70	26	patients	patient	NOUN
ajlm-2756	70	27	.	.	PUNCT
ajlm-2756	71	1	table	table	NOUN
ajlm-2756	71	2	5	5	NUM
ajlm-2756	71	3	:	:	PUNCT
ajlm-2756	71	4	 	 	SPACE
ajlm-2756	71	5	correlation	correlation	NOUN
ajlm-2756	71	6	among	among	ADP
ajlm-2756	71	7	age	age	NOUN
ajlm-2756	71	8	,	,	PUNCT
ajlm-2756	71	9	viral	viral	ADJ
ajlm-2756	71	10	load	load	NOUN
ajlm-2756	71	11	,	,	PUNCT
ajlm-2756	71	12	c	c	NOUN
ajlm-2756	71	13	-	-	PUNCT
ajlm-2756	71	14	reactive	reactive	ADJ
ajlm-2756	71	15	protein	protein	NOUN
ajlm-2756	71	16	,	,	PUNCT
ajlm-2756	71	17	and	and	CCONJ
ajlm-2756	71	18	d	d	X
ajlm-2756	71	19	-	-	PUNCT
ajlm-2756	71	20	dimer	dimer	ADJ
ajlm-2756	71	21	levels	level	NOUN
ajlm-2756	71	22	in	in	ADP
ajlm-2756	71	23	south	south	PROPN
ajlm-2756	71	24	africa	africa	PROPN
ajlm-2756	71	25	tested	test	VERB
ajlm-2756	71	26	january	january	PROPN
ajlm-2756	71	27	2020	2020	NUM
ajlm-2756	71	28	to	to	ADP
ajlm-2756	71	29	december	december	PROPN
ajlm-2756	71	30	2023	2023	NUM
ajlm-2756	71	31	.	.	PUNCT
ajlm-2756	72	1	spearman	spearman	NOUN
ajlm-2756	72	2	’s	’s	PART
ajlm-2756	72	3	rank	rank	NOUN
ajlm-2756	72	4	correlation	correlation	NOUN
ajlm-2756	72	5	coefficients	coefficient	NOUN
ajlm-2756	72	6	for	for	ADP
ajlm-2756	72	7	age	age	NOUN
ajlm-2756	72	8	,	,	PUNCT
ajlm-2756	72	9	viral	viral	ADJ
ajlm-2756	72	10	load	load	NOUN
ajlm-2756	72	11	,	,	PUNCT
ajlm-2756	72	12	c	c	NOUN
ajlm-2756	72	13	-	-	PUNCT
ajlm-2756	72	14	reactive	reactive	ADJ
ajlm-2756	72	15	protein	protein	NOUN
ajlm-2756	72	16	,	,	PUNCT
ajlm-2756	72	17	and	and	CCONJ
ajlm-2756	72	18	d	d	X
ajlm-2756	72	19	-	-	PUNCT
ajlm-2756	72	20	dimer	dimer	NOUN
ajlm-2756	72	21	levels	level	VERB
ajlm-2756	72	22	a	a	DET
ajlm-2756	72	23	weak	weak	ADJ
ajlm-2756	72	24	negative	negative	ADJ
ajlm-2756	72	25	correlation	correlation	NOUN
ajlm-2756	72	26	between	between	ADP
ajlm-2756	72	27	age	age	NOUN
ajlm-2756	72	28	and	and	CCONJ
ajlm-2756	72	29	viral	viral	ADJ
ajlm-2756	72	30	load	load	NOUN
ajlm-2756	72	31	was	be	AUX
ajlm-2756	72	32	observed	observe	VERB
ajlm-2756	72	33	,	,	PUNCT
ajlm-2756	72	34	which	which	PRON
ajlm-2756	72	35	was	be	AUX
ajlm-2756	72	36	not	not	PART
ajlm-2756	72	37	statistically	statistically	ADV
ajlm-2756	72	38	significant	significant	ADJ
ajlm-2756	72	39	.	.	PUNCT
ajlm-2756	73	1	however	however	ADV
ajlm-2756	73	2	,	,	PUNCT
ajlm-2756	73	3	a	a	DET
ajlm-2756	73	4	significant	significant	ADJ
ajlm-2756	73	5	positive	positive	ADJ
ajlm-2756	73	6	correlation	correlation	NOUN
ajlm-2756	73	7	was	be	AUX
ajlm-2756	73	8	found	find	VERB
ajlm-2756	73	9	between	between	ADP
ajlm-2756	73	10	viral	viral	ADJ
ajlm-2756	73	11	load	load	NOUN
ajlm-2756	73	12	and	and	CCONJ
ajlm-2756	73	13	crp	crp	NOUN
ajlm-2756	73	14	(	(	PUNCT
ajlm-2756	73	15	r	r	NOUN
ajlm-2756	73	16	=	=	SYM
ajlm-2756	73	17	0.140	0.140	NUM
ajlm-2756	73	18	,	,	PUNCT
ajlm-2756	73	19	p	p	X
ajlm-2756	73	20	=	=	NOUN
ajlm-2756	73	21	0.010	0.010	NUM
ajlm-2756	73	22	)	)	PUNCT
ajlm-2756	73	23	,	,	PUNCT
ajlm-2756	73	24	suggesting	suggest	VERB
ajlm-2756	73	25	that	that	SCONJ
ajlm-2756	73	26	higher	high	ADJ
ajlm-2756	73	27	viral	viral	ADJ
ajlm-2756	73	28	loads	load	NOUN
ajlm-2756	73	29	may	may	AUX
ajlm-2756	73	30	be	be	AUX
ajlm-2756	73	31	linked	link	VERB
ajlm-2756	73	32	to	to	ADP
ajlm-2756	73	33	elevated	elevated	ADJ
ajlm-2756	73	34	crp	crp	NOUN
ajlm-2756	73	35	levels	level	NOUN
ajlm-2756	73	36	.	.	PUNCT
ajlm-2756	74	1	additionally	additionally	ADV
ajlm-2756	74	2	,	,	PUNCT
ajlm-2756	74	3	crp	crp	PROPN
ajlm-2756	74	4	and	and	CCONJ
ajlm-2756	74	5	d	d	ADJ
ajlm-2756	74	6	-	-	PUNCT
ajlm-2756	74	7	dimer	dimer	ADJ
ajlm-2756	74	8	levels	level	NOUN
ajlm-2756	74	9	exhibited	exhibit	VERB
ajlm-2756	74	10	a	a	DET
ajlm-2756	74	11	significant	significant	ADJ
ajlm-2756	74	12	negative	negative	ADJ
ajlm-2756	74	13	correlation	correlation	NOUN
ajlm-2756	74	14	(	(	PUNCT
ajlm-2756	74	15	r	r	NOUN
ajlm-2756	74	16	=	=	SYM
ajlm-2756	74	17	−0.133	−0.133	PROPN
ajlm-2756	74	18	,	,	PUNCT
ajlm-2756	74	19	p	p	NOUN
ajlm-2756	74	20	=	=	NOUN
ajlm-2756	74	21	0.014	0.014	NUM
ajlm-2756	74	22	)	)	PUNCT
ajlm-2756	74	23	,	,	PUNCT
ajlm-2756	74	24	indicating	indicate	VERB
ajlm-2756	74	25	that	that	SCONJ
ajlm-2756	74	26	higher	high	ADJ
ajlm-2756	74	27	crp	crp	PROPN
ajlm-2756	74	28	levels	level	NOUN
ajlm-2756	74	29	might	might	AUX
ajlm-2756	74	30	be	be	AUX
ajlm-2756	74	31	associated	associate	VERB
ajlm-2756	74	32	with	with	ADP
ajlm-2756	74	33	lower	low	ADJ
ajlm-2756	74	34	d	d	ADJ
ajlm-2756	74	35	-	-	PUNCT
ajlm-2756	74	36	dimer	dimer	ADJ
ajlm-2756	74	37	levels	level	NOUN
ajlm-2756	74	38	(	(	PUNCT
ajlm-2756	74	39	table	table	NOUN
ajlm-2756	74	40	6	6	NUM
ajlm-2756	74	41	)	)	PUNCT
ajlm-2756	74	42	.	.	PUNCT
ajlm-2756	75	1	table	table	NOUN
ajlm-2756	75	2	6	6	NUM
ajlm-2756	75	3	:	:	PUNCT
ajlm-2756	75	4	 	 	SPACE
ajlm-2756	75	5	spearman	spearman	NOUN
ajlm-2756	75	6	’s	’s	PART
ajlm-2756	75	7	rank	rank	NOUN
ajlm-2756	75	8	correlation	correlation	NOUN
ajlm-2756	75	9	coefficients	coefficient	NOUN
ajlm-2756	75	10	for	for	ADP
ajlm-2756	75	11	age	age	NOUN
ajlm-2756	75	12	,	,	PUNCT
ajlm-2756	75	13	viral	viral	ADJ
ajlm-2756	75	14	load	load	NOUN
ajlm-2756	75	15	,	,	PUNCT
ajlm-2756	75	16	c	c	NOUN
ajlm-2756	75	17	-	-	PUNCT
ajlm-2756	75	18	reactive	reactive	ADJ
ajlm-2756	75	19	protein	protein	NOUN
ajlm-2756	75	20	,	,	PUNCT
ajlm-2756	75	21	and	and	CCONJ
ajlm-2756	75	22	d	d	X
ajlm-2756	75	23	-	-	PUNCT
ajlm-2756	75	24	dimer	dimer	ADJ
ajlm-2756	75	25	levels	level	NOUN
ajlm-2756	75	26	(	(	PUNCT
ajlm-2756	75	27	n	n	NOUN
ajlm-2756	75	28	=	=	NOUN
ajlm-2756	75	29	275	275	NUM
ajlm-2756	75	30	)	)	PUNCT
ajlm-2756	75	31	.	.	PUNCT
ajlm-2756	76	1	south	south	PROPN
ajlm-2756	76	2	africa	africa	PROPN
ajlm-2756	76	3	,	,	PUNCT
ajlm-2756	76	4	tested	test	VERB
ajlm-2756	76	5	january	january	PROPN
ajlm-2756	76	6	2020	2020	NUM
ajlm-2756	76	7	to	to	ADP
ajlm-2756	76	8	december	december	PROPN
ajlm-2756	76	9	2023	2023	NUM
ajlm-2756	76	10	.	.	PUNCT
ajlm-2756	77	1	discussion	discussion	NOUN
ajlm-2756	77	2	this	this	DET
ajlm-2756	77	3	study	study	NOUN
ajlm-2756	77	4	aimed	aim	VERB
ajlm-2756	77	5	to	to	PART
ajlm-2756	77	6	investigate	investigate	VERB
ajlm-2756	77	7	the	the	DET
ajlm-2756	77	8	distribution	distribution	NOUN
ajlm-2756	77	9	of	of	ADP
ajlm-2756	77	10	inflammatory	inflammatory	ADJ
ajlm-2756	77	11	markers	marker	NOUN
ajlm-2756	77	12	(	(	PUNCT
ajlm-2756	77	13	including	include	VERB
ajlm-2756	77	14	crp	crp	PROPN
ajlm-2756	77	15	and	and	CCONJ
ajlm-2756	77	16	d	d	NOUN
ajlm-2756	77	17	-	-	PUNCT
ajlm-2756	77	18	dimer	dimer	NUM
ajlm-2756	77	19	)	)	PUNCT
ajlm-2756	77	20	,	,	PUNCT
ajlm-2756	77	21	and	and	CCONJ
ajlm-2756	77	22	viral	viral	ADJ
ajlm-2756	77	23	load	load	NOUN
ajlm-2756	77	24	,	,	PUNCT
ajlm-2756	77	25	among	among	ADP
ajlm-2756	77	26	hiv	hiv	PROPN
ajlm-2756	77	27	-	-	PUNCT
ajlm-2756	77	28	positive	positive	ADJ
ajlm-2756	77	29	individuals	individual	NOUN
ajlm-2756	77	30	in	in	ADP
ajlm-2756	77	31	durban	durban	PROPN
ajlm-2756	77	32	,	,	PUNCT
ajlm-2756	77	33	kwazulu	kwazulu	NOUN
ajlm-2756	77	34	-	-	PUNCT
ajlm-2756	77	35	natal	natal	NOUN
ajlm-2756	77	36	,	,	PUNCT
ajlm-2756	77	37	and	and	CCONJ
ajlm-2756	77	38	to	to	PART
ajlm-2756	77	39	explore	explore	VERB
ajlm-2756	77	40	potential	potential	ADJ
ajlm-2756	77	41	correlations	correlation	NOUN
ajlm-2756	77	42	between	between	ADP
ajlm-2756	77	43	these	these	DET
ajlm-2756	77	44	biomarkers	biomarker	NOUN
ajlm-2756	77	45	.	.	PUNCT
ajlm-2756	78	1	the	the	DET
ajlm-2756	78	2	study	study	NOUN
ajlm-2756	78	3	highlights	highlight	VERB
ajlm-2756	78	4	that	that	SCONJ
ajlm-2756	78	5	despite	despite	SCONJ
ajlm-2756	78	6	being	be	AUX
ajlm-2756	78	7	on	on	ADP
ajlm-2756	78	8	art	art	NOUN
ajlm-2756	78	9	,	,	PUNCT
ajlm-2756	78	10	there	there	PRON
ajlm-2756	78	11	is	be	VERB
ajlm-2756	78	12	a	a	DET
ajlm-2756	78	13	risk	risk	NOUN
ajlm-2756	78	14	of	of	ADP
ajlm-2756	78	15	elevated	elevated	ADJ
ajlm-2756	78	16	inflammatory	inflammatory	ADJ
ajlm-2756	78	17	markers	marker	NOUN
ajlm-2756	78	18	(	(	PUNCT
ajlm-2756	78	19	notably	notably	ADV
ajlm-2756	78	20	crp	crp	PROPN
ajlm-2756	78	21	)	)	PUNCT
ajlm-2756	78	22	.	.	PUNCT
ajlm-2756	79	1	this	this	PRON
ajlm-2756	79	2	suggests	suggest	VERB
ajlm-2756	79	3	a	a	DET
ajlm-2756	79	4	need	need	NOUN
ajlm-2756	79	5	for	for	ADP
ajlm-2756	79	6	better	well	ADJ
ajlm-2756	79	7	strategies	strategy	NOUN
ajlm-2756	79	8	to	to	PART
ajlm-2756	79	9	manage	manage	VERB
ajlm-2756	79	10	inflammation	inflammation	NOUN
ajlm-2756	79	11	and	and	CCONJ
ajlm-2756	79	12	reduce	reduce	VERB
ajlm-2756	79	13	health	health	NOUN
ajlm-2756	79	14	risks.4,5	risks.4,5	PRON
ajlm-2756	79	15	viral	viral	ADJ
ajlm-2756	79	16	load	load	NOUN
ajlm-2756	79	17	and	and	CCONJ
ajlm-2756	79	18	inflammation	inflammation	NOUN
ajlm-2756	79	19	the	the	DET
ajlm-2756	79	20	findings	finding	NOUN
ajlm-2756	79	21	from	from	ADP
ajlm-2756	79	22	this	this	DET
ajlm-2756	79	23	study	study	NOUN
ajlm-2756	79	24	demonstrate	demonstrate	VERB
ajlm-2756	79	25	that	that	SCONJ
ajlm-2756	79	26	,	,	PUNCT
ajlm-2756	79	27	despite	despite	SCONJ
ajlm-2756	79	28	the	the	DET
ajlm-2756	79	29	majority	majority	NOUN
ajlm-2756	79	30	of	of	ADP
ajlm-2756	79	31	participants	participant	NOUN
ajlm-2756	79	32	having	have	VERB
ajlm-2756	79	33	low	low	ADJ
ajlm-2756	79	34	viral	viral	ADJ
ajlm-2756	79	35	loads	load	NOUN
ajlm-2756	79	36	,	,	PUNCT
ajlm-2756	79	37	a	a	DET
ajlm-2756	79	38	significant	significant	ADJ
ajlm-2756	79	39	proportion	proportion	NOUN
ajlm-2756	79	40	of	of	ADP
ajlm-2756	79	41	hiv	hiv	PROPN
ajlm-2756	79	42	-	-	PUNCT
ajlm-2756	79	43	positive	positive	ADJ
ajlm-2756	79	44	individuals	individual	NOUN
ajlm-2756	79	45	still	still	ADV
ajlm-2756	79	46	exhibited	exhibit	VERB
ajlm-2756	79	47	elevated	elevated	ADJ
ajlm-2756	79	48	crp	crp	PROPN
ajlm-2756	79	49	and	and	CCONJ
ajlm-2756	79	50	d	d	ADJ
ajlm-2756	79	51	-	-	PUNCT
ajlm-2756	79	52	dimer	dimer	ADJ
ajlm-2756	79	53	levels	level	NOUN
ajlm-2756	79	54	,	,	PUNCT
ajlm-2756	79	55	suggesting	suggest	VERB
ajlm-2756	79	56	ongoing	ongoing	ADJ
ajlm-2756	79	57	inflammation	inflammation	NOUN
ajlm-2756	79	58	despite	despite	SCONJ
ajlm-2756	79	59	adherence	adherence	NOUN
ajlm-2756	79	60	to	to	ADP
ajlm-2756	79	61	art.13	art.13	PROPN
ajlm-2756	79	62	this	this	DET
ajlm-2756	79	63	observation	observation	NOUN
ajlm-2756	79	64	is	be	AUX
ajlm-2756	79	65	consistent	consistent	ADJ
ajlm-2756	79	66	with	with	ADP
ajlm-2756	79	67	previous	previous	ADJ
ajlm-2756	79	68	research	research	NOUN
ajlm-2756	79	69	highlighting	highlight	VERB
ajlm-2756	79	70	the	the	DET
ajlm-2756	79	71	association	association	NOUN
ajlm-2756	79	72	of	of	ADP
ajlm-2756	79	73	higher	high	ADJ
ajlm-2756	79	74	viral	viral	ADJ
ajlm-2756	79	75	loads	load	NOUN
ajlm-2756	79	76	with	with	ADP
ajlm-2756	79	77	increased	increase	VERB
ajlm-2756	79	78	immune	immune	ADJ
ajlm-2756	79	79	activation	activation	NOUN
ajlm-2756	79	80	and	and	CCONJ
ajlm-2756	79	81	inflammation.6	inflammation.6	VERB
ajlm-2756	79	82	a	a	DET
ajlm-2756	79	83	noteworthy	noteworthy	ADJ
ajlm-2756	79	84	finding	finding	NOUN
ajlm-2756	79	85	in	in	ADP
ajlm-2756	79	86	our	our	PRON
ajlm-2756	79	87	study	study	NOUN
ajlm-2756	79	88	was	be	AUX
ajlm-2756	79	89	the	the	DET
ajlm-2756	79	90	positive	positive	ADJ
ajlm-2756	79	91	correlation	correlation	NOUN
ajlm-2756	79	92	between	between	ADP
ajlm-2756	79	93	viral	viral	ADJ
ajlm-2756	79	94	load	load	NOUN
ajlm-2756	79	95	and	and	CCONJ
ajlm-2756	79	96	crp	crp	NOUN
ajlm-2756	79	97	levels	level	NOUN
ajlm-2756	79	98	(	(	PUNCT
ajlm-2756	79	99	r	r	NOUN
ajlm-2756	79	100	=	=	SYM
ajlm-2756	79	101	0.140	0.140	NUM
ajlm-2756	79	102	,	,	PUNCT
ajlm-2756	79	103	p	p	X
ajlm-2756	79	104	=	=	NOUN
ajlm-2756	79	105	0.010	0.010	NUM
ajlm-2756	79	106	)	)	PUNCT
ajlm-2756	79	107	,	,	PUNCT
ajlm-2756	79	108	which	which	PRON
ajlm-2756	79	109	aligns	align	VERB
ajlm-2756	79	110	with	with	ADP
ajlm-2756	79	111	prior	prior	ADJ
ajlm-2756	79	112	research	research	NOUN
ajlm-2756	79	113	conducted	conduct	VERB
ajlm-2756	79	114	in	in	ADP
ajlm-2756	79	115	france	france	PROPN
ajlm-2756	79	116	(	(	PUNCT
ajlm-2756	79	117	2012)10	2012)10	NUM
ajlm-2756	79	118	and	and	CCONJ
ajlm-2756	79	119	china	china	PROPN
ajlm-2756	79	120	(	(	PUNCT
ajlm-2756	79	121	2023),7	2023),7	NUM
ajlm-2756	79	122	and	and	CCONJ
ajlm-2756	79	123	that	that	PRON
ajlm-2756	79	124	suggests	suggest	VERB
ajlm-2756	79	125	persistent	persistent	ADJ
ajlm-2756	79	126	immune	immune	ADJ
ajlm-2756	79	127	activation	activation	NOUN
ajlm-2756	79	128	in	in	ADP
ajlm-2756	79	129	hiv	hiv	PROPN
ajlm-2756	79	130	-	-	PUNCT
ajlm-2756	79	131	positive	positive	ADJ
ajlm-2756	79	132	individuals	individual	NOUN
ajlm-2756	79	133	,	,	PUNCT
ajlm-2756	79	134	even	even	ADV
ajlm-2756	79	135	under	under	ADP
ajlm-2756	79	136	art	art	NOUN
ajlm-2756	79	137	conditions	condition	NOUN
ajlm-2756	79	138	.	.	PUNCT
ajlm-2756	80	1	this	this	DET
ajlm-2756	80	2	finding	finding	NOUN
ajlm-2756	80	3	supports	support	VERB
ajlm-2756	80	4	the	the	DET
ajlm-2756	80	5	hypothesis	hypothesis	NOUN
ajlm-2756	80	6	that	that	SCONJ
ajlm-2756	80	7	suboptimal	suboptimal	ADJ
ajlm-2756	80	8	viral	viral	ADJ
ajlm-2756	80	9	suppression	suppression	NOUN
ajlm-2756	80	10	may	may	AUX
ajlm-2756	80	11	contribute	contribute	VERB
ajlm-2756	80	12	to	to	ADP
ajlm-2756	80	13	sustained	sustained	ADJ
ajlm-2756	80	14	inflammation	inflammation	NOUN
ajlm-2756	80	15	,	,	PUNCT
ajlm-2756	80	16	which	which	PRON
ajlm-2756	80	17	has	have	AUX
ajlm-2756	80	18	been	be	AUX
ajlm-2756	80	19	linked	link	VERB
ajlm-2756	80	20	to	to	ADP
ajlm-2756	80	21	various	various	ADJ
ajlm-2756	80	22	hiv	hiv	PROPN
ajlm-2756	80	23	-	-	PUNCT
ajlm-2756	80	24	associated	associate	VERB
ajlm-2756	80	25	complications	complication	NOUN
ajlm-2756	80	26	,	,	PUNCT
ajlm-2756	80	27	including	include	VERB
ajlm-2756	80	28	cardiovascular	cardiovascular	ADJ
ajlm-2756	80	29	diseases	disease	NOUN
ajlm-2756	80	30	and	and	CCONJ
ajlm-2756	80	31	neurocognitive	neurocognitive	ADJ
ajlm-2756	80	32	disorders.7,8,14	disorders.7,8,14	NOUN
ajlm-2756	80	33	in	in	ADP
ajlm-2756	80	34	contrast	contrast	NOUN
ajlm-2756	80	35	,	,	PUNCT
ajlm-2756	80	36	the	the	DET
ajlm-2756	80	37	weak	weak	ADJ
ajlm-2756	80	38	correlation	correlation	NOUN
ajlm-2756	80	39	observed	observe	VERB
ajlm-2756	80	40	between	between	ADP
ajlm-2756	80	41	age	age	NOUN
ajlm-2756	80	42	and	and	CCONJ
ajlm-2756	80	43	viral	viral	ADJ
ajlm-2756	80	44	load	load	NOUN
ajlm-2756	80	45	,	,	PUNCT
ajlm-2756	80	46	as	as	ADV
ajlm-2756	80	47	well	well	ADV
ajlm-2756	80	48	as	as	ADP
ajlm-2756	80	49	age	age	NOUN
ajlm-2756	80	50	and	and	CCONJ
ajlm-2756	80	51	crp	crp	PROPN
ajlm-2756	80	52	levels	level	NOUN
ajlm-2756	80	53	,	,	PUNCT
ajlm-2756	80	54	suggests	suggest	VERB
ajlm-2756	80	55	that	that	SCONJ
ajlm-2756	80	56	other	other	ADJ
ajlm-2756	80	57	factors	factor	NOUN
ajlm-2756	80	58	,	,	PUNCT
ajlm-2756	80	59	such	such	ADJ
ajlm-2756	80	60	as	as	ADP
ajlm-2756	80	61	art	art	NOUN
ajlm-2756	80	62	adherence	adherence	NOUN
ajlm-2756	80	63	,	,	PUNCT
ajlm-2756	80	64	immune	immune	ADJ
ajlm-2756	80	65	status	status	NOUN
ajlm-2756	80	66	,	,	PUNCT
ajlm-2756	80	67	and	and	CCONJ
ajlm-2756	80	68	co	co	NOUN
ajlm-2756	80	69	-	-	NOUN
ajlm-2756	80	70	morbidities	morbidity	NOUN
ajlm-2756	80	71	,	,	PUNCT
ajlm-2756	80	72	may	may	AUX
ajlm-2756	80	73	play	play	VERB
ajlm-2756	80	74	a	a	DET
ajlm-2756	80	75	more	more	ADV
ajlm-2756	80	76	prominent	prominent	ADJ
ajlm-2756	80	77	role	role	NOUN
ajlm-2756	80	78	in	in	ADP
ajlm-2756	80	79	modulating	modulate	VERB
ajlm-2756	80	80	viral	viral	ADJ
ajlm-2756	80	81	load	load	NOUN
ajlm-2756	80	82	and	and	CCONJ
ajlm-2756	80	83	inflammation	inflammation	NOUN
ajlm-2756	80	84	in	in	ADP
ajlm-2756	80	85	this	this	DET
ajlm-2756	80	86	cohort.15,16	cohort.15,16	NOUN
ajlm-2756	80	87	the	the	DET
ajlm-2756	80	88	lack	lack	NOUN
ajlm-2756	80	89	of	of	ADP
ajlm-2756	80	90	a	a	DET
ajlm-2756	80	91	strong	strong	ADJ
ajlm-2756	80	92	association	association	NOUN
ajlm-2756	80	93	between	between	ADP
ajlm-2756	80	94	age	age	NOUN
ajlm-2756	80	95	and	and	CCONJ
ajlm-2756	80	96	these	these	DET
ajlm-2756	80	97	biomarkers	biomarker	NOUN
ajlm-2756	80	98	reflects	reflect	VERB
ajlm-2756	80	99	the	the	DET
ajlm-2756	80	100	growing	grow	VERB
ajlm-2756	80	101	understanding	understanding	NOUN
ajlm-2756	80	102	that	that	SCONJ
ajlm-2756	80	103	chronic	chronic	ADJ
ajlm-2756	80	104	inflammation	inflammation	NOUN
ajlm-2756	80	105	in	in	ADP
ajlm-2756	80	106	hiv	hiv	PROPN
ajlm-2756	80	107	-	-	PUNCT
ajlm-2756	80	108	positive	positive	ADJ
ajlm-2756	80	109	individuals	individual	NOUN
ajlm-2756	80	110	can	can	AUX
ajlm-2756	80	111	persist	persist	VERB
ajlm-2756	80	112	,	,	PUNCT
ajlm-2756	80	113	regardless	regardless	ADV
ajlm-2756	80	114	of	of	ADP
ajlm-2756	80	115	age	age	NOUN
ajlm-2756	80	116	,	,	PUNCT
ajlm-2756	80	117	particularly	particularly	ADV
ajlm-2756	80	118	if	if	SCONJ
ajlm-2756	80	119	viral	viral	ADJ
ajlm-2756	80	120	suppression	suppression	NOUN
ajlm-2756	80	121	is	be	AUX
ajlm-2756	80	122	not	not	PART
ajlm-2756	80	123	optimal.10,17,18	optimal.10,17,18	PRON
ajlm-2756	80	124	this	this	DET
ajlm-2756	80	125	finding	finding	NOUN
ajlm-2756	80	126	highlights	highlight	VERB
ajlm-2756	80	127	the	the	DET
ajlm-2756	80	128	importance	importance	NOUN
ajlm-2756	80	129	of	of	ADP
ajlm-2756	80	130	considering	consider	VERB
ajlm-2756	80	131	not	not	PART
ajlm-2756	80	132	only	only	ADV
ajlm-2756	80	133	age	age	NOUN
ajlm-2756	80	134	but	but	CCONJ
ajlm-2756	80	135	also	also	ADV
ajlm-2756	80	136	other	other	ADJ
ajlm-2756	80	137	variables	variable	NOUN
ajlm-2756	80	138	when	when	SCONJ
ajlm-2756	80	139	assessing	assess	VERB
ajlm-2756	80	140	inflammation	inflammation	NOUN
ajlm-2756	80	141	and	and	CCONJ
ajlm-2756	80	142	the	the	DET
ajlm-2756	80	143	potential	potential	NOUN
ajlm-2756	80	144	for	for	ADP
ajlm-2756	80	145	hiv	hiv	PROPN
ajlm-2756	80	146	-	-	PUNCT
ajlm-2756	80	147	related	relate	VERB
ajlm-2756	80	148	complications	complication	NOUN
ajlm-2756	80	149	.	.	PUNCT
ajlm-2756	81	1	c	c	X
ajlm-2756	81	2	-	-	PUNCT
ajlm-2756	81	3	reactive	reactive	ADJ
ajlm-2756	81	4	protein	protein	NOUN
ajlm-2756	81	5	and	and	CCONJ
ajlm-2756	81	6	d	d	NOUN
ajlm-2756	81	7	-	-	PUNCT
ajlm-2756	81	8	dimer	dimer	NOUN
ajlm-2756	81	9	levels	level	VERB
ajlm-2756	81	10	the	the	DET
ajlm-2756	81	11	data	datum	NOUN
ajlm-2756	81	12	from	from	ADP
ajlm-2756	81	13	this	this	DET
ajlm-2756	81	14	study	study	NOUN
ajlm-2756	81	15	provide	provide	VERB
ajlm-2756	81	16	insights	insight	NOUN
ajlm-2756	81	17	into	into	ADP
ajlm-2756	81	18	the	the	DET
ajlm-2756	81	19	relationship	relationship	NOUN
ajlm-2756	81	20	between	between	ADP
ajlm-2756	81	21	crp	crp	PROPN
ajlm-2756	81	22	,	,	PUNCT
ajlm-2756	81	23	d	d	NOUN
ajlm-2756	81	24	-	-	PUNCT
ajlm-2756	81	25	dimer	dimer	ADJ
ajlm-2756	81	26	,	,	PUNCT
ajlm-2756	81	27	and	and	CCONJ
ajlm-2756	81	28	viral	viral	ADJ
ajlm-2756	81	29	load	load	NOUN
ajlm-2756	81	30	in	in	ADP
ajlm-2756	81	31	hiv	hiv	PROPN
ajlm-2756	81	32	-	-	PUNCT
ajlm-2756	81	33	positive	positive	ADJ
ajlm-2756	81	34	individuals	individual	NOUN
ajlm-2756	81	35	.	.	PUNCT
ajlm-2756	82	1	elevated	elevated	ADJ
ajlm-2756	82	2	crp	crp	PROPN
ajlm-2756	82	3	levels	level	NOUN
ajlm-2756	82	4	,	,	PUNCT
ajlm-2756	82	5	indicative	indicative	ADJ
ajlm-2756	82	6	of	of	ADP
ajlm-2756	82	7	systemic	systemic	ADJ
ajlm-2756	82	8	inflammation	inflammation	NOUN
ajlm-2756	82	9	,	,	PUNCT
ajlm-2756	82	10	were	be	AUX
ajlm-2756	82	11	associated	associate	VERB
ajlm-2756	82	12	with	with	ADP
ajlm-2756	82	13	higher	high	ADJ
ajlm-2756	82	14	viral	viral	ADJ
ajlm-2756	82	15	loads	load	NOUN
ajlm-2756	82	16	,	,	PUNCT
ajlm-2756	82	17	suggesting	suggest	VERB
ajlm-2756	82	18	a	a	DET
ajlm-2756	82	19	link	link	NOUN
ajlm-2756	82	20	between	between	ADP
ajlm-2756	82	21	hiv	hiv	PROPN
ajlm-2756	82	22	replication	replication	NOUN
ajlm-2756	82	23	and	and	CCONJ
ajlm-2756	82	24	immune	immune	ADJ
ajlm-2756	82	25	activation	activation	NOUN
ajlm-2756	82	26	.	.	PUNCT
ajlm-2756	83	1	the	the	DET
ajlm-2756	83	2	negative	negative	ADJ
ajlm-2756	83	3	correlation	correlation	NOUN
ajlm-2756	83	4	between	between	ADP
ajlm-2756	83	5	crp	crp	PROPN
ajlm-2756	83	6	and	and	CCONJ
ajlm-2756	83	7	d	d	NOUN
ajlm-2756	83	8	-	-	PUNCT
ajlm-2756	83	9	dimer	dimer	NOUN
ajlm-2756	83	10	(	(	PUNCT
ajlm-2756	83	11	r	r	NOUN
ajlm-2756	83	12	=	=	SYM
ajlm-2756	83	13	−0.133	−0.133	PROPN
ajlm-2756	83	14	,	,	PUNCT
ajlm-2756	83	15	p	p	NOUN
ajlm-2756	83	16	=	=	NOUN
ajlm-2756	83	17	0.014	0.014	NUM
ajlm-2756	83	18	)	)	PUNCT
ajlm-2756	83	19	is	be	AUX
ajlm-2756	83	20	intriguing	intriguing	ADJ
ajlm-2756	83	21	,	,	PUNCT
ajlm-2756	83	22	as	as	SCONJ
ajlm-2756	83	23	it	it	PRON
ajlm-2756	83	24	contrasts	contrast	VERB
ajlm-2756	83	25	with	with	ADP
ajlm-2756	83	26	the	the	DET
ajlm-2756	83	27	typical	typical	ADJ
ajlm-2756	83	28	positive	positive	ADJ
ajlm-2756	83	29	association	association	NOUN
ajlm-2756	83	30	between	between	ADP
ajlm-2756	83	31	inflammation	inflammation	NOUN
ajlm-2756	83	32	and	and	CCONJ
ajlm-2756	83	33	coagulation	coagulation	NOUN
ajlm-2756	83	34	markers	marker	NOUN
ajlm-2756	83	35	,	,	PUNCT
ajlm-2756	83	36	such	such	ADJ
ajlm-2756	83	37	as	as	ADP
ajlm-2756	83	38	d	d	NOUN
ajlm-2756	83	39	-	-	NOUN
ajlm-2756	83	40	dimer	dimer	ADJ
ajlm-2756	83	41	,	,	PUNCT
ajlm-2756	83	42	in	in	ADP
ajlm-2756	83	43	hiv.9	hiv.9	PROPN
ajlm-2756	83	44	however	however	ADV
ajlm-2756	83	45	,	,	PUNCT
ajlm-2756	83	46	such	such	ADJ
ajlm-2756	83	47	findings	finding	NOUN
ajlm-2756	83	48	are	be	AUX
ajlm-2756	83	49	contradictory	contradictory	ADJ
ajlm-2756	83	50	to	to	ADP
ajlm-2756	83	51	findings	finding	NOUN
ajlm-2756	83	52	of	of	ADP
ajlm-2756	83	53	other	other	ADJ
ajlm-2756	83	54	studies	study	NOUN
ajlm-2756	83	55	,	,	PUNCT
ajlm-2756	83	56	which	which	PRON
ajlm-2756	83	57	have	have	AUX
ajlm-2756	83	58	found	find	VERB
ajlm-2756	83	59	a	a	DET
ajlm-2756	83	60	positive	positive	ADJ
ajlm-2756	83	61	correlation	correlation	NOUN
ajlm-2756	83	62	between	between	ADP
ajlm-2756	83	63	crp	crp	PROPN
ajlm-2756	83	64	and	and	CCONJ
ajlm-2756	83	65	d	d	NOUN
ajlm-2756	83	66	-	-	PUNCT
ajlm-2756	83	67	dimer	dimer	NOUN
ajlm-2756	83	68	and	and	CCONJ
ajlm-2756	83	69	hiv	hiv	NOUN
ajlm-2756	83	70	-	-	PUNCT
ajlm-2756	83	71	positive	positive	ADJ
ajlm-2756	83	72	patients	patient	NOUN
ajlm-2756	83	73	compared	compare	VERB
ajlm-2756	83	74	to	to	ADP
ajlm-2756	83	75	negative	negative	ADJ
ajlm-2756	83	76	controls.19,20,21	controls.19,20,21	ADP
ajlm-2756	83	77	this	this	DET
ajlm-2756	83	78	inverse	inverse	NOUN
ajlm-2756	83	79	relationship	relationship	NOUN
ajlm-2756	83	80	may	may	AUX
ajlm-2756	83	81	reflect	reflect	VERB
ajlm-2756	83	82	a	a	DET
ajlm-2756	83	83	more	more	ADV
ajlm-2756	83	84	complex	complex	ADJ
ajlm-2756	83	85	inflammatory	inflammatory	ADJ
ajlm-2756	83	86	profile	profile	NOUN
ajlm-2756	83	87	,	,	PUNCT
ajlm-2756	83	88	influenced	influence	VERB
ajlm-2756	83	89	by	by	ADP
ajlm-2756	83	90	factors	factor	NOUN
ajlm-2756	83	91	such	such	ADJ
ajlm-2756	83	92	as	as	ADP
ajlm-2756	83	93	art	art	NOUN
ajlm-2756	83	94	efficacy	efficacy	NOUN
ajlm-2756	83	95	,	,	PUNCT
ajlm-2756	83	96	treatment	treatment	NOUN
ajlm-2756	83	97	duration	duration	NOUN
ajlm-2756	83	98	,	,	PUNCT
ajlm-2756	83	99	and	and	CCONJ
ajlm-2756	83	100	individual	individual	ADJ
ajlm-2756	83	101	variations	variation	NOUN
ajlm-2756	83	102	in	in	ADP
ajlm-2756	83	103	immune	immune	ADJ
ajlm-2756	83	104	and	and	CCONJ
ajlm-2756	83	105	coagulation	coagulation	NOUN
ajlm-2756	83	106	responses	response	NOUN
ajlm-2756	83	107	.	.	PUNCT
ajlm-2756	84	1	while	while	SCONJ
ajlm-2756	84	2	art	art	NOUN
ajlm-2756	84	3	effectively	effectively	ADV
ajlm-2756	84	4	reduces	reduce	VERB
ajlm-2756	84	5	viral	viral	ADJ
ajlm-2756	84	6	load	load	NOUN
ajlm-2756	84	7	and	and	CCONJ
ajlm-2756	84	8	improves	improve	VERB
ajlm-2756	84	9	health	health	NOUN
ajlm-2756	84	10	outcomes	outcome	NOUN
ajlm-2756	84	11	,	,	PUNCT
ajlm-2756	84	12	it	it	PRON
ajlm-2756	84	13	may	may	AUX
ajlm-2756	84	14	not	not	PART
ajlm-2756	84	15	fully	fully	ADV
ajlm-2756	84	16	resolve	resolve	VERB
ajlm-2756	84	17	inflammation	inflammation	NOUN
ajlm-2756	84	18	,	,	PUNCT
ajlm-2756	84	19	particularly	particularly	ADV
ajlm-2756	84	20	in	in	ADP
ajlm-2756	84	21	cases	case	NOUN
ajlm-2756	84	22	of	of	ADP
ajlm-2756	84	23	suboptimal	suboptimal	ADJ
ajlm-2756	84	24	viral	viral	ADJ
ajlm-2756	84	25	suppression	suppression	NOUN
ajlm-2756	84	26	.	.	PUNCT
ajlm-2756	85	1	some	some	DET
ajlm-2756	85	2	studies	study	NOUN
ajlm-2756	85	3	suggest	suggest	VERB
ajlm-2756	85	4	art	art	NOUN
ajlm-2756	85	5	reduces	reduce	VERB
ajlm-2756	85	6	crp	crp	NOUN
ajlm-2756	85	7	levels	level	NOUN
ajlm-2756	85	8	,	,	PUNCT
ajlm-2756	85	9	but	but	CCONJ
ajlm-2756	85	10	its	its	PRON
ajlm-2756	85	11	effect	effect	NOUN
ajlm-2756	85	12	on	on	ADP
ajlm-2756	85	13	d	d	X
ajlm-2756	85	14	-	-	PUNCT
ajlm-2756	85	15	dimer	dimer	NOUN
ajlm-2756	85	16	remains	remain	VERB
ajlm-2756	85	17	more	more	ADJ
ajlm-2756	85	18	variable.10	variable.10	NOUN
ajlm-2756	85	19	gender	gender	NOUN
ajlm-2756	85	20	differences	difference	NOUN
ajlm-2756	85	21	our	our	PRON
ajlm-2756	85	22	study	study	NOUN
ajlm-2756	85	23	also	also	ADV
ajlm-2756	85	24	revealed	reveal	VERB
ajlm-2756	85	25	notable	notable	ADJ
ajlm-2756	85	26	gender	gender	NOUN
ajlm-2756	85	27	-	-	PUNCT
ajlm-2756	85	28	based	base	VERB
ajlm-2756	85	29	differences	difference	NOUN
ajlm-2756	85	30	in	in	ADP
ajlm-2756	85	31	inflammatory	inflammatory	ADJ
ajlm-2756	85	32	markers	marker	NOUN
ajlm-2756	85	33	,	,	PUNCT
ajlm-2756	85	34	with	with	ADP
ajlm-2756	85	35	female	female	ADJ
ajlm-2756	85	36	patients	patient	NOUN
ajlm-2756	85	37	in	in	ADP
ajlm-2756	85	38	the	the	DET
ajlm-2756	85	39	cohort	cohort	NOUN
ajlm-2756	85	40	exhibiting	exhibit	VERB
ajlm-2756	85	41	higher	high	ADJ
ajlm-2756	85	42	levels	level	NOUN
ajlm-2756	85	43	of	of	ADP
ajlm-2756	85	44	normal	normal	ADJ
ajlm-2756	85	45	crp	crp	NOUN
ajlm-2756	85	46	and	and	CCONJ
ajlm-2756	85	47	lower	low	ADJ
ajlm-2756	85	48	rates	rate	NOUN
ajlm-2756	85	49	of	of	ADP
ajlm-2756	85	50	elevated	elevated	ADJ
ajlm-2756	85	51	crp	crp	NOUN
ajlm-2756	85	52	compared	compare	VERB
ajlm-2756	85	53	to	to	ADP
ajlm-2756	85	54	male	male	ADJ
ajlm-2756	85	55	patients	patient	NOUN
ajlm-2756	85	56	.	.	PUNCT
ajlm-2756	86	1	this	this	DET
ajlm-2756	86	2	finding	finding	NOUN
ajlm-2756	86	3	aligns	align	VERB
ajlm-2756	86	4	with	with	ADP
ajlm-2756	86	5	existing	exist	VERB
ajlm-2756	86	6	literature	literature	NOUN
ajlm-2756	86	7	,	,	PUNCT
ajlm-2756	86	8	which	which	PRON
ajlm-2756	86	9	suggests	suggest	VERB
ajlm-2756	86	10	that	that	SCONJ
ajlm-2756	86	11	women	woman	NOUN
ajlm-2756	86	12	tend	tend	VERB
ajlm-2756	86	13	to	to	PART
ajlm-2756	86	14	exhibit	exhibit	VERB
ajlm-2756	86	15	higher	high	ADJ
ajlm-2756	86	16	levels	level	NOUN
ajlm-2756	86	17	of	of	ADP
ajlm-2756	86	18	immune	immune	ADJ
ajlm-2756	86	19	activation	activation	NOUN
ajlm-2756	86	20	and	and	CCONJ
ajlm-2756	86	21	inflammatory	inflammatory	ADJ
ajlm-2756	86	22	responses	response	NOUN
ajlm-2756	86	23	than	than	ADP
ajlm-2756	86	24	men.12,22	men.12,22	PRON
ajlm-2756	86	25	this	this	DET
ajlm-2756	86	26	gender	gender	NOUN
ajlm-2756	86	27	-	-	PUNCT
ajlm-2756	86	28	based	base	VERB
ajlm-2756	86	29	disparity	disparity	NOUN
ajlm-2756	86	30	could	could	AUX
ajlm-2756	86	31	be	be	AUX
ajlm-2756	86	32	because	because	SCONJ
ajlm-2756	86	33	of	of	ADP
ajlm-2756	86	34	biological	biological	ADJ
ajlm-2756	86	35	differences	difference	NOUN
ajlm-2756	86	36	in	in	ADP
ajlm-2756	86	37	immune	immune	ADJ
ajlm-2756	86	38	function	function	NOUN
ajlm-2756	86	39	,	,	PUNCT
ajlm-2756	86	40	as	as	ADV
ajlm-2756	86	41	well	well	ADV
ajlm-2756	86	42	as	as	ADP
ajlm-2756	86	43	sociocultural	sociocultural	ADJ
ajlm-2756	86	44	factors	factor	NOUN
ajlm-2756	86	45	that	that	PRON
ajlm-2756	86	46	influence	influence	VERB
ajlm-2756	86	47	healthcare	healthcare	NOUN
ajlm-2756	86	48	access	access	NOUN
ajlm-2756	86	49	and	and	CCONJ
ajlm-2756	86	50	art	art	NOUN
ajlm-2756	86	51	adherence	adherence	NOUN
ajlm-2756	86	52	.	.	PUNCT
ajlm-2756	87	1	on	on	ADP
ajlm-2756	87	2	the	the	DET
ajlm-2756	87	3	other	other	ADJ
ajlm-2756	87	4	hand	hand	NOUN
ajlm-2756	87	5	,	,	PUNCT
ajlm-2756	87	6	elevated	elevated	ADJ
ajlm-2756	87	7	d	d	X
ajlm-2756	87	8	-	-	PUNCT
ajlm-2756	87	9	dimer	dimer	ADJ
ajlm-2756	87	10	levels	level	NOUN
ajlm-2756	87	11	were	be	AUX
ajlm-2756	87	12	more	more	ADV
ajlm-2756	87	13	frequently	frequently	ADV
ajlm-2756	87	14	observed	observe	VERB
ajlm-2756	87	15	in	in	ADP
ajlm-2756	87	16	male	male	ADJ
ajlm-2756	87	17	patients	patient	NOUN
ajlm-2756	87	18	,	,	PUNCT
ajlm-2756	87	19	which	which	PRON
ajlm-2756	87	20	is	be	AUX
ajlm-2756	87	21	consistent	consistent	ADJ
ajlm-2756	87	22	with	with	ADP
ajlm-2756	87	23	findings	finding	NOUN
ajlm-2756	87	24	in	in	ADP
ajlm-2756	87	25	a	a	DET
ajlm-2756	87	26	study	study	NOUN
ajlm-2756	87	27	conducted	conduct	VERB
ajlm-2756	87	28	in	in	ADP
ajlm-2756	87	29	italy23	italy23	NOUN
ajlm-2756	87	30	and	and	CCONJ
ajlm-2756	87	31	a	a	DET
ajlm-2756	87	32	systematic	systematic	ADJ
ajlm-2756	87	33	review	review	NOUN
ajlm-2756	87	34	conducted	conduct	VERB
ajlm-2756	87	35	in	in	ADP
ajlm-2756	87	36	2021,9	2021,9	NUM
ajlm-2756	87	37	indicating	indicate	VERB
ajlm-2756	87	38	that	that	SCONJ
ajlm-2756	87	39	hiv	hiv	PROPN
ajlm-2756	87	40	-	-	PUNCT
ajlm-2756	87	41	positive	positive	ADJ
ajlm-2756	87	42	men	man	NOUN
ajlm-2756	87	43	may	may	AUX
ajlm-2756	87	44	be	be	AUX
ajlm-2756	87	45	at	at	ADP
ajlm-2756	87	46	higher	high	ADJ
ajlm-2756	87	47	risk	risk	NOUN
ajlm-2756	87	48	for	for	ADP
ajlm-2756	87	49	thrombosis	thrombosis	NOUN
ajlm-2756	87	50	and	and	CCONJ
ajlm-2756	87	51	other	other	ADJ
ajlm-2756	87	52	cardiovascular	cardiovascular	ADJ
ajlm-2756	87	53	complications	complication	NOUN
ajlm-2756	87	54	compared	compare	VERB
ajlm-2756	87	55	to	to	ADP
ajlm-2756	87	56	women	woman	NOUN
ajlm-2756	87	57	.	.	PUNCT
ajlm-2756	88	1	this	this	PRON
ajlm-2756	88	2	could	could	AUX
ajlm-2756	88	3	suggest	suggest	VERB
ajlm-2756	88	4	gender	gender	NOUN
ajlm-2756	88	5	-	-	PUNCT
ajlm-2756	88	6	specific	specific	ADJ
ajlm-2756	88	7	risks	risk	NOUN
ajlm-2756	88	8	for	for	ADP
ajlm-2756	88	9	cardiovascular	cardiovascular	ADJ
ajlm-2756	88	10	and	and	CCONJ
ajlm-2756	88	11	thrombotic	thrombotic	ADJ
ajlm-2756	88	12	events	event	NOUN
ajlm-2756	88	13	among	among	ADP
ajlm-2756	88	14	hiv	hiv	PROPN
ajlm-2756	88	15	-	-	PUNCT
ajlm-2756	88	16	positive	positive	ADJ
ajlm-2756	88	17	individuals	individual	NOUN
ajlm-2756	88	18	,	,	PUNCT
ajlm-2756	88	19	which	which	PRON
ajlm-2756	88	20	may	may	AUX
ajlm-2756	88	21	require	require	VERB
ajlm-2756	88	22	tailored	tailor	VERB
ajlm-2756	88	23	interventions	intervention	NOUN
ajlm-2756	88	24	to	to	PART
ajlm-2756	88	25	mitigate	mitigate	VERB
ajlm-2756	88	26	these	these	DET
ajlm-2756	88	27	risks	risk	NOUN
ajlm-2756	88	28	.	.	PUNCT
ajlm-2756	89	1	implications	implication	NOUN
ajlm-2756	89	2	for	for	ADP
ajlm-2756	89	3	antiretroviral	antiretroviral	ADJ
ajlm-2756	89	4	therapy	therapy	NOUN
ajlm-2756	89	5	and	and	CCONJ
ajlm-2756	89	6	inflammation	inflammation	NOUN
ajlm-2756	89	7	management	management	NOUN
ajlm-2756	89	8	the	the	DET
ajlm-2756	89	9	persistence	persistence	NOUN
ajlm-2756	89	10	of	of	ADP
ajlm-2756	89	11	elevated	elevated	ADJ
ajlm-2756	89	12	crp	crp	NOUN
ajlm-2756	89	13	and	and	CCONJ
ajlm-2756	89	14	d	d	ADJ
ajlm-2756	89	15	-	-	PUNCT
ajlm-2756	89	16	dimer	dimer	ADJ
ajlm-2756	89	17	levels	level	NOUN
ajlm-2756	89	18	despite	despite	SCONJ
ajlm-2756	89	19	art	art	NOUN
ajlm-2756	89	20	use	use	NOUN
ajlm-2756	89	21	is	be	AUX
ajlm-2756	89	22	a	a	DET
ajlm-2756	89	23	critical	critical	ADJ
ajlm-2756	89	24	finding	finding	NOUN
ajlm-2756	89	25	in	in	ADP
ajlm-2756	89	26	this	this	DET
ajlm-2756	89	27	study	study	NOUN
ajlm-2756	89	28	.	.	PUNCT
ajlm-2756	90	1	although	although	SCONJ
ajlm-2756	90	2	art	art	NOUN
ajlm-2756	90	3	has	have	AUX
ajlm-2756	90	4	revolutionised	revolutionise	VERB
ajlm-2756	90	5	the	the	DET
ajlm-2756	90	6	management	management	NOUN
ajlm-2756	90	7	of	of	ADP
ajlm-2756	90	8	hiv	hiv	PROPN
ajlm-2756	90	9	by	by	ADP
ajlm-2756	90	10	reducing	reduce	VERB
ajlm-2756	90	11	mortality	mortality	NOUN
ajlm-2756	90	12	and	and	CCONJ
ajlm-2756	90	13	improving	improve	VERB
ajlm-2756	90	14	quality	quality	NOUN
ajlm-2756	90	15	of	of	ADP
ajlm-2756	90	16	life	life	NOUN
ajlm-2756	90	17	,	,	PUNCT
ajlm-2756	90	18	it	it	PRON
ajlm-2756	90	19	may	may	AUX
ajlm-2756	90	20	not	not	PART
ajlm-2756	90	21	fully	fully	ADV
ajlm-2756	90	22	address	address	VERB
ajlm-2756	90	23	the	the	DET
ajlm-2756	90	24	underlying	underlie	VERB
ajlm-2756	90	25	inflammation	inflammation	NOUN
ajlm-2756	90	26	that	that	PRON
ajlm-2756	90	27	persists	persist	VERB
ajlm-2756	90	28	,	,	PUNCT
ajlm-2756	90	29	even	even	ADV
ajlm-2756	90	30	in	in	ADP
ajlm-2756	90	31	individuals	individual	NOUN
ajlm-2756	90	32	with	with	ADP
ajlm-2756	90	33	viral	viral	ADJ
ajlm-2756	90	34	suppression.10,24,25	suppression.10,24,25	NOUN
ajlm-2756	90	35	these	these	DET
ajlm-2756	90	36	findings	finding	NOUN
ajlm-2756	90	37	call	call	VERB
ajlm-2756	90	38	attention	attention	NOUN
ajlm-2756	90	39	to	to	ADP
ajlm-2756	90	40	the	the	DET
ajlm-2756	90	41	need	need	NOUN
ajlm-2756	90	42	for	for	ADP
ajlm-2756	90	43	ongoing	ongoing	ADJ
ajlm-2756	90	44	monitoring	monitoring	NOUN
ajlm-2756	90	45	of	of	ADP
ajlm-2756	90	46	inflammatory	inflammatory	ADJ
ajlm-2756	90	47	markers	marker	NOUN
ajlm-2756	90	48	,	,	PUNCT
ajlm-2756	90	49	such	such	ADJ
ajlm-2756	90	50	as	as	ADP
ajlm-2756	90	51	crp	crp	PROPN
ajlm-2756	90	52	and	and	CCONJ
ajlm-2756	90	53	d	d	NOUN
ajlm-2756	90	54	-	-	PUNCT
ajlm-2756	90	55	dimer	dimer	ADJ
ajlm-2756	90	56	,	,	PUNCT
ajlm-2756	90	57	as	as	ADP
ajlm-2756	90	58	part	part	NOUN
ajlm-2756	90	59	of	of	ADP
ajlm-2756	90	60	routine	routine	ADJ
ajlm-2756	90	61	clinical	clinical	ADJ
ajlm-2756	90	62	care	care	NOUN
ajlm-2756	90	63	for	for	ADP
ajlm-2756	90	64	people	people	NOUN
ajlm-2756	90	65	living	live	VERB
ajlm-2756	90	66	with	with	ADP
ajlm-2756	90	67	hiv	hiv	PROPN
ajlm-2756	90	68	.	.	PUNCT
ajlm-2756	91	1	such	such	ADJ
ajlm-2756	91	2	monitoring	monitoring	NOUN
ajlm-2756	91	3	could	could	AUX
ajlm-2756	91	4	help	help	AUX
ajlm-2756	91	5	identify	identify	VERB
ajlm-2756	91	6	individuals	individual	NOUN
ajlm-2756	91	7	who	who	PRON
ajlm-2756	91	8	are	be	AUX
ajlm-2756	91	9	not	not	PART
ajlm-2756	91	10	experiencing	experience	VERB
ajlm-2756	91	11	adequate	adequate	ADJ
ajlm-2756	91	12	viral	viral	ADJ
ajlm-2756	91	13	suppression	suppression	NOUN
ajlm-2756	91	14	,	,	PUNCT
ajlm-2756	91	15	or	or	CCONJ
ajlm-2756	91	16	those	those	PRON
ajlm-2756	91	17	who	who	PRON
ajlm-2756	91	18	may	may	AUX
ajlm-2756	91	19	require	require	VERB
ajlm-2756	91	20	adjustments	adjustment	NOUN
ajlm-2756	91	21	to	to	ADP
ajlm-2756	91	22	their	their	PRON
ajlm-2756	91	23	art	art	NOUN
ajlm-2756	91	24	regimen	regiman	NOUN
ajlm-2756	91	25	.	.	PUNCT
ajlm-2756	92	1	additionally	additionally	ADV
ajlm-2756	92	2	,	,	PUNCT
ajlm-2756	92	3	the	the	DET
ajlm-2756	92	4	results	result	NOUN
ajlm-2756	92	5	emphasise	emphasise	VERB
ajlm-2756	92	6	the	the	DET
ajlm-2756	92	7	potential	potential	ADJ
ajlm-2756	92	8	value	value	NOUN
ajlm-2756	92	9	of	of	ADP
ajlm-2756	92	10	therapeutic	therapeutic	ADJ
ajlm-2756	92	11	drug	drug	NOUN
ajlm-2756	92	12	monitoring	monitoring	NOUN
ajlm-2756	92	13	in	in	ADP
ajlm-2756	92	14	the	the	DET
ajlm-2756	92	15	clinical	clinical	ADJ
ajlm-2756	92	16	practice	practice	NOUN
ajlm-2756	92	17	of	of	ADP
ajlm-2756	92	18	hiv	hiv	PROPN
ajlm-2756	92	19	management	management	NOUN
ajlm-2756	92	20	in	in	ADP
ajlm-2756	92	21	different	different	ADJ
ajlm-2756	92	22	populations	population	NOUN
ajlm-2756	92	23	.	.	PUNCT
ajlm-2756	93	1	therapeutic	therapeutic	ADJ
ajlm-2756	93	2	drug	drug	NOUN
ajlm-2756	93	3	monitoring	monitoring	NOUN
ajlm-2756	93	4	could	could	AUX
ajlm-2756	93	5	be	be	AUX
ajlm-2756	93	6	used	use	VERB
ajlm-2756	93	7	to	to	PART
ajlm-2756	93	8	assess	assess	VERB
ajlm-2756	93	9	art	art	NOUN
ajlm-2756	93	10	adherence	adherence	NOUN
ajlm-2756	93	11	and	and	CCONJ
ajlm-2756	93	12	its	its	PRON
ajlm-2756	93	13	efficacy	efficacy	NOUN
ajlm-2756	93	14	.	.	PUNCT
ajlm-2756	94	1	recommendations	recommendation	NOUN
ajlm-2756	94	2	future	future	ADJ
ajlm-2756	94	3	research	research	NOUN
ajlm-2756	94	4	should	should	AUX
ajlm-2756	94	5	explore	explore	VERB
ajlm-2756	94	6	the	the	DET
ajlm-2756	94	7	mechanisms	mechanism	NOUN
ajlm-2756	94	8	driving	drive	VERB
ajlm-2756	94	9	inflammation	inflammation	NOUN
ajlm-2756	94	10	in	in	ADP
ajlm-2756	94	11	hiv	hiv	PROPN
ajlm-2756	94	12	-	-	PUNCT
ajlm-2756	94	13	positive	positive	ADJ
ajlm-2756	94	14	individuals	individual	NOUN
ajlm-2756	94	15	,	,	PUNCT
ajlm-2756	94	16	the	the	DET
ajlm-2756	94	17	role	role	NOUN
ajlm-2756	94	18	of	of	ADP
ajlm-2756	94	19	personalised	personalised	ADJ
ajlm-2756	94	20	art	art	NOUN
ajlm-2756	94	21	regimens	regimen	NOUN
ajlm-2756	94	22	in	in	ADP
ajlm-2756	94	23	managing	manage	VERB
ajlm-2756	94	24	persistent	persistent	ADJ
ajlm-2756	94	25	inflammation	inflammation	NOUN
ajlm-2756	94	26	,	,	PUNCT
ajlm-2756	94	27	and	and	CCONJ
ajlm-2756	94	28	the	the	DET
ajlm-2756	94	29	impact	impact	NOUN
ajlm-2756	94	30	of	of	ADP
ajlm-2756	94	31	art	art	NOUN
ajlm-2756	94	32	on	on	ADP
ajlm-2756	94	33	long	long	ADJ
ajlm-2756	94	34	-	-	PUNCT
ajlm-2756	94	35	term	term	NOUN
ajlm-2756	94	36	health	health	NOUN
ajlm-2756	94	37	outcomes	outcome	NOUN
ajlm-2756	94	38	such	such	ADJ
ajlm-2756	94	39	as	as	ADP
ajlm-2756	94	40	cardiovascular	cardiovascular	ADJ
ajlm-2756	94	41	disease	disease	NOUN
ajlm-2756	94	42	and	and	CCONJ
ajlm-2756	94	43	cognitive	cognitive	ADJ
ajlm-2756	94	44	decline	decline	NOUN
ajlm-2756	94	45	.	.	PUNCT
ajlm-2756	95	1	future	future	ADJ
ajlm-2756	95	2	researchers	researcher	NOUN
ajlm-2756	95	3	should	should	AUX
ajlm-2756	95	4	be	be	AUX
ajlm-2756	95	5	more	more	ADJ
ajlm-2756	95	6	age	age	NOUN
ajlm-2756	95	7	specific	specific	ADJ
ajlm-2756	95	8	and	and	CCONJ
ajlm-2756	95	9	should	should	AUX
ajlm-2756	95	10	include	include	VERB
ajlm-2756	95	11	the	the	DET
ajlm-2756	95	12	length	length	NOUN
ajlm-2756	95	13	of	of	ADP
ajlm-2756	95	14	arv	arv	NOUN
ajlm-2756	95	15	treatment	treatment	NOUN
ajlm-2756	95	16	.	.	PUNCT
ajlm-2756	96	1	by	by	ADP
ajlm-2756	96	2	advancing	advance	VERB
ajlm-2756	96	3	our	our	PRON
ajlm-2756	96	4	understanding	understanding	NOUN
ajlm-2756	96	5	of	of	ADP
ajlm-2756	96	6	the	the	DET
ajlm-2756	96	7	relationship	relationship	NOUN
ajlm-2756	96	8	between	between	ADP
ajlm-2756	96	9	inflammation	inflammation	NOUN
ajlm-2756	96	10	,	,	PUNCT
ajlm-2756	96	11	hiv	hiv	PROPN
ajlm-2756	96	12	,	,	PUNCT
ajlm-2756	96	13	and	and	CCONJ
ajlm-2756	96	14	art	art	NOUN
ajlm-2756	96	15	,	,	PUNCT
ajlm-2756	96	16	this	this	DET
ajlm-2756	96	17	research	research	NOUN
ajlm-2756	96	18	has	have	VERB
ajlm-2756	96	19	the	the	DET
ajlm-2756	96	20	potential	potential	NOUN
ajlm-2756	96	21	to	to	PART
ajlm-2756	96	22	guide	guide	VERB
ajlm-2756	96	23	more	more	ADJ
ajlm-2756	96	24	targeted	target	VERB
ajlm-2756	96	25	interventions	intervention	NOUN
ajlm-2756	96	26	aimed	aim	VERB
ajlm-2756	96	27	at	at	ADP
ajlm-2756	96	28	improving	improve	VERB
ajlm-2756	96	29	the	the	DET
ajlm-2756	96	30	health	health	NOUN
ajlm-2756	96	31	and	and	CCONJ
ajlm-2756	96	32	quality	quality	NOUN
ajlm-2756	96	33	of	of	ADP
ajlm-2756	96	34	life	life	NOUN
ajlm-2756	96	35	of	of	ADP
ajlm-2756	96	36	people	people	NOUN
ajlm-2756	96	37	living	live	VERB
ajlm-2756	96	38	with	with	ADP
ajlm-2756	96	39	hiv	hiv	PROPN
ajlm-2756	96	40	,	,	PUNCT
ajlm-2756	96	41	particularly	particularly	ADV
ajlm-2756	96	42	in	in	ADP
ajlm-2756	96	43	high	high	ADJ
ajlm-2756	96	44	-	-	PUNCT
ajlm-2756	96	45	prevalence	prevalence	NOUN
ajlm-2756	96	46	regions	region	NOUN
ajlm-2756	96	47	such	such	ADJ
ajlm-2756	96	48	as	as	ADP
ajlm-2756	96	49	kwazulu	kwazulu	NOUN
ajlm-2756	96	50	-	-	PUNCT
ajlm-2756	96	51	natal	natal	NOUN
ajlm-2756	96	52	.	.	PUNCT
ajlm-2756	97	1	limitations	limitation	NOUN
ajlm-2756	97	2	of	of	ADP
ajlm-2756	97	3	the	the	DET
ajlm-2756	97	4	study	study	NOUN
ajlm-2756	97	5	the	the	DET
ajlm-2756	97	6	study	study	NOUN
ajlm-2756	97	7	had	have	VERB
ajlm-2756	97	8	limitations	limitation	NOUN
ajlm-2756	97	9	.	.	PUNCT
ajlm-2756	98	1	the	the	DET
ajlm-2756	98	2	relatively	relatively	ADV
ajlm-2756	98	3	small	small	ADJ
ajlm-2756	98	4	sample	sample	NOUN
ajlm-2756	98	5	size	size	NOUN
ajlm-2756	98	6	of	of	ADP
ajlm-2756	98	7	275	275	NUM
ajlm-2756	98	8	participants	participant	NOUN
ajlm-2756	98	9	may	may	AUX
ajlm-2756	98	10	limit	limit	VERB
ajlm-2756	98	11	the	the	DET
ajlm-2756	98	12	generalisability	generalisability	NOUN
ajlm-2756	98	13	of	of	ADP
ajlm-2756	98	14	the	the	DET
ajlm-2756	98	15	findings	finding	NOUN
ajlm-2756	98	16	.	.	PUNCT
ajlm-2756	99	1	a	a	DET
ajlm-2756	99	2	larger	large	ADJ
ajlm-2756	99	3	sample	sample	NOUN
ajlm-2756	99	4	would	would	AUX
ajlm-2756	99	5	provide	provide	VERB
ajlm-2756	99	6	more	more	ADV
ajlm-2756	99	7	robust	robust	ADJ
ajlm-2756	99	8	conclusions	conclusion	NOUN
ajlm-2756	99	9	,	,	PUNCT
ajlm-2756	99	10	especially	especially	ADV
ajlm-2756	99	11	when	when	SCONJ
ajlm-2756	99	12	analysing	analyse	VERB
ajlm-2756	99	13	demographic	demographic	ADJ
ajlm-2756	99	14	subgroups	subgroup	NOUN
ajlm-2756	99	15	such	such	ADJ
ajlm-2756	99	16	as	as	ADP
ajlm-2756	99	17	age	age	NOUN
ajlm-2756	99	18	and	and	CCONJ
ajlm-2756	99	19	gender	gender	NOUN
ajlm-2756	99	20	.	.	PUNCT
ajlm-2756	100	1	the	the	DET
ajlm-2756	100	2	study	study	NOUN
ajlm-2756	100	3	focused	focus	VERB
ajlm-2756	100	4	solely	solely	ADV
ajlm-2756	100	5	on	on	ADP
ajlm-2756	100	6	crp	crp	PROPN
ajlm-2756	100	7	and	and	CCONJ
ajlm-2756	100	8	d	d	NOUN
ajlm-2756	100	9	-	-	PUNCT
ajlm-2756	100	10	dimer	dimer	NOUN
ajlm-2756	100	11	as	as	ADP
ajlm-2756	100	12	indicators	indicator	NOUN
ajlm-2756	100	13	of	of	ADP
ajlm-2756	100	14	inflammation	inflammation	NOUN
ajlm-2756	100	15	,	,	PUNCT
ajlm-2756	100	16	which	which	PRON
ajlm-2756	100	17	limits	limit	VERB
ajlm-2756	100	18	the	the	DET
ajlm-2756	100	19	findings	finding	NOUN
ajlm-2756	100	20	.	.	PUNCT
ajlm-2756	101	1	including	include	VERB
ajlm-2756	101	2	other	other	ADJ
ajlm-2756	101	3	markers	marker	NOUN
ajlm-2756	101	4	,	,	PUNCT
ajlm-2756	101	5	such	such	ADJ
ajlm-2756	101	6	as	as	ADP
ajlm-2756	101	7	il-6	il-6	NUM
ajlm-2756	101	8	or	or	CCONJ
ajlm-2756	101	9	tumour	tumour	NOUN
ajlm-2756	101	10	necrosis	necrosis	NOUN
ajlm-2756	101	11	factor	factor	NOUN
ajlm-2756	101	12	-	-	PUNCT
ajlm-2756	101	13	alpha	alpha	NOUN
ajlm-2756	101	14	,	,	PUNCT
ajlm-2756	101	15	could	could	AUX
ajlm-2756	101	16	offer	offer	VERB
ajlm-2756	101	17	a	a	DET
ajlm-2756	101	18	more	more	ADV
ajlm-2756	101	19	comprehensive	comprehensive	ADJ
ajlm-2756	101	20	view	view	NOUN
ajlm-2756	101	21	of	of	ADP
ajlm-2756	101	22	inflammation	inflammation	NOUN
ajlm-2756	101	23	in	in	ADP
ajlm-2756	101	24	hiv	hiv	PROPN
ajlm-2756	101	25	-	-	PUNCT
ajlm-2756	101	26	positive	positive	ADJ
ajlm-2756	101	27	individuals	individual	NOUN
ajlm-2756	101	28	.	.	PUNCT
ajlm-2756	102	1	conducting	conduct	VERB
ajlm-2756	102	2	the	the	DET
ajlm-2756	102	3	study	study	NOUN
ajlm-2756	102	4	in	in	ADP
ajlm-2756	102	5	a	a	DET
ajlm-2756	102	6	single	single	ADJ
ajlm-2756	102	7	location	location	NOUN
ajlm-2756	102	8	may	may	AUX
ajlm-2756	102	9	limit	limit	VERB
ajlm-2756	102	10	the	the	DET
ajlm-2756	102	11	applicability	applicability	NOUN
ajlm-2756	102	12	of	of	ADP
ajlm-2756	102	13	the	the	DET
ajlm-2756	102	14	findings	finding	NOUN
ajlm-2756	102	15	to	to	ADP
ajlm-2756	102	16	other	other	ADJ
ajlm-2756	102	17	populations	population	NOUN
ajlm-2756	102	18	.	.	PUNCT
ajlm-2756	103	1	including	include	VERB
ajlm-2756	103	2	different	different	ADJ
ajlm-2756	103	3	populations	population	NOUN
ajlm-2756	103	4	in	in	ADP
ajlm-2756	103	5	other	other	ADJ
ajlm-2756	103	6	laboratories	laboratory	NOUN
ajlm-2756	103	7	in	in	ADP
ajlm-2756	103	8	south	south	PROPN
ajlm-2756	103	9	africa	africa	PROPN
ajlm-2756	103	10	would	would	AUX
ajlm-2756	103	11	enhance	enhance	VERB
ajlm-2756	103	12	the	the	DET
ajlm-2756	103	13	external	external	ADJ
ajlm-2756	103	14	validity	validity	NOUN
ajlm-2756	103	15	of	of	ADP
ajlm-2756	103	16	the	the	DET
ajlm-2756	103	17	results	result	NOUN
ajlm-2756	103	18	.	.	PUNCT
ajlm-2756	104	1	conclusion	conclusion	NOUN
ajlm-2756	104	2	in	in	ADP
ajlm-2756	104	3	summary	summary	NOUN
ajlm-2756	104	4	,	,	PUNCT
ajlm-2756	104	5	this	this	DET
ajlm-2756	104	6	study	study	NOUN
ajlm-2756	104	7	highlights	highlight	VERB
ajlm-2756	104	8	the	the	DET
ajlm-2756	104	9	complex	complex	ADJ
ajlm-2756	104	10	interplay	interplay	NOUN
ajlm-2756	104	11	between	between	ADP
ajlm-2756	104	12	viral	viral	ADJ
ajlm-2756	104	13	load	load	NOUN
ajlm-2756	104	14	,	,	PUNCT
ajlm-2756	104	15	inflammatory	inflammatory	ADJ
ajlm-2756	104	16	markers	marker	NOUN
ajlm-2756	104	17	(	(	PUNCT
ajlm-2756	104	18	crp	crp	PROPN
ajlm-2756	104	19	and	and	CCONJ
ajlm-2756	104	20	d	d	NOUN
ajlm-2756	104	21	-	-	PUNCT
ajlm-2756	104	22	dimer	dimer	NUM
ajlm-2756	104	23	)	)	PUNCT
ajlm-2756	104	24	,	,	PUNCT
ajlm-2756	104	25	and	and	CCONJ
ajlm-2756	104	26	art	art	NOUN
ajlm-2756	104	27	in	in	ADP
ajlm-2756	104	28	hiv	hiv	PROPN
ajlm-2756	104	29	-	-	PUNCT
ajlm-2756	104	30	positive	positive	ADJ
ajlm-2756	104	31	individuals	individual	NOUN
ajlm-2756	104	32	.	.	PUNCT
ajlm-2756	105	1	while	while	SCONJ
ajlm-2756	105	2	art	art	NOUN
ajlm-2756	105	3	effectively	effectively	ADV
ajlm-2756	105	4	suppresses	suppress	VERB
ajlm-2756	105	5	the	the	DET
ajlm-2756	105	6	virus	virus	NOUN
ajlm-2756	105	7	,	,	PUNCT
ajlm-2756	105	8	it	it	PRON
ajlm-2756	105	9	does	do	AUX
ajlm-2756	105	10	not	not	PART
ajlm-2756	105	11	always	always	ADV
ajlm-2756	105	12	normalise	normalise	VERB
ajlm-2756	105	13	inflammation	inflammation	NOUN
ajlm-2756	105	14	,	,	PUNCT
ajlm-2756	105	15	as	as	SCONJ
ajlm-2756	105	16	evidenced	evidence	VERB
ajlm-2756	105	17	by	by	ADP
ajlm-2756	105	18	the	the	DET
ajlm-2756	105	19	elevated	elevated	ADJ
ajlm-2756	105	20	crp	crp	NOUN
ajlm-2756	105	21	and	and	CCONJ
ajlm-2756	105	22	d	d	ADJ
ajlm-2756	105	23	-	-	PUNCT
ajlm-2756	105	24	dimer	dimer	ADJ
ajlm-2756	105	25	levels	level	NOUN
ajlm-2756	105	26	observed	observe	VERB
ajlm-2756	105	27	in	in	ADP
ajlm-2756	105	28	this	this	DET
ajlm-2756	105	29	cohort	cohort	NOUN
ajlm-2756	105	30	.	.	PUNCT
ajlm-2756	106	1	these	these	DET
ajlm-2756	106	2	findings	finding	NOUN
ajlm-2756	106	3	suggest	suggest	VERB
ajlm-2756	106	4	that	that	SCONJ
ajlm-2756	106	5	hiv	hiv	PROPN
ajlm-2756	106	6	-	-	PUNCT
ajlm-2756	106	7	related	relate	VERB
ajlm-2756	106	8	inflammation	inflammation	NOUN
ajlm-2756	106	9	is	be	AUX
ajlm-2756	106	10	a	a	DET
ajlm-2756	106	11	persistent	persistent	ADJ
ajlm-2756	106	12	issue	issue	NOUN
ajlm-2756	106	13	,	,	PUNCT
ajlm-2756	106	14	even	even	ADV
ajlm-2756	106	15	in	in	ADP
ajlm-2756	106	16	individuals	individual	NOUN
ajlm-2756	106	17	with	with	ADP
ajlm-2756	106	18	viral	viral	ADJ
ajlm-2756	106	19	suppression	suppression	NOUN
ajlm-2756	106	20	.	.	PUNCT
ajlm-2756	107	1	given	give	VERB
ajlm-2756	107	2	the	the	DET
ajlm-2756	107	3	potential	potential	ADJ
ajlm-2756	107	4	link	link	NOUN
ajlm-2756	107	5	between	between	ADP
ajlm-2756	107	6	chronic	chronic	ADJ
ajlm-2756	107	7	inflammation	inflammation	NOUN
ajlm-2756	107	8	and	and	CCONJ
ajlm-2756	107	9	hiv	hiv	NOUN
ajlm-2756	107	10	-	-	PUNCT
ajlm-2756	107	11	related	relate	VERB
ajlm-2756	107	12	complications	complication	NOUN
ajlm-2756	107	13	,	,	PUNCT
ajlm-2756	107	14	ongoing	ongoing	ADJ
ajlm-2756	107	15	monitoring	monitoring	NOUN
ajlm-2756	107	16	of	of	ADP
ajlm-2756	107	17	inflammatory	inflammatory	ADJ
ajlm-2756	107	18	biomarkers	biomarker	NOUN
ajlm-2756	107	19	is	be	AUX
ajlm-2756	107	20	essential	essential	ADJ
ajlm-2756	107	21	for	for	ADP
ajlm-2756	107	22	improving	improve	VERB
ajlm-2756	107	23	the	the	DET
ajlm-2756	107	24	management	management	NOUN
ajlm-2756	107	25	of	of	ADP
ajlm-2756	107	26	hiv	hiv	PROPN
ajlm-2756	107	27	and	and	CCONJ
ajlm-2756	107	28	reducing	reduce	VERB
ajlm-2756	107	29	the	the	DET
ajlm-2756	107	30	risk	risk	NOUN
ajlm-2756	107	31	of	of	ADP
ajlm-2756	107	32	associated	associate	VERB
ajlm-2756	107	33	comorbidities	comorbiditie	NOUN
ajlm-2756	107	34	.	.	PUNCT
ajlm-2756	108	1	acknowledgements	acknowledgement	NOUN
ajlm-2756	108	2	the	the	DET
ajlm-2756	108	3	authors	author	NOUN
ajlm-2756	108	4	would	would	AUX
ajlm-2756	108	5	like	like	VERB
ajlm-2756	108	6	to	to	PART
ajlm-2756	108	7	express	express	VERB
ajlm-2756	108	8	their	their	PRON
ajlm-2756	108	9	gratitude	gratitude	NOUN
ajlm-2756	108	10	to	to	ADP
ajlm-2756	108	11	the	the	DET
ajlm-2756	108	12	collaborative	collaborative	ADJ
ajlm-2756	108	13	partnership	partnership	NOUN
ajlm-2756	108	14	to	to	ADP
ajlm-2756	108	15	the	the	DET
ajlm-2756	108	16	department	department	NOUN
ajlm-2756	108	17	of	of	ADP
ajlm-2756	108	18	biomedical	biomedical	ADJ
ajlm-2756	108	19	science	science	NOUN
ajlm-2756	108	20	at	at	ADP
ajlm-2756	108	21	mangosuthu	mangosuthu	NOUN
ajlm-2756	108	22	university	university	PROPN
ajlm-2756	108	23	of	of	ADP
ajlm-2756	108	24	technology	technology	NOUN
ajlm-2756	108	25	and	and	CCONJ
ajlm-2756	108	26	the	the	DET
ajlm-2756	108	27	national	national	PROPN
ajlm-2756	108	28	health	health	PROPN
ajlm-2756	108	29	laboratory	laboratory	PROPN
ajlm-2756	108	30	service	service	NOUN
ajlm-2756	108	31	for	for	ADP
ajlm-2756	108	32	enabling	enable	VERB
ajlm-2756	108	33	and	and	CCONJ
ajlm-2756	108	34	supporting	support	VERB
ajlm-2756	108	35	this	this	DET
ajlm-2756	108	36	research	research	NOUN
ajlm-2756	108	37	.	.	PUNCT
ajlm-2756	109	1	this	this	DET
ajlm-2756	109	2	article	article	NOUN
ajlm-2756	109	3	is	be	AUX
ajlm-2756	109	4	partially	partially	ADV
ajlm-2756	109	5	based	base	VERB
ajlm-2756	109	6	on	on	ADP
ajlm-2756	109	7	l.n	l.n	PROPN
ajlm-2756	109	8	.	.	PROPN
ajlm-2756	109	9	’s	’s	PART
ajlm-2756	109	10	thesis	thesis	NOUN
ajlm-2756	109	11	entitled	entitle	VERB
ajlm-2756	109	12	‘	'	PUNCT
ajlm-2756	109	13	exploring	explore	VERB
ajlm-2756	109	14	the	the	DET
ajlm-2756	109	15	inflammatory	inflammatory	ADJ
ajlm-2756	109	16	markers	marker	NOUN
ajlm-2756	109	17	of	of	ADP
ajlm-2756	109	18	individuals	individual	NOUN
ajlm-2756	109	19	receiving	receive	VERB
ajlm-2756	109	20	antiretroviral	antiretroviral	ADJ
ajlm-2756	109	21	treatment	treatment	NOUN
ajlm-2756	109	22	for	for	ADP
ajlm-2756	109	23	human	human	ADJ
ajlm-2756	109	24	immunodeficiency	immunodeficiency	NOUN
ajlm-2756	109	25	virus	virus	NOUN
ajlm-2756	109	26	compared	compare	VERB
ajlm-2756	109	27	to	to	ADP
ajlm-2756	109	28	hiv	hiv	PROPN
ajlm-2756	109	29	negative	negative	ADJ
ajlm-2756	109	30	individuals	individual	NOUN
ajlm-2756	109	31	’	'	PUNCT
ajlm-2756	109	32	towards	towards	ADP
ajlm-2756	109	33	the	the	DET
ajlm-2756	109	34	bachelor	bachelor	NOUN
ajlm-2756	109	35	of	of	ADP
ajlm-2756	109	36	health	health	NOUN
ajlm-2756	109	37	sciences	science	NOUN
ajlm-2756	109	38	:	:	PUNCT
ajlm-2756	109	39	medical	medical	ADJ
ajlm-2756	109	40	laboratory	laboratory	NOUN
ajlm-2756	109	41	science	science	NOUN
ajlm-2756	109	42	degree	degree	NOUN
ajlm-2756	109	43	in	in	ADP
ajlm-2756	109	44	the	the	DET
ajlm-2756	109	45	department	department	NOUN
ajlm-2756	109	46	of	of	ADP
ajlm-2756	109	47	biomedical	biomedical	ADJ
ajlm-2756	109	48	sciences	science	NOUN
ajlm-2756	109	49	,	,	PUNCT
ajlm-2756	109	50	mangosuthu	mangosuthu	NOUN
ajlm-2756	109	51	university	university	NOUN
ajlm-2756	109	52	of	of	ADP
ajlm-2756	109	53	technology	technology	NOUN
ajlm-2756	109	54	,	,	PUNCT
ajlm-2756	109	55	south	south	PROPN
ajlm-2756	109	56	africa	africa	PROPN
ajlm-2756	109	57	,	,	PUNCT
ajlm-2756	109	58	on	on	ADP
ajlm-2756	109	59	15	15	NUM
ajlm-2756	109	60	november	november	PROPN
ajlm-2756	109	61	2024	2024	NUM
ajlm-2756	109	62	,	,	PUNCT
ajlm-2756	109	63	with	with	ADP
ajlm-2756	109	64	dr	dr	PROPN
ajlm-2756	109	65	z.n	z.n	PROPN
ajlm-2756	109	66	.	.	PROPN
ajlm-2756	109	67	jaya	jaya	PROPN
ajlm-2756	109	68	as	as	ADP
ajlm-2756	109	69	supervisor	supervisor	NOUN
ajlm-2756	109	70	and	and	CCONJ
ajlm-2756	109	71	ms	ms	PROPN
ajlm-2756	109	72	n.	n.	PROPN
ajlm-2756	109	73	thembane	thembane	PROPN
ajlm-2756	109	74	as	as	ADP
ajlm-2756	109	75	co	co	NOUN
ajlm-2756	109	76	-	-	NOUN
ajlm-2756	109	77	supervisor	supervisor	NOUN
ajlm-2756	109	78	.	.	PUNCT
ajlm-2756	110	1	competing	compete	VERB
ajlm-2756	110	2	interests	interest	NOUN
ajlm-2756	110	3	the	the	DET
ajlm-2756	110	4	authors	author	NOUN
ajlm-2756	110	5	declare	declare	VERB
ajlm-2756	110	6	that	that	SCONJ
ajlm-2756	110	7	they	they	PRON
ajlm-2756	110	8	have	have	VERB
ajlm-2756	110	9	no	no	DET
ajlm-2756	110	10	financial	financial	ADJ
ajlm-2756	110	11	or	or	CCONJ
ajlm-2756	110	12	personal	personal	ADJ
ajlm-2756	110	13	relationships	relationship	NOUN
ajlm-2756	110	14	that	that	PRON
ajlm-2756	110	15	may	may	AUX
ajlm-2756	110	16	have	have	AUX
ajlm-2756	110	17	inappropriately	inappropriately	ADV
ajlm-2756	110	18	influenced	influence	VERB
ajlm-2756	110	19	them	they	PRON
ajlm-2756	110	20	in	in	ADP
ajlm-2756	110	21	writing	write	VERB
ajlm-2756	110	22	this	this	DET
ajlm-2756	110	23	article	article	NOUN
ajlm-2756	110	24	.	.	PUNCT
ajlm-2756	111	1	authors	author	NOUN
ajlm-2756	111	2	’	’	PART
ajlm-2756	111	3	contributions	contribution	NOUN
ajlm-2756	111	4	l.n	l.n	PROPN
ajlm-2756	111	5	.	.	PROPN
ajlm-2756	111	6	collected	collect	VERB
ajlm-2756	111	7	the	the	DET
ajlm-2756	111	8	data	datum	NOUN
ajlm-2756	111	9	.	.	PUNCT
ajlm-2756	112	1	z.n.j	z.n.j	PROPN
ajlm-2756	112	2	.	.	PROPN
ajlm-2756	112	3	and	and	CCONJ
ajlm-2756	112	4	n.t	n.t	PROPN
ajlm-2756	112	5	.	.	PROPN
ajlm-2756	112	6	were	be	AUX
ajlm-2756	112	7	involved	involve	VERB
ajlm-2756	112	8	in	in	ADP
ajlm-2756	112	9	conceptualising	conceptualise	VERB
ajlm-2756	112	10	and	and	CCONJ
ajlm-2756	112	11	supervising	supervise	VERB
ajlm-2756	112	12	the	the	DET
ajlm-2756	112	13	work	work	NOUN
ajlm-2756	112	14	.	.	PUNCT
ajlm-2756	113	1	l.n	l.n	AUX
ajlm-2756	113	2	.	.	PROPN
ajlm-2756	113	3	cleaned	clean	VERB
ajlm-2756	113	4	and	and	CCONJ
ajlm-2756	113	5	analysed	analyse	VERB
ajlm-2756	113	6	the	the	DET
ajlm-2756	113	7	data	datum	NOUN
ajlm-2756	113	8	and	and	CCONJ
ajlm-2756	113	9	wrote	write	VERB
ajlm-2756	113	10	the	the	DET
ajlm-2756	113	11	draft	draft	NOUN
ajlm-2756	113	12	manuscript	manuscript	NOUN
ajlm-2756	113	13	.	.	PUNCT
ajlm-2756	114	1	z.n.j	z.n.j	PROPN
ajlm-2756	114	2	.	.	PROPN
ajlm-2756	114	3	and	and	CCONJ
ajlm-2756	114	4	n.t	n.t	PROPN
ajlm-2756	114	5	.	.	PROPN
ajlm-2756	114	6	supervised	supervise	VERB
ajlm-2756	114	7	all	all	DET
ajlm-2756	114	8	stages	stage	NOUN
ajlm-2756	114	9	of	of	ADP
ajlm-2756	114	10	the	the	DET
ajlm-2756	114	11	research	research	NOUN
ajlm-2756	114	12	,	,	PUNCT
ajlm-2756	114	13	reviewed	review	VERB
ajlm-2756	114	14	the	the	DET
ajlm-2756	114	15	draft	draft	NOUN
ajlm-2756	114	16	manuscript	manuscript	NOUN
ajlm-2756	114	17	,	,	PUNCT
ajlm-2756	114	18	and	and	CCONJ
ajlm-2756	114	19	provided	provide	VERB
ajlm-2756	114	20	general	general	ADJ
ajlm-2756	114	21	supervision	supervision	NOUN
ajlm-2756	114	22	and	and	CCONJ
ajlm-2756	114	23	mentorship	mentorship	NOUN
ajlm-2756	114	24	.	.	PUNCT
ajlm-2756	115	1	sources	source	NOUN
ajlm-2756	115	2	of	of	ADP
ajlm-2756	115	3	support	support	NOUN
ajlm-2756	115	4	the	the	DET
ajlm-2756	115	5	authors	author	NOUN
ajlm-2756	115	6	received	receive	VERB
ajlm-2756	115	7	no	no	DET
ajlm-2756	115	8	financial	financial	ADJ
ajlm-2756	115	9	support	support	NOUN
ajlm-2756	115	10	for	for	ADP
ajlm-2756	115	11	the	the	DET
ajlm-2756	115	12	research	research	NOUN
ajlm-2756	115	13	,	,	PUNCT
ajlm-2756	115	14	authorship	authorship	NOUN
ajlm-2756	115	15	,	,	PUNCT
ajlm-2756	115	16	and/or	and/or	CCONJ
ajlm-2756	115	17	publication	publication	NOUN
ajlm-2756	115	18	of	of	ADP
ajlm-2756	115	19	this	this	DET
ajlm-2756	115	20	article	article	NOUN
ajlm-2756	115	21	.	.	PUNCT
ajlm-2756	116	1	data	datum	NOUN
ajlm-2756	116	2	availability	availability	NOUN
ajlm-2756	116	3	the	the	DET
ajlm-2756	116	4	authors	author	NOUN
ajlm-2756	116	5	confirm	confirm	VERB
ajlm-2756	116	6	that	that	SCONJ
ajlm-2756	116	7	the	the	DET
ajlm-2756	116	8	data	datum	NOUN
ajlm-2756	116	9	supporting	support	VERB
ajlm-2756	116	10	the	the	DET
ajlm-2756	116	11	findings	finding	NOUN
ajlm-2756	116	12	of	of	ADP
ajlm-2756	116	13	this	this	DET
ajlm-2756	116	14	study	study	NOUN
ajlm-2756	116	15	are	be	AUX
ajlm-2756	116	16	available	available	ADJ
ajlm-2756	116	17	within	within	ADP
ajlm-2756	116	18	the	the	DET
ajlm-2756	116	19	article	article	NOUN
ajlm-2756	116	20	.	.	PUNCT
ajlm-2756	117	1	disclaimer	disclaimer	VERB
ajlm-2756	117	2	the	the	DET
ajlm-2756	117	3	views	view	NOUN
ajlm-2756	117	4	and	and	CCONJ
ajlm-2756	117	5	opinions	opinion	NOUN
ajlm-2756	117	6	expressed	express	VERB
ajlm-2756	117	7	in	in	ADP
ajlm-2756	117	8	this	this	DET
ajlm-2756	117	9	article	article	NOUN
ajlm-2756	117	10	are	be	AUX
ajlm-2756	117	11	those	those	PRON
ajlm-2756	117	12	of	of	ADP
ajlm-2756	117	13	the	the	DET
ajlm-2756	117	14	authors	author	NOUN
ajlm-2756	117	15	and	and	CCONJ
ajlm-2756	117	16	are	be	AUX
ajlm-2756	117	17	the	the	DET
ajlm-2756	117	18	product	product	NOUN
ajlm-2756	117	19	of	of	ADP
ajlm-2756	117	20	professional	professional	ADJ
ajlm-2756	117	21	research	research	NOUN
ajlm-2756	117	22	.	.	PUNCT
ajlm-2756	118	1	the	the	DET
ajlm-2756	118	2	article	article	NOUN
ajlm-2756	118	3	does	do	AUX
ajlm-2756	118	4	not	not	PART
ajlm-2756	118	5	necessarily	necessarily	ADV
ajlm-2756	118	6	reflect	reflect	VERB
ajlm-2756	118	7	the	the	DET
ajlm-2756	118	8	official	official	ADJ
ajlm-2756	118	9	policy	policy	NOUN
ajlm-2756	118	10	or	or	CCONJ
ajlm-2756	118	11	position	position	NOUN
ajlm-2756	118	12	of	of	ADP
ajlm-2756	118	13	any	any	DET
ajlm-2756	118	14	affiliated	affiliated	ADJ
ajlm-2756	118	15	institution	institution	NOUN
ajlm-2756	118	16	,	,	PUNCT
ajlm-2756	118	17	funder	funder	NOUN
ajlm-2756	118	18	,	,	PUNCT
ajlm-2756	118	19	agency	agency	NOUN
ajlm-2756	118	20	,	,	PUNCT
ajlm-2756	118	21	or	or	CCONJ
ajlm-2756	118	22	that	that	PRON
ajlm-2756	118	23	of	of	ADP
ajlm-2756	118	24	the	the	DET
ajlm-2756	118	25	publisher	publisher	NOUN
ajlm-2756	118	26	.	.	PUNCT
ajlm-2756	119	1	the	the	DET
ajlm-2756	119	2	authors	author	NOUN
ajlm-2756	119	3	are	be	AUX
ajlm-2756	119	4	responsible	responsible	ADJ
ajlm-2756	119	5	for	for	ADP
ajlm-2756	119	6	this	this	DET
ajlm-2756	119	7	article	article	NOUN
ajlm-2756	119	8	’s	’s	PART
ajlm-2756	119	9	results	result	NOUN
ajlm-2756	119	10	,	,	PUNCT
ajlm-2756	119	11	findings	finding	NOUN
ajlm-2756	119	12	,	,	PUNCT
ajlm-2756	119	13	and	and	CCONJ
ajlm-2756	119	14	content	content	NOUN
ajlm-2756	119	15	.	.	PUNCT
ajlm-2756	120	1	references	reference	NOUN
ajlm-2756	120	2	thurlow	thurlow	PROPN
ajlm-2756	120	3	j	j	PROPN
ajlm-2756	120	4	,	,	PUNCT
ajlm-2756	120	5	gow	gow	PROPN
ajlm-2756	120	6	j	j	PROPN
ajlm-2756	120	7	,	,	PUNCT
ajlm-2756	120	8	george	george	PROPN
ajlm-2756	120	9	g.	g.	PROPN
ajlm-2756	120	10	hiv	hiv	PROPN
ajlm-2756	120	11	/	/	SYM
ajlm-2756	120	12	aids	aids	PROPN
ajlm-2756	120	13	,	,	PUNCT
ajlm-2756	120	14	growth	growth	NOUN
ajlm-2756	120	15	and	and	CCONJ
ajlm-2756	120	16	poverty	poverty	NOUN
ajlm-2756	120	17	in	in	ADP
ajlm-2756	120	18	kwazulu	kwazulu	PROPN
ajlm-2756	120	19	-	-	PUNCT
ajlm-2756	120	20	natal	natal	ADJ
ajlm-2756	120	21	and	and	CCONJ
ajlm-2756	120	22	south	south	PROPN
ajlm-2756	120	23	africa	africa	PROPN
ajlm-2756	120	24	:	:	PUNCT
ajlm-2756	120	25	an	an	DET
ajlm-2756	120	26	integrated	integrated	ADJ
ajlm-2756	120	27	survey	survey	NOUN
ajlm-2756	120	28	,	,	PUNCT
ajlm-2756	120	29	demographic	demographic	ADJ
ajlm-2756	120	30	and	and	CCONJ
ajlm-2756	120	31	economy	economy	NOUN
ajlm-2756	120	32	-	-	PUNCT
ajlm-2756	120	33	wide	wide	ADJ
ajlm-2756	120	34	analysis	analysis	NOUN
ajlm-2756	120	35	.	.	PUNCT
ajlm-2756	121	1	j	j	PROPN
ajlm-2756	121	2	int	int	PROPN
ajlm-2756	121	3	aids	aids	PROPN
ajlm-2756	121	4	soc	soc	PROPN
ajlm-2756	121	5	.	.	PUNCT
ajlm-2756	122	1	2009;12:1–3	2009;12:1–3	NUM
ajlm-2756	122	2	.	.	PUNCT
ajlm-2756	123	1	https://doi.org/10.1186/1758-2652-12-18	https://doi.org/10.1186/1758-2652-12-18	PROPN
ajlm-2756	123	2	conan	conan	PROPN
ajlm-2756	123	3	n	n	PROPN
ajlm-2756	123	4	,	,	PUNCT
ajlm-2756	123	5	simons	simons	PROPN
ajlm-2756	123	6	e	e	PROPN
ajlm-2756	123	7	,	,	PUNCT
ajlm-2756	123	8	chihana	chihana	PROPN
ajlm-2756	123	9	ml	ml	PROPN
ajlm-2756	123	10	,	,	PUNCT
ajlm-2756	123	11	et	et	PROPN
ajlm-2756	123	12	al	al	PROPN
ajlm-2756	123	13	.	.	PUNCT
ajlm-2756	123	14	increase	increase	NOUN
ajlm-2756	123	15	in	in	ADP
ajlm-2756	123	16	hiv	hiv	PROPN
ajlm-2756	123	17	viral	viral	ADJ
ajlm-2756	123	18	suppression	suppression	NOUN
ajlm-2756	123	19	in	in	ADP
ajlm-2756	123	20	kwazulu	kwazulu	NOUN
ajlm-2756	123	21	-	-	PUNCT
ajlm-2756	123	22	natal	natal	ADJ
ajlm-2756	123	23	,	,	PUNCT
ajlm-2756	123	24	south	south	PROPN
ajlm-2756	123	25	africa	africa	PROPN
ajlm-2756	123	26	:	:	PUNCT
ajlm-2756	123	27	community	community	NOUN
ajlm-2756	123	28	-	-	PUNCT
ajlm-2756	123	29	based	base	VERB
ajlm-2756	123	30	cross	cross	NOUN
ajlm-2756	123	31	sectional	sectional	ADJ
ajlm-2756	123	32	surveys	survey	NOUN
ajlm-2756	123	33	2018	2018	NUM
ajlm-2756	123	34	and	and	CCONJ
ajlm-2756	123	35	2013	2013	NUM
ajlm-2756	123	36	.	.	PUNCT
ajlm-2756	124	1	what	what	PRON
ajlm-2756	124	2	remains	remain	VERB
ajlm-2756	124	3	to	to	PART
ajlm-2756	124	4	be	be	AUX
ajlm-2756	124	5	done	do	VERB
ajlm-2756	124	6	?	?	PUNCT
ajlm-2756	125	1	plos	plos	PROPN
ajlm-2756	125	2	one	one	NUM
ajlm-2756	125	3	.	.	PUNCT
ajlm-2756	126	1	2022;17(3):e0265488	2022;17(3):e0265488	NUM
ajlm-2756	126	2	.	.	PUNCT
ajlm-2756	127	1	https://doi.org/10.1371/journal.pone.0265488	https://doi.org/10.1371/journal.pone.0265488	NOUN
ajlm-2756	127	2	ntombela	ntombela	PROPN
ajlm-2756	127	3	np	np	INTJ
ajlm-2756	127	4	,	,	PUNCT
ajlm-2756	127	5	kharsany	kharsany	PROPN
ajlm-2756	127	6	ab	ab	PROPN
ajlm-2756	127	7	,	,	PUNCT
ajlm-2756	127	8	soogun	soogun	VERB
ajlm-2756	127	9	a	a	DET
ajlm-2756	127	10	,	,	PUNCT
ajlm-2756	127	11	et	et	PROPN
ajlm-2756	127	12	al	al	PROPN
ajlm-2756	127	13	.	.	PROPN
ajlm-2756	127	14	viral	viral	ADJ
ajlm-2756	127	15	suppression	suppression	NOUN
ajlm-2756	127	16	among	among	ADP
ajlm-2756	127	17	pregnant	pregnant	ADJ
ajlm-2756	127	18	adolescents	adolescent	NOUN
ajlm-2756	127	19	and	and	CCONJ
ajlm-2756	127	20	women	woman	NOUN
ajlm-2756	127	21	living	live	VERB
ajlm-2756	127	22	with	with	ADP
ajlm-2756	127	23	hiv	hiv	PROPN
ajlm-2756	127	24	in	in	ADP
ajlm-2756	127	25	rural	rural	ADJ
ajlm-2756	127	26	kwazulu	kwazulu	NOUN
ajlm-2756	127	27	-	-	PUNCT
ajlm-2756	127	28	natal	natal	ADJ
ajlm-2756	127	29	,	,	PUNCT
ajlm-2756	127	30	south	south	PROPN
ajlm-2756	127	31	africa	africa	PROPN
ajlm-2756	127	32	:	:	PUNCT
ajlm-2756	127	33	a	a	DET
ajlm-2756	127	34	cross	cross	ADJ
ajlm-2756	127	35	sectional	sectional	ADJ
ajlm-2756	127	36	study	study	NOUN
ajlm-2756	127	37	to	to	PART
ajlm-2756	127	38	assess	assess	VERB
ajlm-2756	127	39	progress	progress	NOUN
ajlm-2756	127	40	towards	towards	ADP
ajlm-2756	127	41	unaids	unaid	NOUN
ajlm-2756	127	42	indicators	indicator	NOUN
ajlm-2756	127	43	and	and	CCONJ
ajlm-2756	127	44	implications	implication	NOUN
ajlm-2756	127	45	for	for	ADP
ajlm-2756	127	46	hiv	hiv	PROPN
ajlm-2756	127	47	epidemic	epidemic	NOUN
ajlm-2756	127	48	control	control	PROPN
ajlm-2756	127	49	.	.	PUNCT
ajlm-2756	128	1	reprod	reprod	PROPN
ajlm-2756	128	2	health	health	PROPN
ajlm-2756	128	3	.	.	PUNCT
ajlm-2756	129	1	2022;19(1):116	2022;19(1):116	PROPN
ajlm-2756	129	2	.	.	PUNCT
ajlm-2756	130	1	https://doi.org/10.1186/s12978-022-01419-5	https://doi.org/10.1186/s12978-022-01419-5	PROPN
ajlm-2756	130	2	lv	lv	PROPN
ajlm-2756	130	3	t	t	PROPN
ajlm-2756	130	4	,	,	PUNCT
ajlm-2756	130	5	cao	cao	PROPN
ajlm-2756	130	6	w	w	PROPN
ajlm-2756	130	7	,	,	PUNCT
ajlm-2756	130	8	li	li	PROPN
ajlm-2756	130	9	t.	t.	PROPN
ajlm-2756	130	10	hiv	hiv	PROPN
ajlm-2756	130	11	-	-	PUNCT
ajlm-2756	130	12	related	relate	VERB
ajlm-2756	130	13	immune	immune	ADJ
ajlm-2756	130	14	activation	activation	NOUN
ajlm-2756	130	15	and	and	CCONJ
ajlm-2756	130	16	inflammation	inflammation	NOUN
ajlm-2756	130	17	:	:	PUNCT
ajlm-2756	130	18	current	current	ADJ
ajlm-2756	130	19	understanding	understanding	NOUN
ajlm-2756	130	20	and	and	CCONJ
ajlm-2756	130	21	strategies	strategy	NOUN
ajlm-2756	130	22	.	.	PUNCT
ajlm-2756	131	1	j	j	PROPN
ajlm-2756	131	2	immunol	immunol	NOUN
ajlm-2756	131	3	res	re	NOUN
ajlm-2756	131	4	.	.	PUNCT
ajlm-2756	132	1	2021;2021(1):7316456	2021;2021(1):7316456	PROPN
ajlm-2756	132	2	.	.	PUNCT
ajlm-2756	133	1	https://doi.org/10.1155/2021/7316456	https://doi.org/10.1155/2021/7316456	PROPN
ajlm-2756	133	2	guerville	guerville	NOUN
ajlm-2756	133	3	f	f	NOUN
ajlm-2756	133	4	,	,	PUNCT
ajlm-2756	133	5	vialemaringe	vialemaringe	NOUN
ajlm-2756	133	6	m	m	PROPN
ajlm-2756	133	7	,	,	PUNCT
ajlm-2756	133	8	cognet	cognet	PROPN
ajlm-2756	133	9	c	c	PROPN
ajlm-2756	133	10	,	,	PUNCT
ajlm-2756	133	11	et	et	PROPN
ajlm-2756	133	12	al	al	PROPN
ajlm-2756	133	13	.	.	PROPN
ajlm-2756	133	14	mechanisms	mechanism	NOUN
ajlm-2756	133	15	of	of	ADP
ajlm-2756	133	16	systemic	systemic	ADJ
ajlm-2756	133	17	low	low	ADJ
ajlm-2756	133	18	-	-	PUNCT
ajlm-2756	133	19	grade	grade	NOUN
ajlm-2756	133	20	inflammation	inflammation	NOUN
ajlm-2756	133	21	in	in	ADP
ajlm-2756	133	22	hiv	hiv	PROPN
ajlm-2756	133	23	patients	patient	NOUN
ajlm-2756	133	24	on	on	ADP
ajlm-2756	133	25	long	long	ADJ
ajlm-2756	133	26	-	-	PUNCT
ajlm-2756	133	27	term	term	NOUN
ajlm-2756	133	28	suppressive	suppressive	ADJ
ajlm-2756	133	29	antiretroviral	antiretroviral	ADJ
ajlm-2756	133	30	therapy	therapy	NOUN
ajlm-2756	133	31	:	:	PUNCT
ajlm-2756	133	32	the	the	DET
ajlm-2756	133	33	inflammasome	inflammasome	NOUN
ajlm-2756	133	34	hypothesis	hypothesis	NOUN
ajlm-2756	133	35	.	.	PUNCT
ajlm-2756	134	1	aids	aids	PROPN
ajlm-2756	134	2	.	.	PUNCT
ajlm-2756	135	1	2023;37(7):1035–1046	2023;37(7):1035–1046	ADJ
ajlm-2756	135	2	.	.	PUNCT
ajlm-2756	136	1	https://doi.org/10.1097/qad.0000000000003546	https://doi.org/10.1097/qad.0000000000003546	PROPN
ajlm-2756	136	2	ashuro	ashuro	NOUN
ajlm-2756	136	3	aa	aa	PROPN
ajlm-2756	136	4	,	,	PUNCT
ajlm-2756	136	5	fan	fan	PROPN
ajlm-2756	136	6	yg	yg	PROPN
ajlm-2756	136	7	,	,	PUNCT
ajlm-2756	136	8	fu	fu	PROPN
ajlm-2756	136	9	ys	ys	PROPN
ajlm-2756	136	10	,	,	PUNCT
ajlm-2756	136	11	et	et	PROPN
ajlm-2756	136	12	al	al	PROPN
ajlm-2756	136	13	.	.	PUNCT
ajlm-2756	137	1	the	the	DET
ajlm-2756	137	2	effect	effect	NOUN
ajlm-2756	137	3	of	of	ADP
ajlm-2756	137	4	rosuvastatin	rosuvastatin	NOUN
ajlm-2756	137	5	on	on	ADP
ajlm-2756	137	6	plasma	plasma	NOUN
ajlm-2756	137	7	/	/	SYM
ajlm-2756	137	8	serum	serum	NOUN
ajlm-2756	137	9	levels	level	NOUN
ajlm-2756	137	10	of	of	ADP
ajlm-2756	137	11	high	high	ADJ
ajlm-2756	137	12	-	-	PUNCT
ajlm-2756	137	13	sensitivity	sensitivity	NOUN
ajlm-2756	137	14	c	c	NOUN
ajlm-2756	137	15	-	-	PUNCT
ajlm-2756	137	16	reactive	reactive	ADJ
ajlm-2756	137	17	protein	protein	NOUN
ajlm-2756	137	18	,	,	PUNCT
ajlm-2756	137	19	interleukin-6	interleukin-6	PROPN
ajlm-2756	137	20	,	,	PUNCT
ajlm-2756	137	21	and	and	CCONJ
ajlm-2756	137	22	d	d	X
ajlm-2756	137	23	-	-	PUNCT
ajlm-2756	137	24	dimer	dimer	NOUN
ajlm-2756	137	25	in	in	ADP
ajlm-2756	137	26	people	people	NOUN
ajlm-2756	137	27	living	live	VERB
ajlm-2756	137	28	with	with	ADP
ajlm-2756	137	29	human	human	ADJ
ajlm-2756	137	30	immunodeficiency	immunodeficiency	NOUN
ajlm-2756	137	31	virus	virus	NOUN
ajlm-2756	137	32	:	:	PUNCT
ajlm-2756	137	33	a	a	DET
ajlm-2756	137	34	systematic	systematic	ADJ
ajlm-2756	137	35	review	review	NOUN
ajlm-2756	137	36	and	and	CCONJ
ajlm-2756	137	37	meta	meta	ADJ
ajlm-2756	137	38	-	-	PUNCT
ajlm-2756	137	39	analysis	analysis	NOUN
ajlm-2756	137	40	.	.	PUNCT
ajlm-2756	138	1	aids	aids	PROPN
ajlm-2756	138	2	res	re	NOUN
ajlm-2756	138	3	hum	hum	ADJ
ajlm-2756	138	4	retroviruses	retrovirus	NOUN
ajlm-2756	138	5	.	.	PUNCT
ajlm-2756	139	1	2021;37(11):821–833	2021;37(11):821–833	NUM
ajlm-2756	139	2	.	.	PUNCT
ajlm-2756	139	3	https://doi.org/10.1089/aid.2020.0273	https://doi.org/10.1089/aid.2020.0273	PROPN
ajlm-2756	139	4	ou	ou	PROPN
ajlm-2756	139	5	-	-	PUNCT
ajlm-2756	139	6	yang	yang	PROPN
ajlm-2756	139	7	h	h	PROPN
ajlm-2756	139	8	,	,	PUNCT
ajlm-2756	139	9	fu	fu	PROPN
ajlm-2756	139	10	hy	hy	PROPN
ajlm-2756	139	11	,	,	PUNCT
ajlm-2756	139	12	luo	luo	PROPN
ajlm-2756	139	13	y	y	PROPN
ajlm-2756	139	14	,	,	PUNCT
ajlm-2756	139	15	et	et	PROPN
ajlm-2756	139	16	al	al	PROPN
ajlm-2756	139	17	.	.	PUNCT
ajlm-2756	140	1	inflammation	inflammation	NOUN
ajlm-2756	140	2	markers	marker	NOUN
ajlm-2756	140	3	and	and	CCONJ
ajlm-2756	140	4	the	the	DET
ajlm-2756	140	5	risk	risk	NOUN
ajlm-2756	140	6	of	of	ADP
ajlm-2756	140	7	hypertension	hypertension	NOUN
ajlm-2756	140	8	in	in	ADP
ajlm-2756	140	9	people	people	NOUN
ajlm-2756	140	10	living	live	VERB
ajlm-2756	140	11	with	with	ADP
ajlm-2756	140	12	hiv	hiv	PROPN
ajlm-2756	140	13	.	.	PUNCT
ajlm-2756	141	1	front	front	ADJ
ajlm-2756	141	2	immunol	immunol	NOUN
ajlm-2756	141	3	.	.	PUNCT
ajlm-2756	142	1	2023;14:1133640	2023;14:1133640	NUM
ajlm-2756	142	2	.	.	PUNCT
ajlm-2756	143	1	https://doi.org/10.3389/fimmu.2023.1133640	https://doi.org/10.3389/fimmu.2023.1133640	PROPN
ajlm-2756	143	2	stewart	stewart	PROPN
ajlm-2756	143	3	sl	sl	PROPN
ajlm-2756	143	4	,	,	PUNCT
ajlm-2756	143	5	savenkov	savenkov	PROPN
ajlm-2756	143	6	o	o	PROPN
ajlm-2756	143	7	,	,	PUNCT
ajlm-2756	143	8	hurd	hurd	PROPN
ajlm-2756	143	9	ma	ma	PROPN
ajlm-2756	143	10	,	,	PUNCT
ajlm-2756	143	11	et	et	PROPN
ajlm-2756	143	12	al	al	PROPN
ajlm-2756	143	13	.	.	PUNCT
ajlm-2756	144	1	genetic	genetic	ADJ
ajlm-2756	144	2	and	and	CCONJ
ajlm-2756	144	3	metabolic	metabolic	NOUN
ajlm-2756	144	4	determinants	determinant	NOUN
ajlm-2756	144	5	of	of	ADP
ajlm-2756	144	6	lipoprotein	lipoprotein	ADJ
ajlm-2756	144	7	(	(	PUNCT
ajlm-2756	144	8	a	a	NOUN
ajlm-2756	144	9	)	)	PUNCT
ajlm-2756	144	10	.	.	PUNCT
ajlm-2756	145	1	j	j	PROPN
ajlm-2756	145	2	clin	clin	PROPN
ajlm-2756	145	3	lipidol	lipidol	VERB
ajlm-2756	145	4	.	.	PUNCT
ajlm-2756	146	1	2023;17(4):e5	2023;17(4):e5	NUM
ajlm-2756	146	2	–	–	PUNCT
ajlm-2756	146	3	e6	e6	NOUN
ajlm-2756	146	4	.	.	PUNCT
ajlm-2756	147	1	https://doi.org/10.1016/j.jacl.2023.05.009	https://doi.org/10.1016/j.jacl.2023.05.009	NUM
ajlm-2756	147	2	zhang	zhang	PROPN
ajlm-2756	148	1	p	p	X
ajlm-2756	148	2	,	,	PUNCT
ajlm-2756	148	3	wang	wang	PROPN
ajlm-2756	148	4	c	c	PROPN
ajlm-2756	148	5	,	,	PUNCT
ajlm-2756	148	6	wu	wu	PROPN
ajlm-2756	148	7	j	j	PROPN
ajlm-2756	148	8	,	,	PUNCT
ajlm-2756	148	9	zhang	zhang	PROPN
ajlm-2756	148	10	s.	s.	PROPN
ajlm-2756	148	11	a	a	DET
ajlm-2756	148	12	systematic	systematic	ADJ
ajlm-2756	148	13	review	review	NOUN
ajlm-2756	148	14	of	of	ADP
ajlm-2756	148	15	the	the	DET
ajlm-2756	148	16	predictive	predictive	ADJ
ajlm-2756	148	17	value	value	NOUN
ajlm-2756	148	18	of	of	ADP
ajlm-2756	148	19	plasma	plasma	NOUN
ajlm-2756	148	20	d	d	NOUN
ajlm-2756	148	21	-	-	PUNCT
ajlm-2756	148	22	dimer	dimer	ADJ
ajlm-2756	148	23	levels	level	NOUN
ajlm-2756	148	24	for	for	ADP
ajlm-2756	148	25	predicting	predict	VERB
ajlm-2756	148	26	stroke	stroke	NOUN
ajlm-2756	148	27	outcome	outcome	NOUN
ajlm-2756	148	28	.	.	PUNCT
ajlm-2756	149	1	front	front	ADJ
ajlm-2756	149	2	neurol	neurol	NOUN
ajlm-2756	149	3	.	.	PUNCT
ajlm-2756	150	1	2021;12:693524	2021;12:693524	NUM
ajlm-2756	150	2	.	.	PUNCT
ajlm-2756	151	1	https://doi.org/10.3389/fneur.2021.693524	https://doi.org/10.3389/fneur.2021.693524	PROPN
ajlm-2756	151	2	bourgeois	bourgeois	ADJ
ajlm-2756	151	3	c	c	NOUN
ajlm-2756	151	4	,	,	PUNCT
ajlm-2756	151	5	gorwood	gorwood	PROPN
ajlm-2756	151	6	j	j	PROPN
ajlm-2756	151	7	,	,	PUNCT
ajlm-2756	151	8	olivo	olivo	NOUN
ajlm-2756	151	9	a	a	PRON
ajlm-2756	151	10	,	,	PUNCT
ajlm-2756	151	11	et	et	PROPN
ajlm-2756	151	12	al	al	PROPN
ajlm-2756	151	13	.	.	PROPN
ajlm-2756	151	14	contribution	contribution	NOUN
ajlm-2756	151	15	of	of	ADP
ajlm-2756	151	16	adipose	adipose	ADJ
ajlm-2756	151	17	tissue	tissue	NOUN
ajlm-2756	151	18	to	to	ADP
ajlm-2756	151	19	the	the	DET
ajlm-2756	151	20	chronic	chronic	ADJ
ajlm-2756	151	21	immune	immune	ADJ
ajlm-2756	151	22	activation	activation	NOUN
ajlm-2756	151	23	and	and	CCONJ
ajlm-2756	151	24	inflammation	inflammation	NOUN
ajlm-2756	151	25	associated	associate	VERB
ajlm-2756	151	26	with	with	ADP
ajlm-2756	151	27	hiv	hiv	PROPN
ajlm-2756	151	28	infection	infection	NOUN
ajlm-2756	151	29	and	and	CCONJ
ajlm-2756	151	30	its	its	PRON
ajlm-2756	151	31	treatment	treatment	NOUN
ajlm-2756	151	32	.	.	PUNCT
ajlm-2756	152	1	front	front	ADJ
ajlm-2756	152	2	immunol	immunol	NOUN
ajlm-2756	152	3	.	.	PUNCT
ajlm-2756	153	1	2021;12:670566	2021;12:670566	NUM
ajlm-2756	153	2	.	.	PUNCT
ajlm-2756	154	1	https://doi.org/10.3389/fimmu.2021.670566	https://doi.org/10.3389/fimmu.2021.670566	PROPN
ajlm-2756	154	2	punyawudho	punyawudho	NOUN
ajlm-2756	154	3	b	b	PROPN
ajlm-2756	154	4	,	,	PUNCT
ajlm-2756	154	5	singkham	singkham	NOUN
ajlm-2756	154	6	n	n	CCONJ
ajlm-2756	154	7	,	,	PUNCT
ajlm-2756	154	8	thammajaruk	thammajaruk	NOUN
ajlm-2756	154	9	n	n	CCONJ
ajlm-2756	154	10	,	,	PUNCT
ajlm-2756	154	11	et	et	PROPN
ajlm-2756	154	12	al	al	PROPN
ajlm-2756	154	13	.	.	PUNCT
ajlm-2756	155	1	therapeutic	therapeutic	ADJ
ajlm-2756	155	2	drug	drug	NOUN
ajlm-2756	155	3	monitoring	monitoring	NOUN
ajlm-2756	155	4	of	of	ADP
ajlm-2756	155	5	antiretroviral	antiretroviral	ADJ
ajlm-2756	155	6	drugs	drug	NOUN
ajlm-2756	155	7	in	in	ADP
ajlm-2756	155	8	hiv	hiv	PROPN
ajlm-2756	155	9	-	-	PUNCT
ajlm-2756	155	10	infected	infect	VERB
ajlm-2756	155	11	patients	patient	NOUN
ajlm-2756	155	12	.	.	PUNCT
ajlm-2756	156	1	expert	expert	NOUN
ajlm-2756	156	2	rev	rev	PROPN
ajlm-2756	156	3	clin	clin	PROPN
ajlm-2756	156	4	pharmacol	pharmacol	PROPN
ajlm-2756	156	5	.	.	PUNCT
ajlm-2756	157	1	2016;9(12):1583–1595	2016;9(12):1583–1595	PROPN
ajlm-2756	157	2	.	.	PUNCT
ajlm-2756	158	1	https://doi.org/10.1080/17512433.2016.1235972	https://doi.org/10.1080/17512433.2016.1235972	PROPN
ajlm-2756	158	2	temu	temu	PROPN
ajlm-2756	158	3	tm	tm	PROPN
ajlm-2756	158	4	,	,	PUNCT
ajlm-2756	158	5	zifodya	zifodya	PROPN
ajlm-2756	158	6	js	js	PROPN
ajlm-2756	158	7	,	,	PUNCT
ajlm-2756	158	8	polyak	polyak	NOUN
ajlm-2756	158	9	sj	sj	PROPN
ajlm-2756	158	10	,	,	PUNCT
ajlm-2756	158	11	et	et	PROPN
ajlm-2756	158	12	al	al	PROPN
ajlm-2756	158	13	.	.	PROPN
ajlm-2756	159	1	antiretroviral	antiretroviral	ADJ
ajlm-2756	159	2	therapy	therapy	NOUN
ajlm-2756	159	3	reduces	reduce	VERB
ajlm-2756	159	4	but	but	CCONJ
ajlm-2756	159	5	does	do	AUX
ajlm-2756	159	6	not	not	PART
ajlm-2756	159	7	normalize	normalize	VERB
ajlm-2756	159	8	immune	immune	ADJ
ajlm-2756	159	9	and	and	CCONJ
ajlm-2756	159	10	vascular	vascular	ADJ
ajlm-2756	159	11	inflammatory	inflammatory	ADJ
ajlm-2756	159	12	markers	marker	NOUN
ajlm-2756	159	13	in	in	ADP
ajlm-2756	159	14	adults	adult	NOUN
ajlm-2756	159	15	with	with	ADP
ajlm-2756	159	16	chronic	chronic	ADJ
ajlm-2756	159	17	hiv	hiv	PROPN
ajlm-2756	159	18	infection	infection	NOUN
ajlm-2756	159	19	in	in	ADP
ajlm-2756	159	20	kenya	kenya	PROPN
ajlm-2756	159	21	.	.	PUNCT
ajlm-2756	160	1	aids	aids	PROPN
ajlm-2756	160	2	.	.	PUNCT
ajlm-2756	161	1	2021;35(1):45–51	2021;35(1):45–51	X
ajlm-2756	161	2	.	.	PUNCT
ajlm-2756	162	1	https://doi.org/10.1097/qad.0000000000002729	https://doi.org/10.1097/qad.0000000000002729	VERB
ajlm-2756	162	2	masyuko	masyuko	PROPN
ajlm-2756	162	3	sj	sj	PROPN
ajlm-2756	162	4	,	,	PUNCT
ajlm-2756	162	5	page	page	NOUN
ajlm-2756	162	6	st	st	PROPN
ajlm-2756	162	7	,	,	PUNCT
ajlm-2756	162	8	polyak	polyak	NOUN
ajlm-2756	162	9	sj	sj	PROPN
ajlm-2756	162	10	,	,	PUNCT
ajlm-2756	162	11	et	et	PROPN
ajlm-2756	162	12	al	al	PROPN
ajlm-2756	162	13	.	.	PUNCT
ajlm-2756	163	1	human	human	ADJ
ajlm-2756	163	2	immunodeficiency	immunodeficiency	NOUN
ajlm-2756	163	3	virus	virus	NOUN
ajlm-2756	163	4	is	be	AUX
ajlm-2756	163	5	associated	associate	VERB
ajlm-2756	163	6	with	with	ADP
ajlm-2756	163	7	higher	high	ADJ
ajlm-2756	163	8	levels	level	NOUN
ajlm-2756	163	9	of	of	ADP
ajlm-2756	163	10	systemic	systemic	ADJ
ajlm-2756	163	11	inflammation	inflammation	NOUN
ajlm-2756	163	12	among	among	ADP
ajlm-2756	163	13	kenyan	kenyan	ADJ
ajlm-2756	163	14	adults	adult	NOUN
ajlm-2756	163	15	despite	despite	SCONJ
ajlm-2756	163	16	viral	viral	ADJ
ajlm-2756	163	17	suppression	suppression	NOUN
ajlm-2756	163	18	.	.	PUNCT
ajlm-2756	164	1	clin	clin	PROPN
ajlm-2756	164	2	infect	infect	PROPN
ajlm-2756	164	3	dis	dis	PROPN
ajlm-2756	164	4	.	.	PUNCT
ajlm-2756	165	1	2021;73(7):e2034	2021;73(7):e2034	NUM
ajlm-2756	165	2	–	–	PUNCT
ajlm-2756	165	3	e2042	e2042	NOUN
ajlm-2756	165	4	.	.	PUNCT
ajlm-2756	166	1	https://doi.org/10.1093/cid/ciaa1650	https://doi.org/10.1093/cid/ciaa1650	PROPN
ajlm-2756	166	2	castillo	castillo	PROPN
ajlm-2756	166	3	-	-	PUNCT
ajlm-2756	166	4	mancilla	mancilla	PROPN
ajlm-2756	166	5	jr	jr	PROPN
ajlm-2756	166	6	,	,	PUNCT
ajlm-2756	166	7	brown	brown	PROPN
ajlm-2756	166	8	tt	tt	PROPN
ajlm-2756	166	9	,	,	PUNCT
ajlm-2756	166	10	erlandson	erlandson	PROPN
ajlm-2756	166	11	km	km	PROPN
ajlm-2756	166	12	,	,	PUNCT
ajlm-2756	166	13	et	et	PROPN
ajlm-2756	166	14	al	al	PROPN
ajlm-2756	166	15	.	.	PUNCT
ajlm-2756	167	1	suboptimal	suboptimal	ADJ
ajlm-2756	167	2	adherence	adherence	NOUN
ajlm-2756	167	3	to	to	ADP
ajlm-2756	167	4	combination	combination	NOUN
ajlm-2756	167	5	antiretroviral	antiretroviral	ADJ
ajlm-2756	167	6	therapy	therapy	NOUN
ajlm-2756	167	7	is	be	AUX
ajlm-2756	167	8	associated	associate	VERB
ajlm-2756	167	9	with	with	ADP
ajlm-2756	167	10	higher	high	ADJ
ajlm-2756	167	11	levels	level	NOUN
ajlm-2756	167	12	of	of	ADP
ajlm-2756	167	13	inflammation	inflammation	NOUN
ajlm-2756	167	14	despite	despite	SCONJ
ajlm-2756	167	15	hiv	hiv	PROPN
ajlm-2756	167	16	suppression	suppression	NOUN
ajlm-2756	167	17	.	.	PUNCT
ajlm-2756	168	1	clin	clin	PROPN
ajlm-2756	168	2	infect	infect	PROPN
ajlm-2756	168	3	dis	dis	PROPN
ajlm-2756	168	4	.	.	PUNCT
ajlm-2756	169	1	2016;63(12):1661–1667	2016;63(12):1661–1667	NUM
ajlm-2756	169	2	.	.	PUNCT
ajlm-2756	170	1	https://doi.org/10.1093/cid/ciw650	https://doi.org/10.1093/cid/ciw650	PROPN
ajlm-2756	170	2	mabhida	mabhida	PROPN
ajlm-2756	170	3	se	se	X
ajlm-2756	170	4	,	,	PUNCT
ajlm-2756	170	5	mchiza	mchiza	PROPN
ajlm-2756	170	6	zj	zj	PROPN
ajlm-2756	170	7	,	,	PUNCT
ajlm-2756	170	8	mokgalaboni	mokgalaboni	PROPN
ajlm-2756	170	9	k	k	PROPN
ajlm-2756	170	10	,	,	PUNCT
ajlm-2756	170	11	hanser	hanser	NOUN
ajlm-2756	170	12	s	s	PROPN
ajlm-2756	170	13	,	,	PUNCT
ajlm-2756	170	14	choshi	choshi	PROPN
ajlm-2756	170	15	j	j	PROPN
ajlm-2756	170	16	,	,	PUNCT
ajlm-2756	170	17	mokoena	mokoena	PROPN
ajlm-2756	170	18	h.	h.	PROPN
ajlm-2756	170	19	high	high	ADJ
ajlm-2756	170	20	-	-	PUNCT
ajlm-2756	170	21	sensitivity	sensitivity	NOUN
ajlm-2756	170	22	c	c	NOUN
ajlm-2756	170	23	-	-	PUNCT
ajlm-2756	170	24	reactive	reactive	ADJ
ajlm-2756	170	25	protein	protein	NOUN
ajlm-2756	170	26	among	among	ADP
ajlm-2756	170	27	people	people	NOUN
ajlm-2756	170	28	living	live	VERB
ajlm-2756	170	29	with	with	ADP
ajlm-2756	170	30	hiv	hiv	PROPN
ajlm-2756	170	31	on	on	ADP
ajlm-2756	170	32	highly	highly	ADV
ajlm-2756	170	33	active	active	ADJ
ajlm-2756	170	34	antiretroviral	antiretroviral	ADJ
ajlm-2756	170	35	therapy	therapy	NOUN
ajlm-2756	170	36	:	:	PUNCT
ajlm-2756	170	37	a	a	DET
ajlm-2756	170	38	systemic	systemic	ADJ
ajlm-2756	170	39	review	review	NOUN
ajlm-2756	170	40	and	and	CCONJ
ajlm-2756	170	41	meta	meta	ADJ
ajlm-2756	170	42	-	-	PUNCT
ajlm-2756	170	43	analysis	analysis	NOUN
ajlm-2756	170	44	.	.	PUNCT
ajlm-2756	171	1	bmc	bmc	PROPN
ajlm-2756	171	2	infect	infect	PROPN
ajlm-2756	171	3	dis	dis	PROPN
ajlm-2756	171	4	.	.	PUNCT
ajlm-2756	172	1	2024;24(1):160	2024;24(1):160	NUM
ajlm-2756	172	2	.	.	PUNCT
ajlm-2756	173	1	https://doi.org/10.1186/s12879-024-09050-4	https://doi.org/10.1186/s12879-024-09050-4	PROPN
ajlm-2756	173	2	zhu	zhu	PROPN
ajlm-2756	173	3	b	b	PROPN
ajlm-2756	173	4	,	,	PUNCT
ajlm-2756	173	5	chen	chen	PROPN
ajlm-2756	173	6	x	x	PROPN
ajlm-2756	173	7	,	,	PUNCT
ajlm-2756	173	8	shen	shen	PROPN
ajlm-2756	173	9	w	w	PROPN
ajlm-2756	173	10	,	,	PUNCT
ajlm-2756	173	11	ding	de	VERB
ajlm-2756	173	12	y	y	PROPN
ajlm-2756	173	13	,	,	PUNCT
ajlm-2756	173	14	lin	lin	PROPN
ajlm-2756	173	15	h	h	PROPN
ajlm-2756	173	16	,	,	PUNCT
ajlm-2756	173	17	he	he	PRON
ajlm-2756	173	18	n.	n.	PROPN
ajlm-2756	173	19	association	association	PROPN
ajlm-2756	173	20	between	between	ADP
ajlm-2756	173	21	inflammation	inflammation	NOUN
ajlm-2756	173	22	and	and	CCONJ
ajlm-2756	173	23	coagulation	coagulation	NOUN
ajlm-2756	173	24	biomarkers	biomarker	NOUN
ajlm-2756	173	25	and	and	CCONJ
ajlm-2756	173	26	carotid	carotid	NOUN
ajlm-2756	173	27	atherosclerosis	atherosclerosis	NOUN
ajlm-2756	173	28	among	among	ADP
ajlm-2756	173	29	treated	treat	VERB
ajlm-2756	173	30	people	people	NOUN
ajlm-2756	173	31	with	with	ADP
ajlm-2756	173	32	human	human	ADJ
ajlm-2756	173	33	immunodeficiency	immunodeficiency	NOUN
ajlm-2756	173	34	virus	virus	NOUN
ajlm-2756	173	35	.	.	PUNCT
ajlm-2756	174	1	open	open	ADJ
ajlm-2756	174	2	forum	forum	PROPN
ajlm-2756	174	3	infect	infect	VERB
ajlm-2756	174	4	dis	dis	PROPN
ajlm-2756	174	5	.	.	PUNCT
ajlm-2756	175	1	2022;9(7):ofac208	2022;9(7):ofac208	NUM
ajlm-2756	175	2	.	.	PUNCT
ajlm-2756	176	1	https://doi.org/10.1093/ofid/ofac208	https://doi.org/10.1093/ofid/ofac208	VERB
ajlm-2756	176	2	de	de	X
ajlm-2756	176	3	armas	armas	PROPN
ajlm-2756	176	4	lr	lr	PROPN
ajlm-2756	176	5	,	,	PUNCT
ajlm-2756	176	6	pallikkuth	pallikkuth	PROPN
ajlm-2756	176	7	s	s	PART
ajlm-2756	176	8	,	,	PUNCT
ajlm-2756	176	9	george	george	PROPN
ajlm-2756	176	10	v	v	PROPN
ajlm-2756	176	11	,	,	PUNCT
ajlm-2756	176	12	et	et	PROPN
ajlm-2756	176	13	al	al	PROPN
ajlm-2756	176	14	.	.	PROPN
ajlm-2756	176	15	re	re	PROPN
ajlm-2756	176	16	-	-	NOUN
ajlm-2756	176	17	evaluation	evaluation	NOUN
ajlm-2756	176	18	of	of	ADP
ajlm-2756	176	19	immune	immune	ADJ
ajlm-2756	176	20	activation	activation	NOUN
ajlm-2756	176	21	in	in	ADP
ajlm-2756	176	22	the	the	DET
ajlm-2756	176	23	era	era	NOUN
ajlm-2756	176	24	of	of	ADP
ajlm-2756	176	25	cart	cart	NOUN
ajlm-2756	176	26	and	and	CCONJ
ajlm-2756	176	27	an	an	DET
ajlm-2756	176	28	aging	age	VERB
ajlm-2756	176	29	hiv	hiv	NOUN
ajlm-2756	176	30	-	-	PUNCT
ajlm-2756	176	31	infected	infect	VERB
ajlm-2756	176	32	population	population	NOUN
ajlm-2756	176	33	.	.	PUNCT
ajlm-2756	177	1	jci	jci	PROPN
ajlm-2756	177	2	insight	insight	PROPN
ajlm-2756	177	3	.	.	PUNCT
ajlm-2756	178	1	2017;2(20):e95726	2017;2(20):e95726	X
ajlm-2756	178	2	.	.	PUNCT
ajlm-2756	178	3	https://doi.org/10.1172/jci.insight.95726	https://doi.org/10.1172/jci.insight.95726	PROPN
ajlm-2756	178	4	peterson	peterson	PROPN
ajlm-2756	178	5	te	te	PROPN
ajlm-2756	178	6	,	,	PUNCT
ajlm-2756	178	7	baker	baker	PROPN
ajlm-2756	178	8	jv	jv	PROPN
ajlm-2756	178	9	.	.	PUNCT
ajlm-2756	179	1	assessing	assess	VERB
ajlm-2756	179	2	inflammation	inflammation	NOUN
ajlm-2756	179	3	and	and	CCONJ
ajlm-2756	179	4	its	its	PRON
ajlm-2756	179	5	role	role	NOUN
ajlm-2756	179	6	in	in	ADP
ajlm-2756	179	7	comorbidities	comorbiditie	NOUN
ajlm-2756	179	8	among	among	ADP
ajlm-2756	179	9	persons	person	NOUN
ajlm-2756	179	10	living	live	VERB
ajlm-2756	179	11	with	with	ADP
ajlm-2756	179	12	hiv	hiv	PROPN
ajlm-2756	179	13	.	.	PUNCT
ajlm-2756	180	1	curr	curr	PROPN
ajlm-2756	180	2	opin	opin	PROPN
ajlm-2756	180	3	infect	infect	PROPN
ajlm-2756	180	4	dis	dis	PROPN
ajlm-2756	180	5	.	.	PUNCT
ajlm-2756	181	1	2019;32(1):8–15	2019;32(1):8–15	X
ajlm-2756	181	2	.	.	PUNCT
ajlm-2756	182	1	https://doi.org/10.1097/qco.0000000000000510	https://doi.org/10.1097/qco.0000000000000510	PROPN
ajlm-2756	182	2	baker	baker	PROPN
ajlm-2756	182	3	j	j	PROPN
ajlm-2756	182	4	,	,	PUNCT
ajlm-2756	182	5	ayenew	ayenew	VERB
ajlm-2756	182	6	w	w	ADP
ajlm-2756	182	7	,	,	PUNCT
ajlm-2756	182	8	quick	quick	ADJ
ajlm-2756	182	9	h	h	NOUN
ajlm-2756	182	10	,	,	PUNCT
ajlm-2756	182	11	et	et	PROPN
ajlm-2756	182	12	al	al	PROPN
ajlm-2756	182	13	.	.	PROPN
ajlm-2756	182	14	high	high	ADJ
ajlm-2756	182	15	-	-	PUNCT
ajlm-2756	182	16	density	density	NOUN
ajlm-2756	182	17	lipoprotein	lipoprotein	ADJ
ajlm-2756	182	18	particles	particle	NOUN
ajlm-2756	182	19	and	and	CCONJ
ajlm-2756	182	20	markers	marker	NOUN
ajlm-2756	182	21	of	of	ADP
ajlm-2756	182	22	inflammation	inflammation	NOUN
ajlm-2756	182	23	and	and	CCONJ
ajlm-2756	182	24	thrombotic	thrombotic	ADJ
ajlm-2756	182	25	activity	activity	NOUN
ajlm-2756	182	26	in	in	ADP
ajlm-2756	182	27	patients	patient	NOUN
ajlm-2756	182	28	with	with	ADP
ajlm-2756	182	29	untreated	untreated	ADJ
ajlm-2756	182	30	hiv	hiv	PROPN
ajlm-2756	182	31	infection	infection	NOUN
ajlm-2756	182	32	.	.	PUNCT
ajlm-2756	183	1	j	j	PROPN
ajlm-2756	183	2	infect	infect	VERB
ajlm-2756	183	3	dis	dis	PROPN
ajlm-2756	183	4	.	.	PUNCT
ajlm-2756	184	1	2010;201(2):285–292	2010;201(2):285–292	X
ajlm-2756	184	2	.	.	PUNCT
ajlm-2756	185	1	https://doi.org/10.1086/649560	https://doi.org/10.1086/649560	PROPN
ajlm-2756	186	1	nixon	nixon	PROPN
ajlm-2756	186	2	de	de	PROPN
ajlm-2756	186	3	,	,	PUNCT
ajlm-2756	186	4	landay	landay	PROPN
ajlm-2756	186	5	al	al	PROPN
ajlm-2756	186	6	.	.	PUNCT
ajlm-2756	186	7	biomarkers	biomarker	NOUN
ajlm-2756	186	8	of	of	ADP
ajlm-2756	186	9	immune	immune	ADJ
ajlm-2756	186	10	dysfunction	dysfunction	NOUN
ajlm-2756	186	11	in	in	ADP
ajlm-2756	186	12	hiv	hiv	PROPN
ajlm-2756	186	13	.	.	PUNCT
ajlm-2756	187	1	curr	curr	PROPN
ajlm-2756	187	2	opin	opin	PROPN
ajlm-2756	187	3	hiv	hiv	PROPN
ajlm-2756	187	4	aids	aids	PROPN
ajlm-2756	187	5	.	.	PUNCT
ajlm-2756	188	1	2010;5(6):498–503	2010;5(6):498–503	X
ajlm-2756	188	2	.	.	PUNCT
ajlm-2756	189	1	https://doi.org/10.1097/coh.0b013e32833ed6f4	https://doi.org/10.1097/coh.0b013e32833ed6f4	PROPN
ajlm-2756	189	2	borges	borge	VERB
ajlm-2756	189	3	ah	ah	INTJ
ajlm-2756	189	4	,	,	PUNCT
ajlm-2756	189	5	o’connor	o’connor	ADV
ajlm-2756	189	6	jl	jl	PROPN
ajlm-2756	189	7	,	,	PUNCT
ajlm-2756	189	8	phillips	phillips	PROPN
ajlm-2756	189	9	an	an	PROPN
ajlm-2756	189	10	,	,	PUNCT
ajlm-2756	189	11	et	et	PROPN
ajlm-2756	189	12	al	al	PROPN
ajlm-2756	189	13	.	.	PROPN
ajlm-2756	190	1	insight	insight	PROPN
ajlm-2756	190	2	smart	smart	ADJ
ajlm-2756	190	3	and	and	CCONJ
ajlm-2756	190	4	esprit	esprit	NOUN
ajlm-2756	190	5	study	study	NOUN
ajlm-2756	190	6	groups	group	NOUN
ajlm-2756	190	7	and	and	CCONJ
ajlm-2756	190	8	the	the	DET
ajlm-2756	190	9	silcaat	silcaat	VERB
ajlm-2756	190	10	scientific	scientific	ADJ
ajlm-2756	190	11	committee	committee	NOUN
ajlm-2756	190	12	.	.	PUNCT
ajlm-2756	191	1	factors	factor	NOUN
ajlm-2756	191	2	associated	associate	VERB
ajlm-2756	191	3	with	with	ADP
ajlm-2756	191	4	d	d	ADJ
ajlm-2756	191	5	-	-	PUNCT
ajlm-2756	191	6	dimer	dimer	ADJ
ajlm-2756	191	7	levels	level	NOUN
ajlm-2756	191	8	in	in	ADP
ajlm-2756	191	9	hiv	hiv	PROPN
ajlm-2756	191	10	-	-	PUNCT
ajlm-2756	191	11	infected	infect	VERB
ajlm-2756	191	12	individuals	individual	NOUN
ajlm-2756	191	13	.	.	PUNCT
ajlm-2756	192	1	plos	plos	PROPN
ajlm-2756	192	2	one	one	NUM
ajlm-2756	192	3	.	.	PUNCT
ajlm-2756	193	1	2014;9(3):e90978	2014;9(3):e90978	NUM
ajlm-2756	193	2	.	.	PUNCT
ajlm-2756	194	1	https://doi.org/10.1371/journal.pone.0090978	https://doi.org/10.1371/journal.pone.0090978	PROPN
ajlm-2756	194	2	santinelli	santinelli	PROPN
ajlm-2756	194	3	l	l	PROPN
ajlm-2756	194	4	,	,	PUNCT
ajlm-2756	194	5	ceccarelli	ceccarelli	ADV
ajlm-2756	194	6	g	g	NOUN
ajlm-2756	194	7	,	,	PUNCT
ajlm-2756	194	8	borrazzo	borrazzo	X
ajlm-2756	194	9	c	c	AUX
ajlm-2756	194	10	,	,	PUNCT
ajlm-2756	194	11	et	et	PROPN
ajlm-2756	194	12	al	al	PROPN
ajlm-2756	194	13	.	.	PROPN
ajlm-2756	194	14	sex	sex	NOUN
ajlm-2756	194	15	-	-	PUNCT
ajlm-2756	194	16	related	relate	VERB
ajlm-2756	194	17	differences	difference	NOUN
ajlm-2756	194	18	in	in	ADP
ajlm-2756	194	19	markers	marker	NOUN
ajlm-2756	194	20	of	of	ADP
ajlm-2756	194	21	immune	immune	ADJ
ajlm-2756	194	22	activation	activation	NOUN
ajlm-2756	194	23	in	in	ADP
ajlm-2756	194	24	virologically	virologically	ADV
ajlm-2756	194	25	suppressed	suppress	VERB
ajlm-2756	194	26	hiv	hiv	PROPN
ajlm-2756	194	27	-	-	PUNCT
ajlm-2756	194	28	infected	infect	VERB
ajlm-2756	194	29	patients	patient	NOUN
ajlm-2756	194	30	.	.	PUNCT
ajlm-2756	195	1	biol	biol	PROPN
ajlm-2756	195	2	sex	sex	NOUN
ajlm-2756	195	3	differ	differ	VERB
ajlm-2756	195	4	.	.	PUNCT
ajlm-2756	196	1	2020;11:1–1	2020;11:1–1	NUM
ajlm-2756	196	2	.	.	PUNCT
ajlm-2756	197	1	https://doi.org/10.1186/s13293-020-00302-x	https://doi.org/10.1186/s13293-020-00302-x	NOUN
ajlm-2756	197	2	micieli	micieli	NOUN
ajlm-2756	197	3	e	e	NOUN
ajlm-2756	197	4	,	,	PUNCT
ajlm-2756	197	5	dentali	dentali	VERB
ajlm-2756	197	6	f	f	PROPN
ajlm-2756	197	7	,	,	PUNCT
ajlm-2756	197	8	giola	giola	PROPN
ajlm-2756	197	9	m	m	PROPN
ajlm-2756	197	10	,	,	PUNCT
ajlm-2756	197	11	grossi	grossi	PROPN
ajlm-2756	197	12	p	p	X
ajlm-2756	197	13	,	,	PUNCT
ajlm-2756	197	14	venco	venco	NOUN
ajlm-2756	197	15	a	a	X
ajlm-2756	197	16	,	,	PUNCT
ajlm-2756	197	17	ageno	ageno	NOUN
ajlm-2756	197	18	w.	w.	PROPN
ajlm-2756	197	19	venous	venous	NOUN
ajlm-2756	197	20	and	and	CCONJ
ajlm-2756	197	21	arterial	arterial	ADJ
ajlm-2756	197	22	thrombosis	thrombosis	NOUN
ajlm-2756	197	23	in	in	ADP
ajlm-2756	197	24	patients	patient	NOUN
ajlm-2756	197	25	with	with	ADP
ajlm-2756	197	26	hiv	hiv	PROPN
ajlm-2756	197	27	infection	infection	NOUN
ajlm-2756	197	28	.	.	PUNCT
ajlm-2756	198	1	blood	blood	NOUN
ajlm-2756	198	2	coagulat	coagulat	NOUN
ajlm-2756	198	3	fibrin	fibrin	NOUN
ajlm-2756	198	4	.	.	PUNCT
ajlm-2756	199	1	2007;18(3):259–263	2007;18(3):259–263	X
ajlm-2756	199	2	.	.	PUNCT
ajlm-2756	200	1	https://doi.org/10.1097/mbc.0b013e32808738a3	https://doi.org/10.1097/mbc.0b013e32808738a3	PROPN
ajlm-2756	200	2	deeks	deek	VERB
ajlm-2756	200	3	sg	sg	PROPN
ajlm-2756	200	4	.	.	PROPN
ajlm-2756	200	5	immune	immune	ADJ
ajlm-2756	200	6	dysfunction	dysfunction	NOUN
ajlm-2756	200	7	,	,	PUNCT
ajlm-2756	200	8	inflammation	inflammation	NOUN
ajlm-2756	200	9	,	,	PUNCT
ajlm-2756	200	10	and	and	CCONJ
ajlm-2756	200	11	accelerated	accelerate	VERB
ajlm-2756	200	12	aging	aging	NOUN
ajlm-2756	200	13	in	in	ADP
ajlm-2756	200	14	patients	patient	NOUN
ajlm-2756	200	15	on	on	ADP
ajlm-2756	200	16	antiretroviral	antiretroviral	ADJ
ajlm-2756	200	17	therapy	therapy	NOUN
ajlm-2756	200	18	.	.	PUNCT
ajlm-2756	201	1	top	top	ADJ
ajlm-2756	201	2	hiv	hiv	PROPN
ajlm-2756	201	3	med	me	VERB
ajlm-2756	201	4	.	.	PUNCT
ajlm-2756	202	1	2009;17(4):118–123	2009;17(4):118–123	NUM
ajlm-2756	202	2	.	.	PUNCT
ajlm-2756	202	3	zicari	zicari	PROPN
ajlm-2756	202	4	s	s	PROPN
ajlm-2756	202	5	,	,	PUNCT
ajlm-2756	202	6	sessa	sessa	PROPN
ajlm-2756	202	7	l	l	PROPN
ajlm-2756	202	8	,	,	PUNCT
ajlm-2756	202	9	cotugno	cotugno	NOUN
ajlm-2756	202	10	n	n	CCONJ
ajlm-2756	202	11	,	,	PUNCT
ajlm-2756	202	12	et	et	PROPN
ajlm-2756	202	13	al	al	PROPN
ajlm-2756	202	14	.	.	PROPN
ajlm-2756	202	15	immune	immune	ADJ
ajlm-2756	202	16	activation	activation	NOUN
ajlm-2756	202	17	,	,	PUNCT
ajlm-2756	202	18	inflammation	inflammation	NOUN
ajlm-2756	202	19	,	,	PUNCT
ajlm-2756	202	20	and	and	CCONJ
ajlm-2756	202	21	non	non	ADJ
ajlm-2756	202	22	-	-	ADJ
ajlm-2756	202	23	aids	aids	ADJ
ajlm-2756	202	24	co	co	NOUN
ajlm-2756	202	25	-	-	NOUN
ajlm-2756	202	26	morbidities	morbidity	NOUN
ajlm-2756	202	27	in	in	ADP
ajlm-2756	202	28	hiv	hiv	PROPN
ajlm-2756	202	29	-	-	PUNCT
ajlm-2756	202	30	infected	infect	VERB
ajlm-2756	202	31	patients	patient	NOUN
ajlm-2756	202	32	under	under	ADP
ajlm-2756	202	33	long	long	ADJ
ajlm-2756	202	34	-	-	PUNCT
ajlm-2756	202	35	term	term	NOUN
ajlm-2756	202	36	art	art	NOUN
ajlm-2756	202	37	.	.	PUNCT
ajlm-2756	203	1	viruses	virus	NOUN
ajlm-2756	203	2	.	.	PUNCT
ajlm-2756	204	1	2019;11(3):200	2019;11(3):200	NUM
ajlm-2756	204	2	.	.	PUNCT
ajlm-2756	205	1	https://doi.org/10.3390/v11030200	https://doi.org/10.3390/v11030200	PRON